Meet the speakers
Diana Alecsandru
Current Job: Dr. Diana Alecsandru, MD, PhD is an attending physician at IVI RMA Madrid where she serves as Consultant Clinical Immunologist Physician for Reproductive Immunology. She is Assistant Professor at Complutense University in the Department of Microbiology, Division of Immunology, and Professor of Master Degree in Human Reproduction at Rey Juan Carlos University, Complutense University and European University-Madrid.Spain. She participates as Speaker in The Annual In Vitro Fertilization and Embryo Transfer, UC San Diego School of Medicine.
Education & Training: She received her medical degree from Carol Davila University Medical School Bucharest. Romania. She completed her residency training in Clinical Immunology in San Carlos Hospital, La Paz Hospital and Gregorio Marañon Hospital in Madrid, Spain and received her Immunology Certification from Education and Health Ministry of Spain. She completed her PhD in Medicine at Complutense University, focused in immunogenetic and her work has awarded with the Extraordinary PhD Award in Medicine Section at Complutense University –Madrid, Spain. Dr. Alecsandru complete her Clinical Immunology fellowship training at Immunology Department of Royal Free Hospital. Jeffrey Modell Foundation. London. UK. Dr. Alecsandru complete her Reproductive Immunology training in Gregorio Marañon Hospital Madrid in the FIS –Carlos III Health Institute (Spain) program.
Research Activity: Her research interests include early placentation, recurrent implantation failure, recurrent miscarriage, immuno-genetic and immunological factors involved in embryo implantation, autoimmunity impact in ART outcome, metabolic status effect on ART success. Dr. Alecsandru is a board certified Clinical Immunologist, board certified Reproductive Immunology. He is active in the Spanish College of Medicine. Dr. Alecsandru has been invited to speak nationally and internationally and has authored and contributed to over 50 peer reviewed publications, published chapters and abstracts. She is author of several textbooks on recurrent implantation failure. She serves on the Editorial Board for Obstetrics & Gynecology International Journal (OGIJ). She serves as Global Fertility and Sterility Associate. Fertility and Sterility USA. She also serves as Ad Hoc Reviewer for Human Reproduction, Fertility and Sterility, Reproductive BioMedicine Online. She is researcher of projects funded by the Ministries of Education and Health in Spain.
Honors & Recognitions:
• Extraordinary PhD Award in Medicine Section at Complutense University.Madrid, Spain
• Member of European Society for Human Reproduction and Embryology (ESHRE), European Society of Reproductive Immunology (ESRI), Spanish Fertility Society (SEF), Spanish Immunology Society (SEI).
Baris Ata
Baris Ata
Baris Ata, M.D., M.Sc., graduated from Istanbul School of Medicine. Following residency training in Obstetrics and Gynecology, he completed fellowship training in Reproductive Endocrinology and Infertility at McGill University, Montreal, Canada. He is a clinical researcher with a Master’s degree in Clinical Trials from the London School of Hygiene and Tropical Medicine. His research focuses on female infertility, endometriosis and clinical aspects of assisted reproductive technology. He has served and serves on editorial boards of leading journals in the field including Human Reproduction Update and Human Reproduction. He is an Executive Committee Member of the European Society of Human Reproduction and Embryology (ESHRE) and the President of the Turkish Society of Reproductive Medicine. He works at the ART Fertility Clinics, Dubai and Koç University, Istanbul, as Professor of Obstetrics and Gynecology. He has received multiple awards for research, education and quality of patient care by several national and international institutions, which include Excellence in Gynecological Reproductive Endocrinology and Infertility by McGill University, American Society of Reproductive Medicine Star Award, Society of Assisted Reproduction Prize Paper, Koç University Outstanding Faculty awards twice, one for research and another educational activity.
Chris Barratt
Professor Barratt is Head of Division Post Graduate Medicine , Head of the Reproductive Medicine Group at the University of Dundee as well as a clinical scientist (Hon) with NHS Tayside. He graduated with an Honours degree in Zoology and then completed a Post Graduate Certificate in Education (University of Wales, Swansea). His PhD, also in Zoology, was under the supervision of Jack Cohen at the University of Birmingham.
Professor Barratt has been awarded a number of honours for outstanding contributions to the discipline e.g. Young Andrologist of the Year (American Andrology Society), the Professor Sir Robert Edwards keynote lecture at ESHRE. He was awarded a DSc from University of Birmingham and has a h index of 57 (Scopus 2022). Professor Barratt is a Fellow of the Royal Society of Edinburgh.
He is a regularly invited speaker at national and international scientific conferences/workshops. He was a member of the WHO Male Fertility Semen Analysis Taskforce (for both the 4th and 5th editions and 6th editions). He recently published the global WHO guidelines for semen reference ranges. He was director of the WHO (2012-2017) Male Fertility Expert Working Group which devised a new system for the diagnosis and treatment of the infertile male. He was a member of the Human Fertilisation and Embryology Authority for 6 years until 2009.
He has been on the Editorial Board of Human Reproduction, Human Fertility, Biology of Reproduction, Human Reproduction Update, Journal of Andrology and was Editor-in-Chief of Molecular Human Reproduction from 2013-2018. Currently he is a member of the Editorial board of Physiological Reviews and a member of the reviewing editors for Science (AAAS) https://www.science.org/
Professor Barratt is helping coordinate the Global Initiative on Male Reproductive Health.
Christina Bergh
Christina Bergh
Curriculum vitae Christina Bergh
PhD 1993, Göteborg University, Sweden
Specialist in Obstetrics and Gynecology 1985
Current position
2009-09-01- Professor Obstetrics and Gynecology with focus on Evidence Based Medicine, Inst of Clinical Sciences, Sahlgrenska Academy, Göteborg University, Sweden
2007-10-01- Head of the Health Technology Assessment unit, Västra Götaland
2007-01-01- Head of the National Quality Registry of Assisted Reproduction in Sweden
Opponent for PhD examinations: Six times 2001-2021
Previous PhD
Main supervisor:11 theses, co-supervisor: three theses
Present PhD
4 PhD doctors
Main research area: Quality and safety in assisted reproduction technology
Single embryo transfer, Children follow up after ART, Embryo selection, Frozen/thawed embryo cycles, Quality of care
Invited lectures at around 70 international congresses
Current Research funding
1.0 million SEK/year (Safety and Quality in ART)
Research publications: 171 original publications, 34 reviews and 50 debates, book chapters or others. H-index: 67 (Google Scholar)
Jacky Boivin
Jacky Boivin
Jacky Boivin is Professor of Health Psychology (since 2010) and Practitioner Health Psychologist (School of Psychology, Cardiff University). She has had a leading role in psychosocial research and clinical developments in the fields of fertility, infertility and reproductive technologies. She has led many international projects (including the International Fertility Decision-Making Study, International FertiQoL), published extensively and produced many tools to support the care of people with fertility problems and barriers to family building (e.g., FertiQoL, FertiSTAT, Endometriosis.Cymru, fertility animations). She is on the the executive committee of the British Fertility Society and Chair of the Prevention sub-group for World Health Organisation Guidelines for Infertility Development Group and International evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Ernesto Bosch
PERSONAL DATA
NAME: Ernesto Bosch Aparicio
BIRTHDATE: March, 9th, 1968
BIRTHPLACE: Philadelphia (PA), USA.
CURRENT WORKPLACE: Instituto Valenciano de Infertilidad. (IVI)
Plaza Policía Local, 3. 46015. Valencia. SPAIN.
Pone: +34 96 305 00 00
FAX: +34 96 305 09 00
e-mail:
ACADEMIC
- 1992: Licensed from Medical School. University of Valencia.
- 1993: General Physician. Hospital Clínico Universitario. Valencia.
- 1994-97: Residency on Obstetrics & Gynaecology. Hospital Universitario La Fe. Valencia.
- 1995-96: Doctoral Courses. University of Valencia.
- 1997: Clinical Fellowship on Human Reproduction at The Hospital of the University of Pennsylvania. Philadelphia. USA.
- 1998: Staff at the Human Reproduction unit. Hospital Universitario La Fe. Valencia.
- 1999: Postdoctoral Research Project: “Influence of intrafollicular LH on oocyte quality in In Vitro Fertilization” qualified with Excellent “cum laude” at the University of Valencia, under the direction of Prof. Alberto Romeu from Hospital Universitario La Fe of Valencia, and Prof. Luis Blasco from The Hospital of The University of Pennsylvania, Philadelphia, USA.
- 2000-2009: Gynaecologist of The Human Reproduction Unit at The Instituto Valenciano de Infertilidad, Valencia. Spain.
- 2010….Director of the Human Reproduction Unit at The Instituto Valenciano de Infertilidad, Valencia, Spain.
OTHER COURSES-PRICES
- 1997-98: Statistical Methods in Health Sciences. (300 hours). Universidad Autónoma de Barcelona.
- 1999-2000: Multivariate Analysis. (240 hours). Universidad Autónoma de Barcelona.
- 2003: European Diplomat in Gynecological Endoscopy. Universidad de Alcalá de Henares, and University of Clermont-Ferrand
- 2008: Master on Design of Research projects. Universidad Autónoma de Barcelona.
- 2008: ASRM General Program Paper Prize.
- 2018. MBA on Healthcare management. IMF Business School. Universidad Camilo José Cela. Madrid.
PUBLICATIONS INDEXED IN MEDLINE DATABASE (by publicaction date)
1: Bosch E, Havelock J, Martin FS, Rasmussen BB, Klein BM, Mannaerts B, Arce JC; ESTHER-2 Study Group. Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial. Reprod Biomed Online. 2018 Dec14. pii: S1472-6483(18)30605-9. doi: 10.1016/j.rbmo.2018.10.012. [Epub ahead of print].
2: Spanish Infertility SWOT Group (SISG), Checa MA, Bellver J, Bosch E, EspinósJJ, Fabregues F, Fontes J, García-Velasco J, Requena A. Hysteroscopic septumresection and reproductive medicine: A SWOT analysis. Reprod Biomed Online. 2018 Dec;37(6):709-715. doi: 10.1016/j.rbmo.2018.09.013. Epub 2018 Oct 22.
3: Bosch E, Bulletti C, Copperman AB, Fanchin R, Yarali H, Petta CA, Polyzos NP, Shapiro D, Ubaldi FM, Garcia Velasco JA, Longobardi S, D'Hooghe T, Humaidan P; Delphi TTP Consensus Group. How time to healthy singleton delivery could affect decision-making during infertility treatment: a Delphi consensus. Reprod Biomed Online. 2018 Nov 7. pii: S1472-6483(18)30526-1. doi: 10.1016/j.rbmo.2018.09.019. [Epub ahead of print]
4: Labarta E, Marin D, Remohí J, Bosch E. Conventional versus minimal ovarian stimulation: an intra-patient comparison of ovarian response in poor-responder women according to Bologna Criteria. Reprod Biomed Online. 2018
Oct;37(4):434-441. doi: 10.1016/j.rbmo.2018.07.007. Epub 2018 Aug 23.
5: Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H, Bosch E, Garcia-Velasco J. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro
fertilization/intracytoplasmic sperm injection: a multicenter multinational
analysis including ∼15,000 women. Fertil Steril. 2018 Sep;110(4):661-670.e1. doi: 10.1016/j.fertnstert.2018.04.039.
6. Drakopoulos P, Santos-Ribeiro S, Bosch E, Garcia-Velasco J, Blockeel C, Romito A, Tournaye H, Polyzos N. The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation . Front Endocrinol 2018; 9: 361.
7: Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, Bühler K, Ferraretti AP, De Placido G, Mollo A, Fischer R, Humaidan P; International Collaborative Group for the Study of r-hLH (iCOS-LH). Recombinant luteinizing hormonesupplementation in assisted reproductive technology: a systematic review. Fertil Steril. 2018 Apr;109(4):644-664.
8: Lawrenz B, Labarta E, Fatemi H, Bosch E. Premature progesterone elevation: targets and rescue strategies. Fertil Steril. 2018 Apr;109(4):577-582.
9: La Marca A, Blockeel C, Bosch E, Fanchin R, Fatemi HM, Fauser BC,
García-Velasco JA, Humaidan P, Tarlatzis BC, Nelson SM. Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates. Hum Reprod. 2018 May 1;33(5):982-983.
10. Bosch E, Labarta E, Pellicer A. Does cumulative live birth plateau beyond a certain ovarian response? Fertil Steril. 2017 Dec;108(6):943
11. Labarta E, Mariani G, Holtmann N, Celada P, Remohí J, Bosch E. Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study. Hum Reprod. 2017 Oct 13:1-6
12. Labarta E, Bosch E, Mercader A, Alamá P, Mateu E, Pellicer A. A Higher Ovarian Response after Stimulation for IVF Is Related to a Higher Number of Euploid Embryos. Biomed Res Int. 2017;2017:5637923.
13. Nyboe Andersen A, Nelson SM, Fauser BC, García-Velasco JA, Klein BM, Arce JC; ESTHER-1 study group. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril. 2017 Feb;107(2):387-396.
14. Bosch E, Labarta E, Kolibianakis E, Rosen M, Meldrum D. Regimen of ovarian stimulation affects oocyte and therefore embryo quality. Fertil Steril. 2016.
15. Garcia-Velasco JA, Bosch E. The necessity to define the sub-optimalresponders. Hum Reprod. 2015 Dec;30(12):2958.
16. Martin J, Asan, Yi Y, Alberola T, Rodríguez-Iglesias B, Jiménez-Almazán J, Li Q, Du H, Alama P, Ruiz A, Bosch E, Garrido N, Simon C. Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology. Fertil Steril. 2015 Nov;104(5):1286-93.
17. Garrido N, Bosch E, Alamá P, Ruiz A. The time to prevent mendelian genetic diseases from donated or own gametes has come. Fertil Steril. 2015. Oct;104(4):833-5.
18. Bosch E, Nyboe Andersen A, Barri P, García-Velasco JA, de Sutter P,Fernández-Sánchez M, Visnova H, Klein BM, Mannaerts B, Arce JC. Follicular and endocrine dose-responses according to anti-Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049). Clin Endocrinol (Oxf). 2015 Jul 23. doi: 10.1111/cen.12864. [Epub ahead of print] PubMed PMID:26202150.
19. Bosch E. High responders and patients with a good prognosis are not immune to the negative impact on live birth rate of elevated P on the day of triggering.Fertil Steril. 2015 Jun;103(6):1423. doi: 10.1016/j.fertnstert.2015.03.031. Epub 2015 May 5. PubMed PMID: 25956373.
20. Anderson RA, Anckaert E, Bosch E, Dewailly D, Dunlop CE, Fehr D, Nardo L, Smitz J, Tremellen K, Denk B, Geistanger A, Hund M. Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool. Fertil Steril. 2015 Apr;103(4):1074-1080.
21. Simón C, Bosch E, Bellver J. Reply: Endometrial scratching for women with repeated implantation failure. Hum Reprod. 2014 Oct 14.
22. Arce JC, Nyboe Andersen A, Fernández-Sánchez M, Visnova H, Bosch E,García-Velasco JA, Barri P, de Sutter P, Klein BM, Fauser BC. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, anti-Müllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2014 Sep 23[Epub ahead of print]
23. Requena A, Cruz M, Bosch E, Meseguer M, García-Velasco JA. High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study. Reprod Biol Endocrinol. 2014 Jul 26;12:69. doi: 10.1186/1477-7827-12-69. PubMed PMID: 25064138; PubMed Central PMCID: PMC4118192.
24. Labarta E, Bosch E, Pellicer A. Impact of ovarian stimulation withgonadotrophins on embryo aneuploidy. Hum Reprod Update. 2014 Jul 10..[Epub ahead of print].
25. Bosch E. Comment on 'Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years old or older undergoing IVF/ICSI: a randomized controlled multicentre study'. Hum Reprod. 2014 Mar;29(3):636-7.
26. Bosch E. Does progesterone elevation compromise pregnancy rates in high responders? Insufficient evidence to draw a conclusion. Fertil Steril. 2014Jan;101(1):e3-4.
27. Nardo LG, Bosch E, Lambalk CB, Gelbaya TA. Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil (Camb). 2013 Sep;16(3):144-50.
28. Muñoz E, Taboas E, Portela S, Aguilar J, Fernandez I, Muñoz L, Bosch E.Treatment of luteal phase defects in assisted reproduction. Curr Drug Targets.2013 Jul;14(8):832-42.
29. Rubio C, Bellver J, Rodrigo L, Bosch E, Mercader A, Vidal C, De Los Santos MJ, Giles J, Labarta E, Domingo J, Crespo J, Remohí J, Pellicer A, Simón C. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertil Steril. 2013 Apr;99(5):1400-7.
30. Choi B, Bosch E, Lannon BM, Leveille MC, Wong WH, Leader A, Pellicer A, Penzias AS, Yao MW. Personalized prediction of first-cycle in vitro fertilization success. Fertil Steril. 2013 Mar 20. doi:pii: S0015-0282(13)00273-2.10.1016/j.fertnstert.2013.02.016. [Epub ahead of print] PubMed PMID: 23522806.
31. De los Santos MJ, García-Laez V, Beltrán D, Labarta E, Zuzuarregui JL, Alamá P, Gámiz P, Crespo J, Bosch E, Pellicer A. The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: is it hypoandrogenic? Hum Reprod. 2013 Jan;28(1):224-9. doi: 10.1093/humrep/des349. Epub 2012 Sep 27. PubMed PMID: 23019297.
32. Labarta E, Bosch E, Alamá P, Rubio C, Rodrigo L, Pellicer A. Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles. J Clin Endocrinol Metab. 2012 Oct;97(10):E1987-94. doi: 10.1210/jc.2012-1738. Epub 2012 Aug 3. PubMed PMID: 22865900; PubMed Central PMCID: PMC3462940.
33. Bosch E. Can we skip weekends in GnRH antagonist cycles without compromising the final outcome? Fertil Steril. 2012 Jun;97(6):1299-300.
34. Muñoz E, Bosch E, Fernandez I, Portela S, Ortiz G, Remohi J, Pellicer A. The role of LH in ovarian stimulation. Curr Pharm Biotechnol. 2012 Mar;13(3):409-16. Review. PubMed PMID: 21657991.
35. Nardo LG, Fleming R, Howles CM, Bosch E, Hamamah S, Ubaldi FM, Hugues JN, Balen AH, Nelson SM. Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation. Reprod Biomed Online. 2011 Aug;23(2):141-8. doi: 10.1016/j.rbmo.2011.05.008. Epub 2011 May 19. PubMed PMID: 21665542.
36. Labarta E, Martínez-Conejero JA, Alamá P, Horcajadas JA, Pellicer A, Simón C, Bosch E. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011 Jul;26(7):1813-25.
37. Papanikolaou EG, Polyzos NP, Humaidan P, Pados G, Bosch E, Tournaye H, Tarlatzis B. Aromatase inhibitors in stimulated IVF cycles. Reprod Biol Endocrinol. 2011 Jun 21;9:85. doi: 10.1186/1477-7827-9-85. Review. PubMed PMID: 21693033; PubMed Central PMCID: PMC3150251.
38. Bosch E, Ezcurra D. Individualised controlled ovarian stimulation (iCOS):
maximising success rates for assisted reproductive technology patients. Reprod Biol Endocrinol. 2011 Jun 21;9:82. doi: 10.1186/1477-7827-9-82. PubMed PMID: 21693025; PubMed Central PMCID: PMC3150250.
39. Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Pellicer A. Impact luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril. 2011 Mar 1;95(3):1031-6. doi: 10.1016/j.fertnstert.2010.10.021. Epub 2010 Nov 10. PubMed PMID: 21067717.
40. Gabbanini M, Privitera L, Monzó A, Higueras G, Fuster S, Garrido N, Bosch E, Pellicer A. The use of prediction models of spontaneous pregnancy in in vitro fertilization units reveals differences between the expected results of public and private clinics in Spain. Fertil Steril. 2010 Nov;94(6):2376-8. doi:10.1016/j.fertnstert.2010.02.038. Epub 2010 Mar 29. PubMed PMID: 20347077.
41. Bellver J, Labarta E, Bosch E, Melo MA, Vidal C, Remohí J, Pellicer A. GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial. Fertil Steril. 2010 Aug;94(3):1065-71.
42. Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J, Pellicer A.
Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010 Aug;25(8):2092-100.
43. Bosch E. Recombinant human follicular stimulating hormone and recombinant human luteinizing hormone in a 2:1 ratio combination. Pharmacological characteristics and clinical applications. Expert Opin Biol Ther. 2010 Jun;10(6):1001-9. doi: 10.1517/14712598.2010.485607. Review. PubMed
44. Bosch E, Vidal C, Labarta E, Simon C, Remohi J, Pellicer A. Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists—a randomized study. Hum Reprod. 2008 Oct;23(10):2346-51.
45. Soares SR, Velasco JA, Fernandez M, Bosch E, Remohí J, Pellicer A, Simón C. Clinical factors affecting endometrial receptiveness in oocyte donation cycles. Fertil Steril. 2008 Mar;89(3):491.
46. Bosch E. Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al (2007). Hum Reprod Update. 2008 Mar-Apr;14(2):194-5; author reply 195-6. doi: 10.1093/humupd/dmm046. Epub 2008 Jan 28. PubMed PMID: 18230603.
47. Bellver J, Melo MA, Bosch E, Serra V, Remohí J, Pellicer A. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril. 2007 Aug;88(2):446-51. Epub 2007 Apr 6. PubMed PMID: 17418840.
48. Cobo A, Bosch E, Alvarez C, de los Santos MJ, Pellicer A, Remohí J. Effect of a sharp serum oestradiol fall before HCG administration during ovarian stimulation in donors. Reprod Biomed Online. 2007 Aug;15(2):169-74. PubMed
49. Escribá MJ, Bellver J, Bosch E, Sánchez M, Pellicer A, Remohí J. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study. Fertil Steril. 2006 Jul;86(1):92-7.
50. Melo MA, Meseguer M, Garrido N, Bosch E, Pellicer A, Remohí J. The
significance of premature luteinization in an oocyte-donation programme. Hum Reprod. 2006 Jun;21(6):1503-7.
51. Simon C, Oberyé J, Bellver J, Vidal C, Bosch E, Horcajadas JA, Murphy C, Adams S, Riesewijk A, Mannaerts B, Pellicer A. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod. 2005 Dec;20(12):3318-27.
52. Bellver J, Bosch E, Remohí J, Pellicer A. Evidence-based medicine is gaining momentum. Fertil Steril. 2005 Nov;84(5):1555-6; author reply 1556-7.
53. Bosch E, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Serum luteinizing hormone in patients undergoing ovarian stimulation withgonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome. Fertil Steril. 2005 Nov;84(5):1529-32.
54. Soares SR, Troncoso C, Bosch E, Serra V, Simón C, Remohí J, Pellicer A. Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. J Clin Endocrinol Metab. 2005 Jul;90(7):4399-404.
55. Christiansen OB, Nybo Andersen AM, Bosch E, Daya S, Delves PJ, Hviid TV, Kutteh WH, Laird SM, Li TC, van der Ven K. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril. 2005 Apr;83(4):821-39. Review. PubMed PMID: 15820784.
56. Bellver J, Bosch E, Pellicer A. BMI--the fragility of fertility. Fertil Steril. 2004 Mar;81(3):727; author reply 727-8. PubMed PMID: 15037438.
57. Escudero E, Bosch E, Crespo J, Simón C, Remohí J, Pellicer A. Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients. Fertil Steril. 2004 Mar;81(3):562-6. PubMed PMID: 15037403.
58. Bosch E, Valencia I, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003 Dec;80(6):1444-9. PubMed PMID: 14667881.
59. Bellver J, Muñoz EA, Ballesteros A, Soares SR, Bosch E, Simón C, Pellicer A, Remohí J. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Hum Reprod. 2003 Nov;18(11):2283-8. PubMed PMID: 14585874.
60. Bellver J, Rossal LP, Bosch E, Zúñiga A, Corona JT, Meléndez F, Gómez E, Simón C, Remohí J, Pellicer A. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003 May;79(5):1136-40.
61. Troncoso C, Bosch E, Rubio C, Remohí J, Simón C, Pellicer A. The origin of biochemical pregnancies: lessons learned from preimplantation genetic diagnosis. Fertil Steril. 2003 Feb;79(2):449-50..
62. Pellicer A, Navarro J, Bosch E, Garrido N, Garcia-Velasco JA, Remohí J, Simón C. Endometrial quality in infertile women with endometriosis. Ann N Y Acad Sci. 2001 Sep;943:122-30. Review.
CLINICAL STUDIES IN RELEVANT AREA (including responsibilities):
Endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles (2005). Sub-investigator.
Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome. (2005). Principal Investigator
Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists. (2008). Principal Investigator.
GnRH agonist administration at the time of implantation in intrauterine insemination cycles (2009) Sub-Investigator
Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles (2010). Principal Investigator.
Embryoaneuploidy in natural ve stimulated cycles (2009-2011) (sub-investigator)
Endometrial receptivity in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis (2011). Sub-investigator
Human derived recombinant FSH, Phase II (Study-9 by Ferring- 2012): Principal Investigator
Barusiban to prevent uterine contractions in IVF patients (Basic study, by Ferring, 2012-13). Principal investigator and signing investigator.
Serum AMH and correlation with antral follicle count (by Roche diagnosis 2013). Principal investigator.
Recombinant LH in low responders (by MerckSerono, 2014). Principal investigator
Human derived recombinant FSH, phase III (by Ferring, 2014). Principal investigator.
Luteal phase support with duphaston (Study Lottus-1 by Abbott, 2014). Principal investigator.
|
Placebo controlled study of nolasiban to improve pregnancy rates in women undergoing IVF/ICSI (Implant-2) |
Ongoing pregnancy rates in oocyte donation according to serum P levels de day of embryo transfer. Sub investigator (2017)
Follicular steroidgenesis in controlled ovarian stimulation. Principal Investigator (2018).
Comparison of hhCG with hCG+ß in the early prediction of ongoing pregnancy after in-vitro fertilization and embryo transfer. Principal investigator. (2018)
Serdar Bulun
Serdar E. Bulun, MD
John J. Sciarra Professor
Chair, Department of Obstetrics and Gynecology
Serdar Bulun is the John J. Sciarra Professor and Chair of the Department of Obstetrics and Gynecology at Northwestern University in Chicago. He is also the Obstetrician-Gynecologist-in-Chief at Prentice Women’s Hospital at Northwestern Memorial Hospital. He was born in Malatya, Turkey and moved to Istanbul to attend Robert College and thereafter Istanbul University School of Medicine. He completed his residency in obstetrics and gynecology at the University at Buffalo in New York and pursued a sub-specialty fellowship in reproductive endocrinology-infertility at the University of Texas Southwestern Medical Center at Dallas.
Starting from 2003, he established a comprehensive women’s health research program at Northwestern, and recruited and supported numerous faculty who focus on steroid hormone-related aspects of human health and disease. His studies on endometriosis and adenomyosis are widely acknowledged. His team introduced the use of aromatase inhibitors in these disorders. Throughout his career, Dr. Bulun has been awarded over $100 million of research funding in endometriosis, uterine fibroids and breast cancer. Dr. Bulun had a number of awards and honors during his career, most notably, he was elected to National Academy of Medicine in 2015. He’s published more than 250 peer-reviewed publications in top journals including New England Journal of Medicine, Nature Medicine, and the Proceedings of the National Academy of Sciences USA.
For more information on The Bulun Lab, visit:
https://www.feinberg.northwestern.edu/sites/obgyn/research/basic-science-research/bulun/index.html
Rossella Cannarella
Rossella Cannarella
Current Job:
- Rossella Cannarella, MD, PhD is an Endocrinologist and a Researcher currently attending the Glickman Urological & Kidney Institute at the Cleveland Clinic (Cleveland, OH, USA). She serves as a Professor for the Master of Clinical Embriology and Seminological Andrology, at the Department of Biology, University of Catania (Catania, Italy).
Education & Training:
- She received her medical degree from the University of Catania (Catania, Italy) in 2014. She completed her residency training in the European Academy of Andrology (EAA) Training Center of Catania in 2019. She has been a Visiting Researcher at the University of Massachusetts Medical School (Worcester, MA, USA) in 2021-2022, where she studied the impact of sperm epigenetics on mice embryo development. She earned her International PhD in Translational Biomedicine at the University of Catania, in 2022.
Research Activity:
- Her research interests include male infertility, sperm epigenetics, male hypogonadism, genetics in andrology, testicular function in childhood. Dr. Cannarella is a board certified EAA Clinical Andrologist. She has been invited to speak in more than 30 national and international meetings, and has authored and contributed to over 160 peer reviewed publications, 5 book chapters and 29 abstracts. She serves on the Editorial Board for Frontiers in Endocrinology, section Reproduction, Minerva Endocrinology and BMC Urology. She also serves as Ad Hoc Reviewer for Fertility and Sterility, Reproductive BioMedicine Online, Human Genetics and others. She serves the Italian Society of Andrology and Sexual Medicine (SIAMS) as a member of the ART and sperm bank Committee.
Honors & Recognitions:
2020: Winner of the ESHRE Travelling Fellowship, European Society of Human Reproduction and Embryology, for the project: “Role of sperm-carried growth factors in embryogenesis: Possible diagnostic targets?
Antonio Capalbo
Chief Genomic Officer
Juno Genetics
Marcelle Cedars
Marcelle Cedars
Marcelle Cedars is Professor and Director of the Division of Reproductive Endocrinology at UCSF. Dr. Cedars is funded by the NICHD and NIA in her focused areas of research including ovarian aging and assisted reproduction. She is part of a multi-disciplinary team for the ASPIRE study (Assessing the Safety of pregnancy In the CoRona virus pandEmic) which developed a 8,000 woman national cohort to study the impact of first-trimester exposure to SARS-COv-2 on pregnancy and childhood health. She has served as an Associate Editor for Fertility and Sterility, and Editorial Board for Human Reproduction Update and the Journal of Clinical Endocrinology and Infertility. She was the Chair of the FDA Reproductive Devices Committee. She has been a standing member of NIH study sections and served on international study sections for Canada and Europe. She has served as President of the Society for Reproductive Endocrinology and Infertility and is the Immediate Past President for the American Society of Reproductive Medicine.
Joe Conaghan
Dr Joe Conaghan
Dr Joe Conaghan has worked in human embryology for 35 years, mainly as a teacher and IVF laboratory director. He trained in Embryology and Andrology at the Hammersmith Hospital in London and graduated with a Ph.D. in human embryology from the Royal Postgraduate Medical School at the University of London in 1994. He is a Board-Certified High-complexity Clinical Laboratory Director (HCLD) in the disciplines of Embryology and Andrology.Dr. Conaghan has directed at numerous facilities in the US including the University of California San Francisco (UCSF) IVF Program (1995-1999) and Pacific Fertility Center in San Francisco (1999-2022). He is a faculty lecturer in reproductive technology at San Francisco State University (SFSU; 2002-present). Dr. Conaghan is a strong advocate for quality improvement and innovation in IVF and is a dedicated mentor/teacher to the next generation of embryologists and IVF laboratory directors.
Juan Manuel Corral
Training:
Bachelor of Medicine and Surgery (University of Barcelona)
Bachelor's Degree in the September 1994 call, with an Excellent rating.
Extraordinary Degree Award (September 1994)
Doctor of Medicine and Surgery from the Faculty of Medicine of the University of Barcelona. Cytogenetic alterations determined by FISH in disseminated prostate cancer, rated as Excellent "cum laude". January 17, 2000
Master in Laparoscopic Surgery from the University of Paris (Ecole de Chirurgie de Paris, June 2006)
Professional Position:
Urology Service Consultant Hospital Clínic de Barcelona
Member of the Uro-oncology Unit Urology Service Hospital Clínic de Barcelona
Member of the Reproduction Unit (Gynecology and Obstetrics Service, Hospital Clínic de Barcelona Urology Service)
Member of the Clinical Working Group on Sexuality (ICGON, Dr Camil Castelo Branco)
Consultant of the Hematopoietic Transplant Program. Hematology Service Hospital Clínic de Barcelona
Urology Coordinator with Primary Care (AISBE)
General Secretary of ASESA (Spanish Association of Andrology, Sexual and Reproductive Medicine)
Coordinator of the Andrology Section of the Catalan Society of Urology (SCU)
Consultant of the European Cooperation in Science & Technology: COST ACTION CA20119 - European andrology network– research coordination, education and public awareness
Consultant Andrology Department Cleveland Clinic (collaborative research project on varicocele entitled “Impact of varicocele repair on conventional semen parameters, isolated sperm defects, seminal oxidative stress, sperm DNA fragmentation and natural pregnancies). Global Andrology Forum (GAF Cleveland Clinic. Prof A. Agarwal)
Consultant of the National Commission of the Biovigilance Committee on Assisted Human Reproduction Techniques. Spanish Ministry of Health (2012-present).
Consultant of the National Commission of Markets and Competition (CNMC). Spanish Government, (2012-present).
Author or co-author of more than 50 national and international articles
Author of more than 10 book chapters
Clinical Professor in Medicine Degree (Campus Clínic, University of Barcelona) 1999- present
Teaching in Undergraduate students Subject Diseases of the Excretory and Renal System. "Urological Emergencies" and "Assessment of the infertile male" from 1999 to the present.
Professor Uro-oncology Master. Urology Service (2010-present). Faculty of Medicine. Barcelona University
Critical Illness and Emergencies Master Professor (2010-present). Faculty of Medicine. Barcelona University
Critical Illness and Emergencies Master Professor (2010-present). Faculty of Medicine. Barcelona University
Professor of the Master's Degree in Organ Donation and Transplantation. Faculty of Medicine. Barcelona University
Professor of the University Master's Degree in Pathological Anatomy in Uro-oncology. Faculty of Medicine. University of Barcelona. "Surgical treatment of penile neoplasms" (2023)
PUBLICACIONES 2020-2022
- M. Méndez, M. Guimerà, J.M. Corral, S. Cívico, Sperm origin impact on early human embryo kinetics, Clínica e Investigación en Ginecología y Obstetricia, Volume 49, Issue 3,2022,100750,ISSN 0210-573X,https://doi.org/10.1016/j.gine.2022.100750.
- Ribera-Cortada I, Guerrero-Pineda J, Trias I, Veloza L, Garcia A, Marimon L, Diaz-Mercedes S, Alamo JR, Rodrigo-Calvo MT, Vega N, López Del Campo R, Parra-Medina R, Ajami T, Martínez A, Reig O, Ribal MJ, Corral-Molina JM, Jares P, Ordi J, Rakislova N. Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review. Int J Mol Sci. 2021 Dec 27;23(1):251. doi: 10.3390/ijms23010251. PMID: 35008677; PMCID: PMC8745288.
- Guerrero J, Trias I, Veloza L, Del Pino M, Garcia A, Marimon L, Diaz-Mercedes S, Rodrigo-Calvo MT, Alós S, Ajami T, Parra-Medina R, Martinez A, Reig O, Ribal MJ, Corral-Molina JM, Ordi J, Ribera-Cortada I, Rakislova N. HPV-negative Penile Intraepithelial Neoplasia (PeIN) With Basaloid Features. Am J Surg Pathol. 2022 Mar 17. doi: 10.1097/PAS.0000000000001885. Epub ahead of print. PMID: 35297786.
- Peradejordi Font MR, Mercader Barrull C, López Martínez JM, Corral Molina JM, García Cruz E, Alcaraz Asensio A, Peri Cusi L. Consequences of penile fracture: Complications and long-term functional outcomes. Actas Urol Esp (Engl Ed). 2022 Apr;46(3):178-183. English, Spanish. doi: 10.1016/j.acuroe.2021.12.008. Epub 2022 Mar 8. PMID: 35277377.
- Gupta S, Sharma R, Agarwal A, Boitrelle F, Finelli R, Farkouh A, Saleh R, Abdel-Meguid TA, Gül M, Zilaitiene B, Ko E, Rambhatla A, Zini A, Leisegang K, Kuroda S, Henkel R, Cannarella R, Palani A, Cho CL, Ho CCK, Zylbersztejn DS, Pescatori E, Chung E, Dimitriadis F, Pinggera GM, Busetto GM, Balercia G, Salvio G, Colpi GM, Çeker G, Taniguchi H, Kandil H, Park HJ, Maldonado Rosas I, de la Rosette J, Cardoso JPG, Ramsay J, Alvarez J, Molina JMC, Khalafalla K, Bowa K, Tremellen K, Evgeni E, Rocco L, Rodriguez Peña MG, Sabbaghian M, Martinez M, Arafa M, Al-Marhoon MS, Tadros N, Garrido N, Rajmil O, Sengupta P, Vogiatzi P, Kavoussi P, Birowo P, Kosgi R, Bani-Hani S, Micic S, Parekattil S, Jindal S, Le TV, Mostafa T, Toprak T, Morimoto Y, Malhotra V, Aghamajidi A, Durairajanayagam D, Shah R. Antisperm Antibody Testing: A Comprehensive Review of Its Role in the Management of Immunological Male Infertility and Results of a Global Survey of Clinical Practices. World J Mens Health. 2022 Jan 1. doi: 10.5534/wjmh.210164. Epub ahead of print. PMID: 35021297.
- Agarwal A, Sharma RK, Gupta S, Boitrelle F, Finelli R, Parekh N, Durairajanayagam D, Saleh R, Arafa M, Cho CL, Farkouh A, Rambhatla A, Henkel R, Vogiatzi P, Tadros N, Kavoussi P, Ko E, Leisegang K, Kandil H, Palani A, Salvio G, Mostafa T, Rajmil O, Banihani SA, Schon S, Le TV, Birowo P, Çeker G, Alvarez J, Molina JMC, Ho CCK, Calogero AE, Khalafalla K, Duran MB, Kuroda S, Colpi GM, Zini A, Anagnostopoulou C, Pescatori E, Chung E, Caroppo E, Dimitriadis F, Pinggera GM, Busetto GM, Balercia G, Elbardisi H, Taniguchi H, Park HJ, Maldonado Rosas I, de la Rosette J, Ramsay J, Bowa K, Simopoulou M, Rodriguez MG, Sabbaghian M, Martinez M, Gilani MAS, Al-Marhoon MS, Kosgi R, Cannarella R, Micic S, Fukuhara S, Parekattil S, Jindal S, Abdel-Meguid TA, Morimoto Y, Shah R. Sperm Vitality and Necrozoospermia: Diagnosis, Management, and Results of a Global Survey of Clinical Practice. World J Mens Health. 2021 Oct 13. doi: 10.5534/wjmh.210149. Epub ahead of print. PMID: 34666422.
- Agarwal A, Gupta S, Sharma RK, Finelli R, Kuroda S, Vij SC, Boitrelle F, Kavoussi P, Rambhatla A, Saleh R, Chung E, Mostafa T, Zini A, Ko E, Parekh N, Martinez M, Arafa M, Tadros N, de la Rosette J, Le TV, Rajmil O, Kandil H, Blecher G, Liguori G, Caroppo E, Ho CCK, Altman A, Bajic P, Goldfarb D, Gill B, Zylbersztejn DS, Molina JMC, Gava MM, Cardoso JPG, Kosgi R, Çeker G, Zilaitiene B, Pescatori E, Borges E, Duarsa GWK, Pinggera GM, Busetto GM, Balercia G, Franco G, Çalik G, Sallam HN, Park HJ, Ramsay J, Alvarez J, Khalafalla K, Bowa K, Hakim L, Simopoulou M, Rodriguez MG, Sabbaghian M, Elbardisi H, Timpano M, Altan M, Elkhouly M, Al-Marhoon MS, Sadighi Gilani MA, Soebadi MA, Nasr-Esfahani MH, Garrido N, Vogiatzi P, Birowo P, Patel P, Javed Q, Ambar RF, Adriansjah R, AlSaid S, Micic S, Lewis SE, Mutambirwa S, Fukuhara S, Parekattil S, Ahn ST, Jindal S, Takeshima T, Puigvert A, Amano T, Barrett T, Toprak T, Malhotra V, Atmoko W, Yumura Y, Morimoto Y, Lima TFN, Kunz Y, Kato Y, Umemoto Y, Colpi GM, Durairajanayagam D, Shah R. Post-Vasectomy Semen Analysis: Optimizing Laboratory Procedures and Test Interpretation through a Clinical Audit and Global Survey of Practices. World J Mens Health. 2022 Jan 2. doi: 10.5534/wjmh.210191. Epub ahead of print. PMID: 35021311.
- José FG, González JGÁ, Molina JMC, Arnau LB, Iribarren IM, Jabaloyas JMM, Rico FM, García-Baquero R, Gayá MR, García EL, López CL, Castro RP, Salamanca JIM. Infección por SARS-CoV-2: implicaciones para la salud sexual y reproductiva. Una declaración de posición de la Asociación Española de Andrología, Medicina Sexual y Reproductiva (ASESA) [SARS-CoV-2 infection: implications for sexual and reproductive health. A position statement of the Asociación Española de Andrología, Medicina Sexual y Reproductiva (ASESA)]. Rev Int Androl. 2020 Jul-Sep;18(3):117-123. Spanish. doi: 10.1016/j.androl.2020.06.001. PMID: 32660697; PMCID: PMC7351068.
- Prieto-Castro R, Puigvert-Martínez AM, Artigas-Feliu R, Illán-Mateo P, Cruz-Culebra N, Artés-Ferragud M; PANDORA Project Regional Committee. Opinions, Attitudes, and Perceptions in Relation to Erectile Dysfunction and Premature Ejaculation in the Undiagnosed Spanish Male Population. Results of the PANDORA Project. J Sex Med. 2020 Aug;17(8):1495-1508. doi: 10.1016/j.jsxm.2020.04.381. Epub 2020 Jul 1. PMID: 32622766.
- Ballescà Lagarda J.L, Corral Molina J.M. Breve visión histórica de la reproducción desde una óptica andrológica. Revista Iberoamericana de Fertilidad y Reproducci n Humana ⁄ Vol. 37 n 1 Enero-Febrero-Marzo 2020
- Boncoraglio MT, Prieto-González S, Fernandes-Serodio J, Corral-Molina JM, Solé M, Hernández-Rodríguez J. Simultaneous presentation of granulomatosis with polyangiitis (GPA) and immunoglobulin G4-related disease (IgG4-RD). Leaving an open question: widening the spectrum of a single disease or real overlap? Mod Rheumatol Case Rep. 2021 Jan;5(1):108-112. doi: 10.1080/24725625.2020.1782028. Epub 2020 Jul 3. PMID: 33269656.
- Ferran Barrachina, Alberto de la Iglesia, Meritxell Jodar, Ada Soler-Ventura , Carme Mallofré, Leonardo Rodriguez-Carunchio, Afsaneh Goudarzi 5, Juan Manuel Corral, Josep Lluís Ballescà, Judit Castillo, Rafael Oliva. Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours. Hum Reprod 2022 Jul 30;37(8):1712-1726 doi: 10.1093/humrep/deac130.
PONENCIAS ANDROLOGÍA 2020-2022
Reunión del Grupo Uroandrológico, de la Asociación Española de Urología. Vitoria 6-8 febrero 2020: “¿Qué se debe ofrecer al paciente joven con un proceso oncológico?: ¿cómo preservar la fertilidad?”
I Jornada Interdisciplinar en Reproducción y Medicina Sexual, Madrid 1 Octubre 2021 Ponencia: “Aumento de infertilidad en los hombres”
20 Congreso Nacional de la Asociación Española de Andrología, medicina sexual y Reproductiva (ASESA), “Fragmentación del ADN Espermático. ¿Cuándo pedirla?, ¿Cómo tratarla?”, Madrid 21-23 octubre 2021
Reunión del Grupo Uroandrológico, de la Asociación Española de Urología. Vigo 5-6 febrero 2022. “Probióticos y Fertilidad Masculina
II Jornada Interdisciplinar en Reproducción y Medicina Sexual, Barcelona 6 de mayo 2022. “Testosterona como antiaging-mejora muscular, ¿por qué no?”
VIII Curso de Cirugía Protésica y Reconstructiva Urogenital. Barcelona, 24-25 marzo 2022. “Tratamiento local del cáncer de pene con intención reconstructiva”.
Curso Diálogos de Reproducción Asociación Mexicana de Medicina de la Reproducción. 29 y 30 de abril de 2022, Cancún. México. “Actualidades en el uso de antioxidantes en infertilidad masculina”
1st ANDRONET Hybrid Meeting. June 8-10, 2022, Barcelona, Spain. “Uroandrology Unit”
Actualización en urología oncológica: càncer de próstata hormonosensible metastásico (12 horas lectivas) Hospital Clínic de Barcelona, 22 y 23 de septiembre de 2022
2º Curso para residentes en Cirugía URO-PROTÉSICA. 26 de enero de 2023 en el Salón de Actos del Hospital Materno Infantil del Hospital General Univ. Gregorio Marañón de Madrid. Indicaciones actuales de la prótesis de pene. Entrevista con el paciente. Expectativas e información
Areas of interest:
Reproductive Andrology and Sexual Medicine. Assessment of the sterile couple and male factor
Uro-oncology. Prostate cancer, penile and testicular cancer
Kidney transplant
minimally invasive surgery
Andrologic surgery (no-scalpel vasectomy, microsurgical vasectomy reversal, microsurgical microvaricocelectomy, testicular microbiopsy, phimosis)
Vasectomy Reversal Using Robot-Assisted Surgery (da Vinci)
Microsurgical surgery by conventional microscopy or by exoscope (Orbeye)
Ángel Martín
Ángel Martín
Current Job
- Research Embryologist at IVI RMA Valencia.
Education & Training
- External University Lecturer. Universidad de Valencia, Spain.
- PhD, Medicine. Universidad de Valencia, Spain.
- MSc, Biotechnology of Assisted Human Reproduction. Universidad de Valencia, Spain.
- Training at CARE Fertility Nottingham, United Kingdom.
- BSc, Biotechnology. Universidad Pablo de Olavide, Spain.
Research Activity
- Embryonic mosaicism
- Early cell lineage specification
Selected publications
- Zhu M, Shahbazi M*, Martin A*, Zhang C, Sozen B, Borsos M, Mandelbaum RS, Paulson RJ, Mole MA, Esbert M, Titus S, Scott RT, Campbell A, Fishel S, Gradinaru V, Zhao H, Wu K, Chen ZJ, Seli E, de Los Santos MJ, Zernicka Goetz M. Human embryo polarization requires PLC signaling to mediate trophectoderm specification. 2021 Sep 27;10:e65068. doi: 10.7554/eLife.65068. PMID: 34569938; PMCID: PMC8514238. *Equal contribution.
- Martin A, Rodrigo L, Beltrán D, Meseguer M, Rubio C, Mercader A, de Los Santos MJ. The morphokinetic signature of mosaic embryos: evidence in support of their own genetic identity. Fertil Steril. 2021 Jul;116(1):165-173. doi: 10.1016/j.fertnstert.2020.12.031. Epub 2021 Mar 22. PMID: 33766460.
- Kellam L, Pastorelli LM, Bastida AM, Senkbeil A, Montgomery S, Fishel S, Campbell A. Perivitelline threads in cleavage-stage human embryos: observations using time-lapse imaging. Reprod Biomed Online. 2017 Dec;35(6):646-656. doi: 10.1016/j.rbmo.2017.09.004. Epub 2017 Sep 28. PMID: 29074360.
Honors & Recognitions
- Member of Spanish Association for the Study of Reproductive Biology (ASEBIR).
- Member of European Society of Human Reproduction and Embryology (ESHRE) and American Society for Reproductive Medicine (ASRM).
Mauro Cozzolino
Mauro Cozzolino
Mauro Cozzolino is a Gynecologist physician attending IVIRMA Roma, Italy where he serves as a specialist in Human Reproduction and Assisted Reproductive Techniques.Mauro Cozzolino obtained his MD degree from Federico II University, School of Medicine in Naples, Italy. He subsequently entered a residency program in Obstetrics and Gynecology at University Hospital Careggi, University of Florence. After completing a Fellowship in Reproductive Medicine at Instituto Valenciano de Infertilidad (IVI–Madrid), Spain, in 2017, he began his PhD at University Rey Juan Carlos in 2018. He got a Fellowship at the Department of Obstetrics, Gynecology and Reproductive Sciences of Yale School of Medicine from 2018 to 2021.
Dr. Cozzolino has been working on the potential mechanisms leading to infertility and biomarkers associated with treatment outcomes. Within this context, Dr. Cozzolino studies determinants of oocyte and embryo health and mechanisms of ovarian aging. In addition, he investigates factors regulating the response to ovarian hyperstimulation during in vitro fertilization in patients with the polycystic ovarian syndrome (PCOS) and poor ovarian response. Dr. Cozzolino has been focused on the effect of adenomyosis in IVF cycles.
He has authored over 90 peer-reviewed scientific papers and book chapters in international journals and presented many communications at congresses. Furthermore, is an ad-hoc reviewer for different journals classed within the top-ten of Ob/Gyn. He received the Fellowships Award 2017 in Fertility/Infertility from IBSA Foundation. He received the Fellowships Award in 2019 by Ermenegildo Zegna Founder's Scholarship. As the first author, he received the Prize In-Training Award for Research in 2021 at the American Society for Reproductive Medicine (ASRM).
Michel De Vos
Michel De Vos
- Current Job: Michel De Vos, MD, PhD, is a senior medical director at Brussels IVF, the Centre for Reproductive Medicine at Universitair Ziekenhuis Brussel, Belgium and an associate professor in reproductive medicine at Vrije Universiteit Brussel.
- Education & Training: He studied medicine in Ghent, Belgium (MD 1997), has been a gynaecologist since 2006 and holds a PhD in medicine from the University of Leeds, United Kingdom (2007). In 2011, he was recognised as a subspecialist in reproductive medicine and surgery by ESHRE and the European Board and College of Obstetrics and Gynaecology (EBCOG).
- Research Activity: His main research focus is on fertility treatment in women with polycystic ovary syndrome and on fertility preservation.
- Honors & Recognitions: He is the current Chair of the In Vitro Maturation Special Interest Group of the ASRM. He is a member of the Female Oncofertility Scientific Committee of The Oncofertility Consortium of Michigan State University.
María José De Los Santos
Maria José de los Santos, Msc, Ph.D
Education & Training:
Dr. Maria J. de los Santos started her career in 1991 in the IVF laboratory of IVI Valencia. She received her PhD in Biology from University of Valencia in 1996, and from 1996-1999 she carried out her postdoctoral fellowship in Reproductive Immunology at Fearing Research Laboratory at Harvard Medical School, under the supervision of Dr. Deborah Anderson and Dr. Joseph Hill. She also worked as clinical embryologist at the Brigham and Women´s Hospital under the direction of Dr. Catherine Racowsky.
As a clinical ESHRE and ASEBIR Senior Clinical Embryologist and researcher her main focus is study embryo quality, embryo development and in vitro embryo culture conditions. Currently, she is the Director of the Clinical Embryology Laboratory at IVI Valencia and designated participant from Spanish Government for the 3rd, 4th and 5th edition of “Guide to the Quality and Safety of Tissues and Cells for Human Application” of the European Council.
Research Activity
She has published over 40 original “peer review” articles in leading reproductive journals (Hum Reprod, Fertil & Steril, PLos One, etc.) and wrote more than 20 book chapters. She has also participated as researcher in competitive projects funded by Generalitat Valenciana (IMPIVA) APOTI, ACIF, and Spanish Government , CDTI , FIS. Dr. De los Santos has been involved in teaching since his early career, imparting courses since 1996. Presently she is the Coordinator of two modules (The Clinical Embryology Laboratory and Improving Embryo Quality) from the Master's Degree in Biotechnology of Assisted Human Reproduction (former doctorate degree of the Pediatrics, Obstetrics and Gynaecology Department of University of Valencia School of Medicine) given by ADEIT since 2001.
Memberships:
1992-present Member of Sociedad Española de Infertilidad (SEF)
1993-present Member of ASEBIR
1999-2004 Member of ESHRE
2004-2009 Board Member of ASEBIR
2009-2013 President of the Interest Group in Embryo Quality of ASEBIR
2013-2015 Deputy of the Interest Group in Embryo Quality of ASEBIR
2010-2013 Deputy Member of Special Interest Group in Embryology ESHRE
2013-2015 Coordinator of Special Interest Group in Embryology ESHRE
2015-present Past -Coordinator of Special Interest Group in Embryology ESHRE
2013- present Member of National Spanish Registry of Activity ( SEF Registry)
2015-preset Designated participant from Spanish Government for the 3rd , 4th and 5th edition of “Guide to the Quality and Safety of Tissues and Cells for Human Application” of the European Council
2021- present Member ESHRE Working Group Guidelines in Implantation failure
Education and Training
B.Sc. Biology. University of Valencia, Spain (1990), Spain
Master Degree Biology of Reproduction. University of Valencia, Spain (1991), Spain
Ph.D (Biology) Valencia School of Medicine. University of Valencia, Spain (1996)
Fellowship Postdoctoral fellowship on Immunology of Reproduction at Fearing Research Laboratory. Harvard Medical School, MA, USA (1996-1999)
Grants WILLIAM F. MILTON FUNDATION 1997 Real Colegio Complutense (RCC), Harvard 1998
Honors and Recognition
1991 Sociedad Española de Infertilidad Award. Alicante. Spain.
1994 American Fertility for Reproductive Medicine Award. Seattle. USA.
1995 Sociedad Española de Infertilidad Oral Communication Award. Tenerife. Spain.
2000 Sociedad Española de Infertilidad Oral Communication Award. Sevilla. Spain.
2009 ASEBIR Best Clinical Oral Communication Award. Valencia. Spain
2013 Associate Editor of Medres
Publications
- 1. Martínez-Granados L, Cuevas I, Prados F, Isabel Pons I, de Andrés M, Sánchez-Castro L Lafuente R, de los Santos MJ, Herrero J, Cabello Y, Castel AB , Rodríguez I, Gijón L, Castilla JA Registro Nacional de Actividad – Registro de la Sociedad Española de Fertilidad de fecundación in vitro e inyección espermática intracitoplasmática: años 2018 y 2019, Medicina Reproductiva y Embriología Clínica, Volume 9, Issue 2, 2022,100116
- 2. Pardiñas M L, , Martin A, David Ortega-Jaén D, De los Santos JM Viloria ; Gámiz P, De los Santos MJ Sperm DNA fragmentation and microfluidics: A new era in human sperm selection edicina Reproductiva y Embriología Clínica, Volume 9, Issue 3,2022, 100121
- 3. Ortega-Jaén D, Martin A,. Pardiñas M.L, Mifsud A, Mercader A, De los Santos M.J. Extended embryo culture up to 14 days, Medicina Reproductiva y Embriología Clínica, Volume 9, Issue 3, 2022,100118
- 4. Labarta, E., M. J. De Los Santos, et al. (2019). "Mitochondria as a tool for oocyte rejuvenation." Fertil Steril 111(2): 219-226.
- 5. Labarta, E., M. J. De Los Santos, et al. (2019). "Autologous mitochondrial transfer as a complementary technique to intracytoplasmic sperm injection to improve embryo quality in patients undergoing in vitro fertilization-a randomized pilot study." Fertil Steril 111(1): 86-96.
- 6. De Los Santos MJ, Diez Juan A 2, Mifsud A, Mercader A, Meseguer M, Rubio C Pellicer A. Variables associated with mitochondrial copy number in human blastocysts: what can we learn from trophectoderm biopsies? Fertil Steril In press
- 7. Bellver J, De Los Santos MJ, Alama P, Castello D, Privitera L, Galliano D, Labarta E, Vidal C, Pellicer A and Dominguez F. Day-3 embryo metabolomics in the spent culture media is altered in obese women undergoing in vitro fertilization. Fertility and sterility 2015; 103:1407-1415 e1401.
- 8. Cobo A, Bellver J, De Los Santos MJ and Remohi J. Viral screening of spent culture media and liquid nitrogen samples of oocytes and embryos from hepatitis B, hepatitis C, and human immunodeficiency virus chronically infected women undergoing in vitro fertilization cycles. Fertility and sterility 2012; 97:74-78.
- 9. Cobo A, Bosch E, Alvarez C, De Los Santos MJ, Pellicer A and Remohi J. Effect of a sharp serum oestradiol fall before HCG administration during ovarian stimulation in donors. Reproductive biomedicine online 2007; 15:169-174.
- 10. Cobo A, De Los Santos MJ, Castello D, Gamiz P, Campos P and Remohi J. Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3,150 warming cycles. Fertility and sterility 2012; 98:1138-1146 e1131.
- 11. Cobo A, Perez S, De Los Santos MJ, Zulategui J, Domingo J and Remohi J. Effect of different cryopreservation protocols on the metaphase II spindle in human oocytes. Reproductive biomedicine online 2008; 17:350-359.
- 12. Cobo A, Romero JL, Perez S, De Los Santos MJ, Meseguer M and Remohi J. Storage of human oocytes in the vapor phase of nitrogen. Fertility and sterility 2010; 94:1903-1907. 13. De Los Santos MJ. Reply of the authors. Fertility and sterility 2014; 101:e35.
- 14. De Los Santos MJ, Anderson DJ, Racowsky C, Simon C and Hill JA. Expression of interleukin-1 system genes in human gametes. Biology of reproduction 1998; 59:1419-1424.
- 15. De Los Santos MJ, Apter S, Coticchio G, Debrock S, Lundin K, Plancha CE, Prados F, Rienzi L, Verheyen G, Woodward B et al. Revised guidelines for good practice in IVF laboratories (2015). Hum Reprod 2016; 31:685-686.
- 16. De Los Santos MJ, Gamiz P, Albert C, Galan A, Viloria T, Perez S, Romero JL and Remohi J. Reduced oxygen tension improves embryo quality but not clinical pregnancy rates: a randomized clinical study into ovum donation cycles. Fertility and sterility 2013; 100:402-407.
- 17. De Los Santos MJ, Gamiz P, de Los Santos JM, Romero JL, Prados N, Alonso C, Remohi J and Dominguez F. The Metabolomic Profile of Spent Culture Media from Day-3 Human Embryos Cultured under Low Oxygen Tension. PloS one 2015; 10:e0142724.
- 18. De Los Santos MJ, Garcia-Laez V, Beltran D, Labarta E, Zuzuarregui JL, Alama P, Gamiz P, Crespo J, Bosch E and Pellicer A. The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: Is it hypoandrogenic? Hum Reprod 2013; 28:224-229.
- 19. De Los Santos MJ, Garcia-Laez V, Beltran-Torregrosa D, Horcajadas JA, Martinez-Conejero JA, Esteban FJ, Pellicer A and Labarta E. Hormonal and molecular characterization of follicular fluid, cumulus cells and oocytes from pre-ovulatory follicles in stimulated and unstimulated cycles. Hum Reprod 2012; 27:1596-1605.
- 20. De Los Santos MJ, Mercader A, Frances A, Portoles E, Remohi J, Pellicer A and Simon C. Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development. Biology of reproduction 1996; 54:563-574.
- 21. De Los Santos MJ and Ruiz A. Protocols for tracking and witnessing samples and patients in assisted reproductive technology. Fertility and sterility 2013; 100:1499-1502.
- 22. Escriba MJ, Escobedo-Lucea C, Mercader A, De Los Santos MJ, Pellicer A and Remohi J. Ultrastructure of preimplantation genetic diagnosis-derived human blastocysts grown in a coculture system after vitrification. Fertility and sterility 2006; 86:664-671.
- 23. Escriba MJ, Zulategui JF, Galan A, Mercader A, Remohi J and De Los Santos MJ Vitrification of preimplantation genetically diagnosed human blastocysts and its contribution to the cumulative ongoing pregnancy rate per cycle by using a closed device. Fertility and sterility 2008; 89:840-846.
- 24. Escrich L, Grau N, De Los Santos MJ, Romero JL, Pellicer A and Escriba MJ. The dynamics of in vitro maturation of germinal vesicle oocytes. Fertility and sterility 2012; 98:1147-1151.
- 25. Gamiz P, Rubio C, De Los Santos MJ, Mercader A, Simon C, Remohi J and Pellicer A. The effect of pronuclear morphology on early development and chromosomal abnormalities in cleavage-stage embryos. Hum Reprod 2003; 18:2413-2419.
- 26. García Léaez V, De los Santos JM, Serra V, Pellir A, De Los Santos MJ. Expresión del complejo principal de histocompatibilidad (MHC) clase I y clase II en gametos humanos Revista Iberoamericana de Fertilidad 2008; 25.
- 27. Gil-Salom M, Minguez Y, Rubio C, De Los Santos MJ, Remohi J and Pellicer A. Efficacy of intracytoplasmic sperm injection using testicular spermatozoa. Hum Reprod 1995; 10:3166-3170.
- 28. Gil-Salom M, Romero J, Minguez Y, Rubio C, De Los Santos MJ, Remohi J and Pellicer A. Pregnancies after intracytoplasmic sperm injection with cryopreserved testicular spermatozoa. Hum Reprod 1996; 11:1309-1313.
- 29. Gimeno MA MM, De los Santos JM, Pellicer A, Remohi J, De Los Santos MJ. Estudio comparativo de dos medios de cultivo HTF e ISM-1: implicaciones en el fenotipo embrionario y resultados clínicos Revista Iberoamericana de Fertilidad 2006; 23.
- 30. Gomez E, De Los Santos MJ, Ruiz A, Tarin JJ, Remohi J and Pellicer A. Effects of epidermal growth factor in the final stages of nuclear and cytoplasmic oocyte maturation in humans. Hum Reprod 1993; 8:691-694.
- De Los Santos MJ, Anderson DJ, Racowsky C and Hill JA. Presence of Fas-Fas ligand system and bcl-2 gene products in cells and fluids from gonadotropin-stimulated human ovaries. Biology of reproduction 2000; 63:1811-1816.
- 32. Kovacic B, Plas C, Woodward BJ, Verheyen G, Prados FJ, Hreinsson J, De Los Santos MJ, Magli MC, Lundin K and Plancha CE. The educational and professional status of clinical embryology and clinical embryologists in Europe. Hum Reprod 2015; 30:1755-1762.
- 33. Mendoza R, Perez S, De Los Santos MJ ,Larreategui Z, Ayerdi F, Exposito A, Burgos J, Martinez Indart L, Pijoan JI and Matorras R. Congenital malformations, chromosomal abnormalities and perinatal results in IVF/ICSI newborns resulting from very poor quality embryos: a case-control study. Gynecologic and obstetric investigation 2015; 79:83-89.
- 34. Meseguer M, De Los Santos MJ, Simon C, Pellicer A, Remohi J and Garrido N. Effect of sperm glutathione peroxidases 1 and 4 on embryo asymmetry and blastocyst quality in oocyte donation cycles. Fertility and sterility 2006; 86:1376-1385.
- 35. Motato Y, De Los Santos MJ, Escriba MJ, Ruiz BA, Remohi J and Meseguer M. Morphokinetic analysis and embryonic prediction for blastocyst formation through an integrated time-lapse system. Fertility and sterility 2016; 105:376-384 e379.
- 36. Muriel L, Garrido N, Fernandez JL, Remohi J, Pellicer A, De Los Santos MJ and Meseguer M. Value of the sperm deoxyribonucleic acid fragmentation level, as measured by the sperm chromatin dispersion test, in the outcome of in vitro fertilization and intracytoplasmic sperm injection. Fertility and sterility 2006; 85:371-383.
- 37. Pellicer A, De Los Santos MJ and Remohi J. Simultaneous induction of multiple follicular development with gonadotrophins and steroid replacement for in-vitro fertilization. Hum Reprod 1992; 7:606-607.
- 38. Pellicer A, Mari M, De Los Santos MJ, Simon C, Remohi J and Tarin JJ. Effects of aging on the human ovary: the secretion of immunoreactive alpha-inhibin and progesterone. Fertility and sterility 1994; 61:663-668.
- 39. Pellicer A, Tarin JJ, Miro F, Sampaio M, De Los Santos MJ and Remohi J. The use of gonadotrophin releasing-hormone analogues (GnRHa), in in-vitro fertilization: some clinical and experimental investigations of a direct effect on the human ovary. Hum Reprod 1992; 7 Suppl 1:39-47.
- 40. Pinero-Sagredo E, Nunes S, De Los Santos MJ, Celda B and Esteve V. NMR metabolic profile of human follicular fluid. NMR in biomedicine 2010; 23:485-495.
- 41. Remohi J, Gallardo E, Levy M, Valbuena D, De Los Santos MJ, Simon C and Pellicer A. Oocyte donation in women with recurrent pregnancy loss. Hum Reprod 1996; 11:2048-2051.
- 42. Rubio C, Bellver J, Rodrigo L, Bosch E, Mercader A, Vidal C, De Los Santos MJ, Giles J, Labarta E, Domingo J et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility 2013; 99:1400-1407.
- 43. Rubio C, Minguez Y, De Los Santos MJ, Ruiz A and Romero J. Intracytoplasmic sperm injection (ICSI). Frontiers in bioscience : a journal and virtual library 1997; 2:f1.
- 44. Simon C, Gomez E, Mir A, De Los Santos MJ and Pellicer A. Glucocorticoid treatment decreases sera embryotoxicity in endometriosis patients. Fertility and sterility 1992; 58:284-289.
- 45. Simon C, Gutierrez A, Vidal A, De Los Santos MJ, Tarin JJ, Remohi J and Pellicer A. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod 1994; 9:725-729.
- 46. Tarin JJ, De Los Santos MJ, de Oliveira MN, Pellicer A and Bonilla-Musoles F. Ascorbate-supplemented media in short-term cultures of human embryos. Hum Reprod 1994; 9:1717-1722.
- 47. Tejera A, Herrero J, De Los Santos MJ, Garrido N, Ramsing N and Meseguer M. Oxygen consumption is a quality marker for human oocyte competence conditioned by ovarian stimulation regimens. Fertility and sterility 2011; 96:618-623 e612.
- 48. Wang ZC, Yunis EJ De Los Santos MJ, Xiao L, Anderson DJ and Hill JA. T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region. Genes and immunity 2002; 3:38-42.
Patricia Díaz-Gimeno
Patricia Diaz-Gimeno
Patricia Diaz-Gimeno is a full-time research group leader at IVI Foundation leading the Genomic & Systems Reproductive Medicine Research Group (since 2016) and She is also the bioinformatics director of IVI Foundation (since 2014). She is a Miguel Servet principal investigator at Health Research Institute La Fe (IIS La Fe) in infertility and feto-maternal research area in the group of biomarkers, genomic medicine, statistics and massive data analyisis in assisted reproductive treatments. She obtained her Bachelor’s degree in Biological Sciences with a focus on Genetics (2006) with Excellence Award (2007) and Ph.D. in Biomedicine “cum laude” in the Department of Pediatrics, Obstetrics and Gynaecology at University of Valencia School of Medicine (2011) after applying transcriptomics and artificial intelligence methods for the genetic screening of human endometrial factor in infertility. In her postdoctoral training she focused on computational genomic approaches from a systems biology perspective and its related high throughput technologies (2011-2013). Since 2014 she set up a precision medicine group in reproductive genomics to apply machine learning and network models for improving diagnosis and treatment in assited reproduction. Her group have been focused also on researching the underlying molecular mechanisms related to human reproduction and infertility using these technologies. She is specialised in classical experimental molecular procedures, in massive data analysis and in in silico reproductive biomedicine research using data-driven hypotheses.
Francisco Domínguez
Dr Francisco Domínguez
Dr Francisco Domínguez, Curriculum Vitae – Short Version
Endometrial Receptivity and Embryonic Competence Research Leader and Lab manager at IVI Foundation / IIS LaFe
Graduated in Biology from the University of Valencia in 1998 obtained his doctorate degree “cum laude” with extraordinary award in 2003 in the Pediatrics, Obstetrics and Gynaecology Department from the Medicine Faculty of the University of Valencia. He did part of his post-doctorate studies at the CNIC (Spanish National Center for Cardiovascular Research) and at the Hospital de la Princesa in Madrid, as well as at the Principe Felipe Research Center in Valencia.
As a researcher, he has mainly focused on the study of the endometrium and the human embryo implantation process, both at transcriptomic and at proteomic levels, without dismissing the embryonic aspect, developing new non-invasive aneuploidy diagnostic systems.
Dr Domínguez has published over 60 original articles “peer review” in the most prestigious journals in the field of Reproductive Medicine (Hum Reprod, Fertil & Steril, JCEM) and more than 15 book chapters on the human embryo implantation and endometrial receptivity.
He has also participated as researcher in competitive projects both as emerging researcher (Generalitat Valenciana), and as lead researcher (FIS Projects, Miguel Servet contracts), besides acting as regular editor in numerous specialized journals in the field of reproductive medicine. He is former Associated Editor at Human Reproduction, the first Reproductive Medicine journal and the most influential in its field.
Dr. Domínguez has been involved in teaching since his early career, imparting postgraduate courses since as early as 2003 up until now. Presently he is the Coordinator of the Basic Research in Human Reproduction Module from the Master's Degree in Biotechnology of Assisted Human Reproduction (former doctorate degree of the Pediatrics, Obstetrics and Gynaecology Department from the Medicine Faculty of the University of Valencia) imparted by ADEIT since 2001.
Dr. Domínguez has also worked as Scientific Director at Embryomics, an organization dedicated to the development of non-invasive aneuploidy diagnostic systems, from 2009 until June 2011 and he has received several awards for his research projects, among which the ICIRA Award in 2009, the Spanish Fertility Society Award (2000) and the Merck-Research Foundation Award (2004, 2015 and 2021) Presently he is full-time head investigator at IVI Foundation/ IIS LaFe.
Education and Training
BS University of Valencia (1998), Spain
Ph.D (Biology) University of Valencia (2003), Spain
Honors and Recognition
|
Merck-Serono Award, Merck Research. Fertility Area |
2021 |
|
Merck-Serono Award, Salud 2000 Foundation. Clinical investigation Area |
2015 |
|
Merck Serono Award, Salud 2000 Foundation. Clinical investigation Area |
2004 |
|
ICIRA Award, to the best IVF innovation Project
|
2009 |
|
Spanish Fertility Society Award |
2000 |
|
Associate Editor Human Reproduction |
2013- |
Mike Eisenberg
Michael L. Eisenberg
Michael L. Eisenberg, MD
Professor of Urology and Obstetrics & Gynecology
Director, Male Reproductive Medicine and Surgery
Stanford University School of Medicine
Michael L. Eisenberg, MD earned his bachelor degree from Rice University and his medical doctorate from Yale School of Medicine. He completed his internship and residency in urology at the University of California, San Francisco and a Male Reproductive Medicine and Microsurgery fellowship at Baylor College of Medicine in Houston, Texas. He is board certified in urology.
He joined Stanford University in 2011 to start the Male Reproductive Medicine and Surgery program. Dr. Eisenberg serves as an editorial editor of Fertility and Sterility and associate editor of Andrology, on the editorial boards of the Journal of Assisted Reproduction and Genetics and the World Journal of Men’s Health, and as an ad hoc referee for dozens of leading medical journals and has himself authored numerous peer-reviewed articles. His laboratory seeks to understand the association between a man’s reproductive and overall health as well as the control of spermatogenesis. As a thought leader, he also advises several companies in the reproductive and sexual health space.
Caterina Exacoustos
Caterina Exacoustos, MD, PhD
Associate Professor
University of Rome "Tor Vergata"
Department of Surgical Sciences
Obstetric and Gynecological Unit
University Hospital "Policlinico Tor Vergata"
Viale Oxford 81
00133 Rome ITALY
Mobile +3358303976
E-mail :
Prof. Caterina Exacoustos was born in Rome, Italy, from German father and Italian mother and has greek grand-grand father. She is an associate Professor of Ob/Gyn at the University of Rome Tor Vergata, Italy. She received her medical degree at the Catholic University of Rome in 1984 and completed in 1989 the Ob/Gyn residency and then a fellowship in obstetric and gynecological ultrasound in the same university. During that time her clinical and research interest was mostly on perinatal medicine and she had several important publications in this field. She has been attached since 1993 to the University of Rome ‘Tor Vergata’ in the Department of Obstetrics and Gynecology initially as research fellow then as researcher and now as associate professor. Since 1993 working with endoscopic surgical teams she test the advantages of the use of transvaginal ultrasound as presurgical diagnostic tool and for an accurate management of gynecological diseases. She spends also in 2010 a sabbatical year in US at the University of Connecticut as invited professor teaching 3D transvaginal ultrasound. Actually her main areas of interest are endometriosis and benign diseases including uterine pathology and infertility. She has published more than 150 scientific articles of more than 100 peer reviewed and more than 15 book chapters both in English and in Italian. She has been invited to numerous scientific meetings and conferences of gynecological pathology as speaker in Europe and USA. She has extensive experience in gynecologic ultrasound together with a long history in training activities in several ultrasound courses.
Marcos Ferrando
Marcos Ferrando Serrano
Current Job
- Medical Director IVI Bilbao (2009- ongoing)
Education & Training
- Master’s degree in Medical Direction and Clinical Managemet, Instituto de Salud Carlos III.Ministerio de Sanidad. UNED. 2013
- Master’s degree in Endoscopic gynecologycal surgery, Hospital La Fe, Valencia, 2010
- Specialist in obstetrics and gynecology, Hospital La Fe, Valencia, 2007
- Master’s degree in Human Reproduction. Universidad Complutense de Madrid. Sociedad Española de Fertilidad. 2006.
- Doctoral Program in Obstetrics and Gynaecology. Pediatrics, Obstetrics and Gynaecology Department. University of Valencia 2005.
- Medicine and Surgery, University of Valencia, 2002.
Research Activity
- Participation in 33 Clinical Research Projects (national and international), 24 of them as Principal Investigator and 9 as Secondary Researcher. . Some of these projects are founded by Basque Government:
- ETORGAI in 2010
- GAITEK. SPRI in 2013, 2014
- HAZITEK. SPRI. 2015, 2016, 2018
- Author or co-author in 29 publications on assisted reproductive medicine
- Author or co-author in 100 book chapters related to assisted reproductive medicine
- Co-author in one book in the field of reproductive medicine
- 78 abstracts at national and international congresses on Human Reproductive Medicine
Honors & Recognitions
- Member of Spanish Obstetrics and Gynaecology Society (SEGO)
- Member of Spanish Fertility Society (SEF) and European Society of Human Reproduction and Embryology (ESHRE)
- Member of International Fertility Preservation Society
- Best medical resident doctor award. 2007. Hospital La Fe.
- Higher diploma in Research Methodology. Instituto San Carlos III. Ministerio de Sanidad.
- Coordinator in several courses related to reproductive medicine.
- Speaker at several national and international meetings related to reproductive medicine.
Nicolás Garrido
Nicolás Garrido Puchalt
Nicolás Garrido Puchalt, Ph.D., M.Sc., is the Director of IVI Foundation, and Director of Research Administration at IVI RMA Global. Dr. Garrido obtained his B.Sc. in Biology from the University of Valencia in 1997, followed by a Post-graduate Research Fellowship at the Department of Gynaecology, Heinrich-Heine University, in Düsseldorf, Germany.
He obtained his Doctorate Degree from the University of Valencia in 2001, receiving the Extraordinary Prize in 2002, and a Master’s Degree in Research Methodology: Design and Statistics in Health Sciences from the Universitat Autònoma de Barcelona (UAB) in 2009, in Science and Innovation Management in 2018 and in Project Management in 2020, both from Universidad Politécnica de Valencia. He served as the Director of the Andrology Laboratory and Sperm Bank at the IVI University Institute in Valencia from 2000 until 2016, and lead the IVI Teaching Program starting in 2004, and afterwards the IVI Learning Center until 2017.
He is an Adjunct Professor at the University of Valencia, heading numerous research projects funded by the local and federal governments. His research interests include male infertility, sperm physiology, sperm selection techniques, biomarkers of fertility, and statistical approaches to measure ART success.
He authored or co-authored over 350 abstracts, wrote more than 80 book chapters, and 160 original or review articles in scientific journals. He received the Spanish Fertility Society Award in 2002 and 2004, the Spanish Urology Association Award in 2004, the American Society of Andrology Award (2007, 2010, 2011), and the Salud 2000 Foundation Award in 2010, among others.
Dr. Garrido is currently Section Editor at RBM Online, served as Associate Editor for Fertility and Sterility, and is also Ad Hoc Reviewer for the Journal of Assisted Reproduction Genetics, Reproductive BioMedicine Online, Human Reproduction, and Reproductive Biology and Endocrinology, and Andrology, in the field, among others and as the editor for a textbook on Male Fertility.
Currently he is also the Coordinator for ESHRE of the Special Interest Group for Andrology.
Daniella Gilboa
Daniella Gilboa
Daniella is an entrepreneur, embryologist and biostatistician, Daniella is CEO and co-founder of AiVF, which is developing an AI driven end-to-end platform for fertility care. Harnessing her reputation in the IVF industry, AiVF is working with international well-known institutions. Daniella speaks worldwide on new technologies in IVF as well utilizing deep technology in healthcare.
Norbert Gleicher
Dr. Norbert Gleicher
Current Job:Dr. Norbert Gleicher is the President, Medical Director, and Chief Scientist of the Center for Human Reproduction (CHR), which was founded in 1981, after completing his residency at the Mount Sinai School of Medicine in New York and holding top academic and administrative positions in various academic institutions in New York and Chicago. He is also the Founder and President of the Foundation for Reproductive Medicine.
Education & Training:
Dr. Gleicher completed his medical studies at the Medical University of Vienna. After preclinical years, he graduated and completed an internship at the Tel Aviv University Sackler School of Medicine in Israel. He then moved to New York City for a residency in obstetrics and gynecology, and a fellowship in reproductive immunology at Mount Sinai Medical Center.
Research Activity:
Always keen on simultaneously pursuing clinical care and research, Dr. Gleicher has published hundreds of peer-reviewed medical journal articles, abstracts, and book chapters, in addition to editing textbooks that are now regarded as classics. To view Dr. Gleicher’s research, click here:
https://www.researchgate.net/scientific-contributions/Norbert-Gleicher-2082706001
Honors & Recognitions:
Among many honors and awards, Dr. Gleicher was awarded the Dr. Solomon Silver Award in Clinical Medicine as the chief resident of Mount Sinai Hospital in 1979.
Anne Gompel
Anne GOMPEL, MD, PhD
Jacob Hanna
Department of Molecular Genetics
Born in Rama, an Arab Palestinian village in the Galilee region of Israel, Prof. Jacob (Yaqub) Hanna earned his BSc in medical science (2001), PhD in immunology (2007), and MD in clinical medicine summa cum laude (2007) from the Hebrew University of Jerusalem. He conducted postdoctoral research at the Whitehead Institute for Biomedical Research at MIT. He joined the department of Molecular Genetics at the Weizmann Institute in 2011.
Prof. Hanna is pioneering techniques in induced naïve pluripotency from adult cell and synthetic whole embryo models made solely from stem cells ex utero. Induced pluripotent stem (iPS) cells have regenerative properties almost identical to those of embryonic stem cells, but can be created from adult cells without using an egg or fetal material. Prof. Hanna was the lead researcher in a study that showed how further-modified iPS cells could be used to treat sickle-cell anemia in mice, the first proof of concept of the therapeutic application of iPS cells. Prof. Hanna has uncovered novel pathways regulating the reprogramming process and was the first to derive pristine “naïve” human pluripotent cells equivalent to those derived from mice and (i) can generate “cross-species humanized chimeric” mouse models that have human derived tissues (ii) can give rise to human primordial germ cell (progenitors of egg or sperm) or (iii) to all extra-embryonic compartments (placenta and yolk-sac). He was the first to expand prolonged periods of advanced and normal mammalian embryo development from pre-gastrulation until late organogenesis in an “artificial uterus” environment outside the maternal womb. The latter platform enabled him to demonstrate the ability to be the first to generate advanced stage whole synthetic embryos made entirely from naïve pluripotent stem cells in the petri dish, that can complete gastrulation and demonstrate organ formation within adequate extra-embryonic compartments. In addition to demonstrating the power of cell reprogramming and ex utero synthetic advanced embryogenesis, his work offers the promise of powerful new research models for degenerative diseases, infertility, and modelling human early development.
During his postdoctoral work, Prof. Hanna received a prestigious Novartis Fellowship from the Helen Hay Whitney Foundation. In 2010, he was awarded the Sir Charles Clore Prize for Outstanding Appointment in the Weizmann Institute. He received an EMBO young investigator award (2012), a Rappaport Prize in biomedical research (2013), a Krill Prize by the Wolf Foundation (2013), and the Helen and Martin Kimmel Award for Innovative Investigation (2014). In 2014, he was featured among “40 under 40” innovative scientists by the prestigious journal Cell and was elected as a member of EMBO in 2018. In 2021, he ranked at the top of the list of 50 leading world thinkers by Prospect magazine.
Sonia Herraiz
Sonia Herraiz, Ph.D.- Biosketch
Dr. Sonia Herraiz is a full-time scientist at IVI Foundation leading the Ovarian rejuvenation and Fertility Preservation research group, visiting scholar at Stanford University Medical School in the Department of OB/GYN, member of the Reproductive Medicine group at the Instituto Investigación Sanitaria La Fe, and part of the Fertility Preservation Unit at La Fe University Hospital in Valencia.
She graduated in Biology at University of Valencia in 2003, and joined IVI Foundation in 2006 where she obtained her PhD degree by the University of Valencia in 2010.
Her scientific career is focused in the achievement of ovarian rejuvenation by several approaches like the autologous stem cell transplantation or the ovarian fragmentation. She is also focused in the development of new alternatives for Fertility Preservation in cancer patients where the ovarian transplantation is contraindicated, the improvement of ovarian tissue cryopreservation and transplantation techniques as well as. She has participated in several projects funded by the Spanish Ministry of Economy and the Valencian Health Agency as well as from different private institutions.
As a researcher, she completed a one-year postdoctoral stay at the University of Edinburgh (2012-2013) and a 1.5-year stay at Stanford University (2016-2018).
She has authored over 20 peer-reviewed scientific papers and book chapters in international journals and presented over 30 communications in congresses. She has been prized by the Spanish Fertility Society in 2016. Furthermore, is ad-hoc reviewer for different journals classed within the top-ten of Ob/Gyn and has been prized as Star reviewer by Fertility and Sterility.
Professor in the Master’s Degree in Biotechnology of Assisted Human Reproduction (University of Valencia, UV) since 2016. Is co-director of 6 Thesis projects in UV and 3 Degree Final Project in Biotechnology at Polytechnic University of Valencia (UPV).
She has participated as a lecture in several courses and workshops organized by the International Society of Fertility Preservation, Spanish Society for Fertility, Spanish Society of Medical Oncology and IVI.
Education and Training
BSc University of Valencia (2003), Spain
PhD (Biology) University of Valencia (2010), Spain
Fellowship University of Edinburgh (2012)
Fellowship Stanford University School of Medicine (2016)
Memberships
|
2017 |
|
2016 |
|
2011 |
|
2010 |
Teaching experience in Workshops and courses
|
2017 |
|
2017 |
|
2014 |
|
2013 |
|
2014 |
Honors and Recognition
|
2016 |
|
2016 |
|
2016 |
|
2009 |
Linkedin: https://www.linkedin.com/in/sonia-herraiz-raya-6ab91719/
Jim Hotaling
James M. Hotaling
Curriculum Vitae
Last Updated: 10/30/2018
PERSONAL DATA
|
Name: James M. Hotaling |
|
Citizenship: United States |
EDUCATION
|
Years |
Degree |
Institution (Area of Study) |
|
1998 - 2002 |
B.A. |
Dartmouth College (Biophysical Chemistry & History. Magna Cum Laude) |
|
2002 - 2006 |
M.D. |
Duke University School of Medicine (Medicine) |
|
2006 - 2007 |
Intern |
University of Washington School of Medicine (Surgery) |
|
2008 - 2012 |
Resident |
University of Washington School of Medicine (Urology) |
|
2009 - 2010 |
M.S. |
University of Washington School of Public Health (Epidemiology) |
|
2012 - 2013 |
Fellow |
University of Illinois at Chicago School of Medicine, Department of Urology (Andrology) |
BOARD CERTIFICATIONS
|
02/28/2016 - Present |
American Board of Urology, Certified |
CURRENT LICENSES/CERTIFICATIONS
|
2011 - Present |
DEA Certificate |
|
2014 - Present |
European Committee of Sexual Medicine: Certification |
ACADEMIC HISTORY
Obstetrics/Gynecology (General OB/GYN), 05/17/2016 - Present
|
05/17/2016 |
Hire, Adjunct Track, Adjunct Assistant Professor |
Surgery (Urology), 09/15/2013 - Present
|
09/15/2013 |
Hire, Tenure Track - Clinician Scholar, Assistant Professor |
PROFESSIONAL EXPERIENCE
Full-Time Positions
|
2013 - Present |
Assistant Professor, University of Utah, Salt Lake City, UT |
Editorial Experience
|
2012 - Present |
Interactive Associate Editor for Fertility & Sterility, online forum |
|
2014 - Present |
Speciality Editor for International Journal of Impotence Research |
|
2014 - Present |
Section Editor, Ytube Videos for Urology Times |
|
2016 - Present |
Section Editor, Male Infertility, Urology Times |
|
2016 - Present |
Specialty Editor for Fertility & Sterility |
|
2017 - Present |
Section Editor, Tech Talk With Steve & Jim, Urology Times |
|
2017 - Present |
Associate editor for Journal of Assisted Reproduction and Genetics |
Reviewer Experience
|
Ad Hoc Reviewer for Andrology |
|
Ad Hoc Reviewer for Fertility & Sterility |
|
Ad Hoc Reviewer for International Journal of Impotence Research |
|
Ad Hoc Reviewer for Journal of Urology |
|
Ad Hoc Reviewer for PLOS One Medicine |
|
Ad Hoc Reviewer for Systems Biology in Reproductive Medicine |
SCHOLASTIC HONORS
|
1998 - 1999 |
Citations in General Chemistry and Molecular Biology, obtained the highest grade in the class for a given course. |
|
2000 |
Richter Research Grant of $2100 to pursue research in chemistry. Dartmouth College. |
|
2002 |
Honors in Chemistry graduate at Dartmouth College. |
|
2002 |
Presidential Scholar Research Assistant. Dartmouth College. |
|
2004 |
Duke Department of Orthopedics and General Surgery $10,000 scholarship. Duke University School of Medicine. |
|
2004 |
Received Gold Star for excellent patient care. Duke University School of Medicine. |
|
2008 |
American Urologic Association Western Section Resident Scholarship. University of Washington Department of Urology. |
|
2009 |
International Volunteers in Urology Scholarship: $2500: to support travel to Uganda to work with Dr. Stephen Watya. |
|
2009 |
Hirschler Prize for Innovative Urologic Research: $2000 for: “Development of a prospective database to standardize and track trauma outcomes”. University of Washington Department of Urology. |
|
2010 |
Hirschler Prize for Innovative Urologic Research: $4000 for: “Sperm Cryopreservation Oncological Databank”. University of Washington Department of Urology. |
|
2010 |
Summer Institute in Statistical Genetics Training Scholarship: $2400. University of Washington Department of Urology. |
|
2010 |
AUA Annual Meeting Abstract selected for Meet the Press: “Long-term use of supplemental vitamin C, vitamin D and vitamin E does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins and Lifestyle study.” University of Washington Department of Urology. |
|
2010 |
AUA Poster Selected as Best Poster in Session: “Isolated Teratospermia does not appear to predict clinical pregnancy following in vitro fertilization or in vitro fertilization with intracytoplasmic sperm injection: A systematic review and meta-analysis”. University of Washington Department of Urology. |
|
2010 |
Northwest Institute of Genetic Medicine (NWIGM) Resource Grant for: “A Study of the Genetic Predictors of Erectile Dysfunction”. |
|
2010 |
Warren Chapman Resident Research Award. University of Washington Department of Urology. |
|
2011 |
SMRU Travelling Scholar $1000. |
|
2011 |
Hirschler Prize for Innovative Urologic Research: $4000 for: “UWPNS360”. |
|
2013 |
AUA Poster selected as Best Poster In Session: "Validity and Reliability of a Smartphone Application of the Assessment of Penile Deformity in Peyronie's Disease." |
|
2013 |
Award of $5,000 from University of Illinois Enterprise Works for Sperm Dx Inc. |
|
2013 |
Fertility & Sterility Reviewer of the Year Award |
|
2014 |
Fertility and Sterility Reviewer of the Year Award |
|
2014 |
AUA Poster selected as Best Poster in Session: " The Male Orgasm" |
|
2015 |
StreamDx awarded 2nd place 2015 Utah Life Sciences Company of the Year, Utah Innovation Awards, Salt Lake City, Utah |
|
2015 |
Trainee Merit Award, American Association of Andrology, 40th Annual Meeting |
|
2015 |
Fertility and Sterility Reviewer of the Year Award |
|
2015 |
The Effect of Spermatotoxic Medication Use on Semen Parameters of Subfertile Men - Best Poster at Western Sections American Urological Association |
|
2016 |
Prize Abstract: Childhood Cancer Risk in the Siblings and Cousins of Men with Poor Semen Quality, 64th Annual Meeting of the Society for Pediatric Urology. San Diego, CA, May 6-8. |
|
2017 |
2nd Place Prize for Best Poster "Population based semen analysis results and fertility among men with inflammatory bowel disease: results from the "SHARE Study" at the American College of Surgeons, Utah Chapter Meeting, Salt Lake City, May 11. |
|
2017 |
Subfertility Health Assisted Reproduction and Environment (SHARE): Trans-generational impacts of male infertility. Early Career Investigator Showcase Selected for Oral Presentation. American Urologic Association Annual Meeting, Boston, May 12-16. |
ADMINISTRATIVE EXPERIENCE
Professional Organization & Scientific Activities
|
2013 |
Committee Member, International Consultation on Urological Diseases, American Society for Men's Health, International Consultation on Men's Health and Infertility, Committee on Epidemiology and Aging |
|
2013 |
Contributing Member, International Consultation on Urological Diseases, American Society for Men's Health, International Consultation of Men's Health and Infertility, Committee on Infertility Treatment |
|
2015 - 2021 |
Member, American Society for Reproductive Medicine, Video Committee |
|
2015 - Present |
Committee Member, Societe Internationale d' Urologie, Content Development for SIU Academy - Infertility/Men's Health, sub-committee of Multimedia Learning Committee |
|
2015 |
Roundtable Moderator, American Society for Reproductive Medicine, Male infertility and comorbidities: Improving male health through proper evaluation. Scientific Congress, Baltimore, MA, Oct 17-21 |
|
2015 |
Co-Moderator, American Society for Reproductive Medicine, Male reproduction and urology: Traveling Scholars, Scientific Congress, Baltimore, MA, Oct 17-21 |
|
2016 - 2019 |
Member, American Society for Reproductive Medicine, Research Committee |
|
2016 |
Task Force Member, American Society for Reproductive Medicine, SMRU Task Force on the role of sexual dysfunction in the male during infertility treatment. |
|
2016 |
Abstract Reviewer, American Society for Reproductive Medicine, 72nd American Society for Reproductive Medicine 2016 Scientific Congress & Expo, Oct. 15-19, Salt Lake City, UT. |
|
2016 |
Roundtable Moderator, American Society for Reproductive Medicine, Sexual Dysfunction and Male Infertility. 72nd American Society for Reproductive Medicine Scientific Congress & Expo, Oct 15-19, Salt Lake City, UT |
|
2016 |
Co-Moderator, American Society for Reproductive Medicine, Oral Abstracts, Male Reproduction and Urology: Clinical 2, at the 72nd American Society for Reproductive Medicine Scientific Congress & Expo, Oct 15-19, Salt Lake City, UT |
|
2016 |
Co-Moderator, American Society for Reproductive Medicine, Video Session 2, 72nd American Society for Reproductive Medicine Scientific Congress & Expo, October 17, Salt Lake City, UT. |
|
2016 |
Invited Moderator, American Urological Association - Western Section, Sexual Medicine, 92nd Annual Meeting, Kauai, HI, Oct. 23-28. |
|
2017 - 2019 |
Officer at Large, Society for the Study of Male Reproduction, (SSMR) American Urological Association 2017-2019 |
|
2017 - Present |
Panel Member, American Urological Association, National Urology Research Agenda 2017 for male infertility, member of agenda panel for American Urological Association |
|
2017 |
Abstract Reviewer, American Society for Reproductive Medicine, Scientific Congress, San Antonio, TX, Oct 28-Nov 1. |
|
2017 |
Roundtable Moderator, American Society for Reproductive Medicine, Update on culturing human spermatogonial stem cells for oncofertility. Scientific Congress, San Antonio, TX, Oct 28-Nov 1. |
|
2018 - 2021 |
Executive Board Member, American Society of Andrology, 2018-2021 |
|
2018 - 2021 |
Program Chair, American Urological Association - Western Section, Program Chair for Sexual Medicine/Andrology Content |
|
2018 |
Session Co-Moderator, American Society for Reproductive Medicine, Video Session 2, 74th ASRM Scientific Congress & Expo, Denver, CO, Oct 6-10 |
|
2018 |
Conference Abstract Reviewer, American Society for Reproductive Medicine, 74th ASRM Scientific Congress & Expo, Denver, CO Oct. 6-10. |
Grant Review Committee/Study Section
|
2016 |
Pregnancy Risk Assessment Monitoring ad hoc study section member, Center for Disease Control |
|
2016 - 2018 |
ASRM Research Grant Reviewer |
PROFESSIONAL COMMUNITY ACTIVITIES
|
2013 |
Interviewee, Clear Channel Radio, on hypogonadism |
|
2014 |
Interviewee, KTVX TV, Good Things Utah appearance on Men's Health |
|
2014 |
Interviewee, KUED, Male Infertility |
|
2015 |
Interviewee, KUTV TV, Men's Health |
|
2016 |
Interviewee, KUTV TV, Vas Madness |
|
2017 |
Interviewee, Brides.com, Male Factor Infertility: What You Need to Know |
|
2018 |
Interviewee, Furthermore from Equinox, Shortsleeve,C, Furthermore.equinox.com; Don’t Overdo Ibuprofen New research shows the anti-inflammatory might negatively affect male fertility. |
UNIVERSITY COMMUNITY ACTIVITIES
University Level
|
2013 |
Presenter, Utah Center for Reproductive Medicine, Testicular Sperm Extraction |
|
2014 - Present |
Member, Entrepreneurial Faculty Scholars |
|
2014 - Present |
Presenter & Member, Utah Center for Reproductive Medicine, Pathways to Pregnancy |
|
2014 |
Presenter, Utah Center for Reproductive Medicine, Fresh Vs. Frozen Sperm for IVF, Nov. 21 |
Health Sciences Level
|
2014 - 2016 |
Co-Founder, Health Sciences Center, Men's Health Center |
|
2014 - Present |
Co-Medical Director, Fertility Integrated Practice Unit |
|
2016 - Present |
Member, Health Sciences Center, Men's Health Shared Governance Board |
University Hospitals & Clinics
|
2015 - 2016 |
Member, University of Utah Hospitals and Clinics, EPIC Urology Division update for SmartForms |
Department Level
|
2017 - Present |
Co-Director/Director, Surgery, Population Data Research Core |
Programs, Centers & Institutes
|
2015 - Present |
Member, Huntsman Cancer Institute, Genitourinary Disease Orientation Team |
CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIES
|
American Diabetes Association |
|
American Society for Reproductive Medicine |
|
American Society of Andrology |
|
American Urological Association |
|
European Association for the Study of Diabetes |
|
European Society for Sexual Medicine |
|
Northwest Urological Society |
|
Society for Male Reproduction and Urology |
|
Society for the Study of Male Reproduction |
|
World Professional Association for Transgender Health |
FUNDING
Active Grants
|
09/10/14 - 05/30/19 |
Genomics of spermatogenic impairment. (1R01HD78641) |
|
02/24/15 - 01/31/18 |
Transgenerational effects of smoking-induced changes to Sperm DNA. (1R01HD082062) |
|
07/01/15 - 06/30/18 |
Impact of diet, exercise and lifestyle on fertility: The IDEAL fertility study. (N275201500001C) |
|
07/01/16 - 06/30/19 |
Susceptibility Genes for Erectile Dysfunction ED eMERGE (1R01DK104764) |
|
04/03/17 - 03/31/19 |
Stream Dx: accurate and efficient, point-of-care uroflometry for improved diagnosis, monitoring, and post-treatment evaluation of LUTS |
|
12/01/17 - 11/30/19 |
Sperm Epigenetic Profiling & Embryonic Competence |
|
04/20/18 - 04/20/20 |
Sperm sample preparation for point of care applications |
Pending Grants
|
04/01/18 - 03/31/19 |
MiOXSYS |
|
02/01/19 - 07/31/21 |
Sbir Nanonc Sept2018 |
Past Grants
|
01/01/09 - 12/31/09 |
NIH T-32 Training Grant, University of Washington |
|
07/01/09 - 07/01/10 |
Genome wide association search identifies potential loci for risk of erectile dysfunction in type 1 Diabetes using the epidemiology of Diabetes interventions and complications study cohort. |
|
01/01/10 - 12/31/10 |
Institute for Translational Health Research (ITHS) Grant: “Development and Validation of a Rapid, Sutureless Circumcision Device to facilitate Dissemination of Safe Adult Male Circumcision to reduce HIV Infection Rates in Africa.” |
|
10/01/10 - 10/01/11 |
Novel single nucleotide polymorphisms may predict ED: Data from the Group Health Adult Changes in Thought Study |
|
04/01/11 - 04/01/12 |
Development and validation of a rapid, sutureless circumcision device to facilitate dissemination of safe adult male circumcision to reduce HIV infection rates in Africa |
|
08/01/13 - 07/31/15 |
URO-EDICII: Risk and Progression of Urologic Complications in Type 1 -Diabetes |
|
09/01/14 - 01/01/15 |
StreamDX |
|
12/01/14 - 12/01/15 |
StreamDX |
|
01/01/15 - 12/31/15 |
Development of a novel microfluidics device to optimize sperm retrieval and storage from micro dissection testicular sperm extraction mTESE |
|
01/01/15 - 12/31/15 |
Testosterone Concentrations and Cardiovascular Disease in Men with Type 1 Diabetes. DiaComp Pilot &Feasibility Project |
|
04/30/15 - 04/30/16 |
StreamDx |
|
05/12/15 - 12/31/15 |
Raman Spectrometer for Novel Microfluidics Applications |
|
07/01/16 - 06/30/17 |
Development of a Novel Microfluidics Device to Optimize Sperm |
TEACHING RESPONSIBILITIES/ASSIGNMENTS
Course Lectures
|
2014 |
Instructor, MS2: Lecture "Men's Health 101", University of Utah |
|
2014 |
Instructor, MS2: Lecture "The GU History and Physical", University of Utah |
|
2015 |
Instructor, MS2: Lecture "Men's Health 101", University of Utah |
|
2015 |
Instructor, MS2: Lecture "The GU History and Physical", University of Utah |
Clinical Teaching
|
2015 - Present |
Developed Male Infertility Clinical Program for Reproductive Endocrinology Fellows |
|
2015 - Present |
Co-director of Reconstructive Urology Fellowship |
Small Group Teaching
|
2014 - 2016 |
Microsurgical Course, Urology, University of Utah School of Medicine, Residents |
Trainee Supervision
|
Fellow |
|
|
2013 - 2014 |
Supervisor, Kristin Murphy, University of Utah. Male infertility/genetics |
|
2013 - 2015 |
Supervisor, Monis Bilal Shamsi, University of Utah. Male infertility/genetics |
|
2013 - 2014 |
Supervisor, Jeff Redshaw, University of Utah. Urology Research Fellow |
|
2014 - Present |
Supervisor, Raheel Samuel, University of Utah |
|
2014 - 2015 |
Supervisor, Darshan Patel, University of Utah |
|
2015 - 2016 |
Supervisor, Jason Chandrapal, University of Utah |
|
2016 - 2017 |
Supervisor, James Craig, University of Utah |
|
2016 - Present |
Supervisor, Soren Keiheui, University of Utah |
|
PhD/Doctorate |
|
|
2014 - 2017 |
Supervisor, Jiyoung Son, University of Utah. Mechanical Engineering |
|
2014 - Present |
Supervisor, Jingtao Guo, University of Utah |
|
MD, PhD |
|
|
2013 - 2014 |
Supervisor, John Gannon, University of Utah. Urology Resident |
|
2014 - Present |
Supervisor, Jeff Redshaw, University of Utah |
|
2015 - Present |
Supervisor, Darshan Patel, University of Utah |
|
2015 - Present |
Supervisor, Ross Anderson, University of Utah |
|
2015 - 2017 |
Supervisor, Vera Trofemenko, University of Utah |
Educational Lectures
Didactic Lectures
|
2013 |
Pathways to Pregnancy with Dr. Ahmad Hammoud |
|
2014 |
Microscopy skills with Urology Residents |
|
2014 |
Pathways to Pregnancy with Dr. Andrew Moore |
|
2014 |
Chemotherapy and Spermatogenesis, presented to HCI Oncologists |
|
2014 |
Erectile dysfunction and male infertility, 2nd year med students, University of Utah |
|
2015 |
Erectile dysfunction and male infertility, 2nd year med students, University of Utah |
Continuing Education
CE Courses Developed
|
2013 - Present |
Surgical Management for Male Infertility. American Urological Association Core Curriculum. |
|
2016 |
Trofimenko V, Jenkins TG, Carrell DT, Hotaling JM. Genetics in Urology: A Urologists Guide. American Urological Association Update Series, Vol 35. |
|
2017 |
Developing A Men's Health Center Post Graduate Course, American Urological Association, May 12, Boston. |
CE Courses Taught
|
2016 |
Value-based Care of the Infertile Male, 49th Annual Pre-Congress Program, 72nd American Society for Reproductive Medicine Scientific Congress & Expo, October 15-19, Salt Lake City, UT |
|
2017 |
Developing A Men's Health Center Post Graduate Course, AUA May 12, 2017 Boston. |
PEER-REVIEWED JOURNAL ARTICLES
|
1. |
Hotaling J, Mulhall JP (1999). Chronology of venous leak development following radical prostatectomy. J Urol, 16(4), 1055A. |
|
2. |
Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB, Flanigan RC (2002). Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol, 167(3), 1371-5. |
|
3. |
Moul JW, Sun L, Hotaling JM, Fitzsimons NJ, Polascik TJ, Robertson CN, Dahm P, Anscher MS, Mouraviev V, Pappas PA, Albala DM (2007). Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol, 177(2), 499-503; discussion 503-4. |
|
4. |
Sun L, Moul JW, Hotaling JM, Rampersaud E, Dahm P, Robertson C, Fitzsimons N, Albala D, Polascik TJ (2007). Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years. BJU Int, 99(4), 753-7. |
|
5. |
Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC Jr, Kane CJ, Terris MK, Aronson WJ, Amling CL (2008). PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database. Eur Urol, 53(4), 758-64; discussion 765-6. |
|
6. |
Wright JL, Hotaling J, Porter MP (2009). Predictors of Upper Tract Urothelial Cell Carcinoma after Primary Bladder Cancer: A Population Based Analysis. J Urol, 181(3), 1035-1039. |
|
7. |
Hotaling JM, Shear S, Lendvay TS (2009). 14-gauge angiocatheter: the assist port. J Laparoendosc Adv Surg Tech A, 19(5), 699-701. |
|
8. |
Wright JL, Risk MC, Hotaling J, Lin DW (2009). Effect of collecting duct histology on renal cell cancer outcome. J Urol, 182(6), 2595-9. |
|
9. |
Hotaling JM, Sorensen MD, Smith TG 3rd, Rivara FP, Wessells H, Voelzke BB (2011). Analysis of diagnostic angiography and angioembolization in the acute management of renal trauma using a national data set. J Urol, 185(4), 1316-20. |
|
10. |
Hotaling JM, Wright JL, Pocobelli G, Bhatti P, Porter MP, White E (2011). Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle study. J Urol, 185(4), 1210-5. |
|
11. |
Hotaling JM, Davenport MT, Eisenberg ML, VanDenEeden SK, Walsh TJ (2012). Men who seek infertility care may not represent the general U.S. population: data from the National Survey of Family Growth. Urology, 79(1), 123-7. |
|
12. |
Vanni AJ, Hotaling J, Hamlat C, Jurkovich GJ, Voelzke BB (2012). Do inclusive trauma systems improve outcomes after renal trauma? J Trauma Acute Care Surg, 72(2), 385-9. |
|
13. |
Hotaling JM, Wang J, Sorensen MD, Rivara FP, Gore JL, Jurkovich J, McClung CD, Wessells H, Voelzke BB (2012). A national study of trauma level designation and renal trauma outcomes. J Urol, 187(2), 536-41. |
|
14. |
Anawalt BD, Hotaling JM, Walsh TJ, Matsumoto AM (2012). Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism. J Urol, 187(4), 1369-73. |
|
15. |
Jacobs MA, Hotaling JM, Mueller BA, Koyle M, Rivara F, Voelzke BB (2012). Conservative management vs early surgery for high grade pediatric renal trauma--do nephrectomy rates differ? J Urol, 187(5), 1817-22. |
|
16. |
Hotaling JM, Walsh TJ, Macleod LC, Heckbert S, Pocobelli G, Wessells H, White E (2012). Erectile dysfunction is not independently associated with cardiovascular death: data from the vitamins and lifestyle (VITAL) study. J Sex Med, 9(8), 2104-2110. |
|
17. |
Hotaling JM, Walsh TJ, Macleod LC, Heckbert S, Pocobelli G, Wessells H, White E (2012). Erectile dysfunction is not independently associated with cardiovascular death: data from the vitamins and lifestyle (VITAL) study. J Sex Med, 9(8), 2104-10. |
|
18. |
Hotaling JM, Waggott DR, Goldberg J, Jarvik G, Paterson AD, Cleary PA, Lachin J, Sarma A, Wessells H (2012). Pilot genome-wide association search identifies potential loci for risk of erectile dysfunction in type 1 diabetes using the DCCT/EDIC study cohort. J Urol, 188(2), 514-20. |
|
19. |
Hotaling JM, Lopushnyan NA, Davenport M, Christensen H, Pagel ER, Muller CH, Walsh TJ (2013). Raw and test-thaw semen parameters after cryopreservation among men with newly diagnosed cancer. Fertil Steril, 99(2), 464-9. |
|
20. |
Macleod L, Hotaling J, Wright JL, Gore JL, Harper J, White E (2013). Risk factors for renal cell carcinoma in the VITAL study. Urol Oncol, 190(5), 1657-1661. |
|
21. |
Walsh TJ, Hotaling JM, Lue TF, Smith JF (2013). How curved is too curved? The severity of penile deformity may predict sexual disability among men with Peyronie's disease. Int J Impot Res, 25(3), 109-12. |
|
22. |
Hsi RS, Hotaling JM, Moore TN, Joyner BD (2013). Publication misrepresentation among urology residency applicants. World J Urol, 31(3), 697-702. |
|
23. |
Hsi RS, Hotaling JM, Hartzler AL, Holt SK, Walsh TJ (2013). Validity and reliability of a smartphone application for the assessment of penile deformity in Peyronie's disease. J Sex Med, 10(7), 1867-1873. |
|
24. |
McClung C, Hotaling J, Wang J, Wessells H, Voelzke B (2013). Contemporary trends in the immediate surgical management of renal trauma using a national database. J Trauma Acute Care Surg, 75(4), 602-606. |
|
25. |
Shih C, Hotaling JM, Wright JL, White E (2013). Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study. Urol Oncol, 31(8), 1689-95. |
|
26. |
Holt S, Lopushnyan N, Hotaling J, Sarma A, Wessells H (2014). Prevalence of Androgen Deficiency and Predisposing Risk Factors in Men with Type I Diabetes Mellitus: Findings from the DCCT/EDIC. J Clin Endocrinol Metab. |
|
27. |
Welty CJ, Wright JL, Hotaling JM, Bhatti P, Porter MP, White E (2014). Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort study. Urol Oncol, 32(1), 25.e21-5. |
|
28. |
Walsh TJ, Hotaling JM, Smith A, Saigal C, Wessells H (2014). Men with diabetes may require more aggressive treatment for erectile dysfunction. Int J Impot Res, May-Jun;26(3), 112-115. |
|
29. |
Kosova G, Hotaling JM, Ohlander S, Niederberger C, Prins GS, Ober C (2014). Variants in DPF3 and DSCAML1 are associated with sperm morphology. J Assist Reprod Genet, 31(2), 131-7. |
|
30. |
Ohlander S, Hotaling J, Kirshenbaum E, Niederberger C, Eisenberg ML (2014). Impact of fresh versus cryopreserved testicular sperm upon intracytoplasmic sperm injection pregnancy outcomes in men with azoospermia due to spermatogenic dysfunction: a meta-analysis. Fertil Steril, 101(2), 344-9. |
|
31. |
Hotaling J, Carrell DT (2014). Clinical genetic testing for male factor infertility: current applications and future directions. Andrology, 2(3), 339-50. |
|
32. |
Hotaling JM, Leddy LS, Haider MA, Mossanen M, Bailey MR, MacConaghy B, Olson F, Krieger JN (2014). Simple circumcision device: proof of concept for a single-visit, adjustable device to facilitate safe adult male circumcision. Fertil Steril, 101(5), 1266-70. |
|
33. |
Simon L, Liu L, Murphy K, Ge S, Hotaling J, Aston KI, Emery B, Carrell DT (2014). Comparative analysis of three sperm DNA damage assays and sperm nuclear protein content in couples undergoing assisted reproduction treatment. Hum Reprod, 29(5), 904-17. |
|
34. |
Kadlec AO, Ohlander S, Hotaling J, Hannick J, Niederberger C, Turk TM (2014). Nonlinear logistic regression model for outcomes after endourologic procedures: a novel predictor. Urolithiasis, 42(4), 323-7. |
|
35. |
Holt SK, Lopushnyan N, Hotaling J, Sarma AV, Dunn RL, Cleary PA, Braffett BH, Gatcomb P, Martin C, Herman WH, Wessells H (2014). Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: findings from the DCCT/EDIC. J Clin Endocrinol Metab, 99(9), E1655-60. |
|
36. |
Myers JB, Hotaling JM, Brant WO (2014). Editorial comment. Urology, 84(4), 933. |
|
37. |
Grimsby GM, Voelzke B, Hotaling J, Sorensen MD, Koyle M, Jacobs MA (2014). Demographics of pediatric renal trauma. J Urol, 192(5), 1498-502. |
|
38. |
Simon L, Murphy K, Shamsi MB, Liu L, Emery B, Aston KI, Hotaling J, Carrell DT (2014). Paternal influence of sperm DNA integrity on early embryonic development. Hum Reprod, 29(11), 2402-12. |
|
39. |
Hotaling JM, Cohen AL, Shiffrin RM, Busemeyer JR (2015). The Dilution Effect and Information Integration in Perceptual Decision Making. PLoS One, 10(9), e0138481. |
|
40. |
Parthiban S, Hotaling JM, Kathrins M, Baftiri AP, Freels S, Niederberger CS (2015). A novel method to determine perineal artery occlusion among male bicyclists. PeerJ, 3, e1477. |
|
41. |
Simon L, Murphy K, Aston KI, Emery BR, Hotaling JM, Carrell DT (2015). Micro-electrophoresis: a noninvasive method of sperm selection based on membrane charge. Fertil Steril, 103(2), 361-6.e3. |
|
42. |
Schliep KC, Mumford SL, Ahrens KA, Hotaling JM, Carrell DT, Link M, Hinkle SN, Kissell K, Porucznik CA, Hammoud AO (2015). Effect of male and female body mass index on pregnancy and live birth success after in vitro fertilization. Fertil Steril, 103(2), 388-95. |
|
43. |
Sarma AV, Hotaling J, Dunn RL, Cleary PA, Braffett BH, Kim C, Martin C, Herman W, Gatcomb P, Jacobson AM, Holt SK, Wessells H (2015). Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes. J Urol, 193(3), 786-93. |
|
44. |
Myers JB, Hotaling JM, Brant WO, Enniss TM (2015). Management of a Case of Severe Pelvic Fracture Related Bladder Trauma. Urol Case Rep, 3(2), 32-4. |
|
45. |
Jenkins TG, Aston KI, Trost C, Farley J, Hotaling JM, Carrell DT (2015). Intra-sample heterogeneity of sperm DNA methylation. Mol Hum Reprod, 21(4), 313-9. |
|
46. |
Patel DP, Brant WO, Myers JB, Zhang C, Presson AP, Johnstone EB, Dorais JA, Aston KI, Carrell DT, Hotaling JM (2015). Sperm concentration is poorly associated with hypoandrogenism in infertile men. Urology, 85(5), 1062-1067. |
|
47. |
Pop-Busui R, Hotaling J, Braffett BH, Cleary PA, Dunn RL, Martin CL, Jacobson AM, Wessells H, Sarma AV (2015). Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC. J Urol, 193(6), 2045-51. |
|
48. |
Patel DP, Redshaw JD, Breyer BN, Smith TG, Erickson BA, Majercik SD, Gaither TW, Craig JR, Gardner S, Presson AP, Zhang C, Hotaling JM, Brant WO, Myers JB (2015). High-grade renal injuries are often isolated in sports-related trauma. Injury, 46(7), 1245-9. |
|
49. |
Hotaling JM, Patel DP, Brant WO, Myers JB, Cullen MR, Eisenberg ML (2015). Demographic and socio-economic differences between men seeking infertility evaluation and those seeking surgical sterilization: from the National Survey of Family Growth. BJU Int, 116(2), 288-92. |
|
50. |
Son J, Murphy K, Samuel R, Gale BK, Carrell DT, Hotaling JM (2015). Non-motile sperm cell separation using a spiral channel. Anal Methods, 7, 8041-8047. |
|
51. |
Patel DP, Brant WO, Myers JB, Presson AP, Johnstone EB, Dorais JA, Aston KI, Carrell DT, Hotaling JM (2015). The safety and efficacy of clomiphene citrate in hypoandrogenic and subfertile men. Int J Impot Res, 27(6), 221-4. |
|
52. |
Parthiban S, Hotaling JM, Kathrins M, Baftiri AP, Freels S, Niederberger CS (2015). A Novel Method to Determine Perineal Artery Occlusion among Male Bicyclists. PeerJ. |
|
53. |
Patel DP, Elliott SP, Stoffel JT, Brant WO, Hotaling JM, Myers JB (2016). Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature. Neurourol Urodyn, 35(1), 8-14. |
|
54. |
Jenkins TG, Aston KI, Meyer TD, Hotaling JM, Shamsi MB, Johnstone EB, Cox KJ, Stanford JB, Porucznik CA, Carrell DT (2016). Decreased fecundity and sperm DNA methylation patterns. Fertil Steril, 105(1), 51-7.e1-3. |
|
55. |
Hanson HA, Anderson RE, Aston KI, Carrell DT, Smith KR, Hotaling JM (2016). Subfertility increases risk of testicular cancer: evidence from population-based semen samples. Fertil Steril, 105(2), 322-8.e1. |
|
56. |
Patel DP, Schenk JM, Darke A, Myers JB, Brant WO, Hotaling JM (2016). Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial. BJU Int, 117(3), 500-6. |
|
57. |
Orchard J, Tward JD, Lenherr S, Hotaling JM, Brant WO, Myers JB (2016). Surgical Management of Ureteral Strictures Arising From Radiotherapy for Prostate Cancer. Urol Case Rep, 6, 47-9. |
|
58. |
Samuel R, Badamjav O, Murphy KE, Patel DP, Son J, Gale BK, Carrell DT, Hotaling JM (2016). Microfluidics: The future of microdissection TESE? Syst Biol Reprod Med, 62(3), 161-70. |
|
59. |
Simon L, Murphy K, Aston KI, Emery BR, Hotaling JM, Carrell DT (2016). Optimization of microelectrophoresis to select highly negatively charged sperm. J Assist Reprod Genet, 33(6), 679-88. |
|
60. |
Anderson RE, Hanson HA, Patel DP, Johnstone E, Aston KI, Carrell DT, Lowrance WT, Smith KR, Hotaling JM (2016). Cancer risk in first- and second-degree relatives of men with poor semen quality. Fertil Steril, 106(3), 731-8. |
|
61. |
Hotaling JM, Sarma AV, Patel DP, Braffett BH, Cleary PA, Feldman E, Herman WH, Martin CL, Jacobson AM, Wessells H, Pop-Busui R (2016). Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes. Diabetes Care, 39(9), 1587-93. |
|
62. |
Jenkins TG, Aston KI, Hotaling JM, Shamsi MB, Simon L, Carrell DT (2016). Teratozoospermia and asthenozoospermia are associated with specific epigenetic signatures. Andrology, 4(5), 843-9. |
|
63. |
Craig JR, Hotaling J, Brant WO (2016). Editorial Comment. J Urol, 196(4), 1089. |
|
64. |
Lenherr SM, Clemens JQ, Braffett BH, Cleary PA, Dunn RL, Hotaling JM, Jacobson AM, Kim C, Herman W, Brown JS, Wessells H, Sarma AV, DCCT/EDIC Research Group (2016). Glycemic control and urinary tract infections in women with Type-1 Diabetes: Results from the DCCT/EDIC. J Urol, 196(4), 1129-1135. |
|
65. |
Lenherr SM, Clemens JQ, Braffett BH, Dunn RL, Cleary PA, Kim C, Herman WH, Hotaling JM, Jacobson AM, Brown JS, Wessells H, Sarma AV (2016). Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabet Med, 33(11), 1528-1535. |
|
66. |
Chandrapal JC, Nielson S, Patel DP, Zhang C, Presson AP, Brant WO, Myers JB, Hotaling JM (2016). Characterizing the safety of clomiphene citrate in male patients through prostate-specific antigen, hematocrit, and testosterone levels. Br J Urol, 118(6), 272. |
|
67. |
Hanson HA, Mayer EN, Anderson RE, Aston KI, Carrell DT, Berger J, Lowrance WT, Smith KR, Hotaling JM (2017). Risk of childhood mortality in family members of men with poor semen quality. Hum Reprod, 32(1), 239-247. |
|
68. |
Anderson RE, Hanson HA, Lowrance WT, Redshaw J, Oottamasathien S, Schaeffer A, Johnstone E, Aston KI, Carrell DT, Cartwright P, Smith KR, Hotaling JM (2017). Childhood Cancer Risk in the Siblings and Cousins of Men with Poor Semen Quality. J Urol, 197(3 Pt 2), 898-905. |
|
69. |
Simon L, Aston KI, Emery BR, Hotaling J, Carrell DT (2017). Sperm DNA damage output parameters measured by the alkaline Comet assay and their importance.LID - 10.1111/and.12608 [doi]. Andrologia, 49(2). |
|
70. |
Rao PK, Boulet SL, Mehta A, Hotaling J, Eisenberg ML, Honig SC, Warner L, Kissin DM, Nangia AK, Ross LS (2017). Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive-Age Men in the United States. J Urol, 197(4), 1121-1126. |
|
71. |
Mayer EN, Tward JD, Bassett M, Lenherr SM, Hotaling JM, Brant WO, Lowrance WT, Myers JB (2017). Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancer. BJU Int, 119(5), 700-708. |
|
72. |
Son J, Samuel R, Gale BK, Carrell DT, Hotaling JM (2017). Separation of sperm cells from samples containing high concentrations of white blood cells using a spiral channel. Biomicrofluidics, 11(5), 054106. |
|
73. |
Hotaling JM (2017). DNA fragmentation: a skeptic sees a bright future. Transl Androl Urol, 6(Suppl 4), S334. |
|
74. |
Carrell DT, Hotaling J (2017). Using sperm testing to improve patient and offspring health: rational, evidence-based care of the infertile male in the ART clinic. Transl Androl Urol, 6(Suppl 4), S443-S445. |
|
75. |
Martin L, Mullaney S, Peche W, Peterson K, Chan S, Morton R, Wan Y, Zhang C, Presson AP, Emery B, Aston K, Jenkins T, Carrell D, Hotaling J (2017). Population-based Semen Analysis Results and Fertility Among Patients With Inflammatory Bowel Disease: Results From Subfertility Health Assisted Reproduction and the Environment (SHARE) Study. Urology, 107, 114-119. |
|
76. |
Palmer MR, Holt SK, Sarma AV, Dunn RL, Hotaling JM, Cleary PA, Braffett BH, Martin C, Herman WH, Jacobson AM, Wessells H (2017). Longitudinal Patterns of Occurrence and Remission of Erectile Dysfunction in Men With Type 1 Diabetes. J Sex Med, 14(10), 1187-1194. |
|
77. |
Oottamasathien S, Hotaling JM, Craig JR, Myers JB, Brant WO (2017). Amniotic therapeutic biomaterials in urology: current and future applications. Transl Androl Urol, 6(5), 943-950. |
|
78. |
Keihani S, Craig JR, Zhang C, Presson AP, Myers JB, Brant WO, Aston KI, Emery BR, Jenkins TG, Carrell DT, Hotaling JM (2017). Impacts of Abstinence Time on Semen Parameters in a Large Population-based Cohort of Subfertile Men. Urology, 108, 90-95. |
|
79. |
Guo J, Grow EJ, Yi C, Mlcochova H, Maher GJ, Lindskog C, Murphy PJ, Wike CL, Carrell DT, Goriely A, Hotaling JM, Cairns BR (2017). Chromatin and Single-Cell RNA-Seq Profiling Reveal Dynamic Signaling and Metabolic Transitions during Human Spermatogonial Stem Cell Development. Cell Stem Cell, 21(4), 533-546.e6. |
|
80. |
Martin L, Peche W, Peterson K, Wan Y, Chan S, Morton R, Zhang C, Presson AP, Hotaling J (2017). Population Based Paternity Rate and Partner Birth Outcomes Among Utah Men With Inflammatory Bowel Disease. Am J Gastroenterol, 112(11), 1722-1727. |
|
81. |
Jenkins TG, James ER, Alonso DF, Hoidal JR, Murphy PJ, Hotaling JM, Cairns BR, Carrell DT, Aston KI (2017). Cigarette smoking significantly alters sperm DNA methylation patterns. Andrology, 5(6), 1089-1099. |
|
82. |
Hotaling JM, Laufer N, Rosenwaks Z (2018). Introduction: Cancer biomarkers and fertility. Fertil Steril, 109(1), 4-5. |
|
83. |
Donnenfeld SR, Keihani S, Young JB, Majercik S, Hotaling JM, Myers JB (2018). The bull's-eye sign: A hallmark radiologic sign of complete ureteropelvic junction disruption after blunt renal trauma. Urol Case Rep, 17, 91-93. |
|
84. |
Keihani S, Xu Y, Presson AP, Hotaling JM, Nirula R, Piotrowski J, Dodgion CM, Black CM, Mukherjee K, Morris BJ, Majercik S, Smith BP, Schwartz I, Elliott SP, DeSoucy ES, Zakaluzny S, Thomsen PB, Erickson BA, Baradaran N, Breyer BN, Miller B, Santucci RA, Carrick MM, Hewitt T, Burks FN, Kocik JF, Askari R, Myers JB (2018). Contemporary management of high-grade renal trauma: Results from the American Association for the Surgery of Trauma Genitourinary Trauma study. J Trauma Acute Care Surg, 84(3), 418-425. |
|
85. |
Keihani S, Anderson RE, Fiander M, McFarland MM, Stoddard GJ, Hotaling JM, Myers JB (2018). Incidence of urinary extravasation and rate of ureteral stenting after high-grade renal trauma in adults: a meta-analysis. Transl Androl Urol, 7(Suppl 2), S169-S178. |
|
86. |
Spektor MS, Kellen D, Hotaling JM (2018). When the Good Looks Bad: An Experimental Exploration of the Repulsion Effect. Psychol Sci, 956797618779041. |
|
87. |
Alder NJ, Keihani S, Hotaling JM, Myers JB (2018). Management of blunt renal trauma in a crossed fused ectopic kidney. Urol Case Rep, 18, 38-40. |
|
88. |
Anderson RE, Hanson HA, Thai D, Zhang C, Presson AP, Aston KI, Carrell DT, Smith KR, Hotaling JM (2018). Do paternal semen parameters influence the birth weight or BMI of the offspring? A study from the Utah Population Database. J Assist Reprod Genet, 35(5), 793-799. |
|
89. |
Keihani S, Martin C, Craig JR, Zhang C, Presson AP, Myers JB, Aston KI, Emery BR, Carrell DT, Hotaling JM (2018). Semen parameters are unaffected by statin use in men evaluated for infertility. Andrologia, 50(5), e12995. |
|
90. |
Alder NJ, Keihani S, Stoddard GJ, Myers JB, Hotaling JM (2018). Combination therapy with clomiphene citrate and anastrozole is a safe and effective alternative for hypoandrogenic subfertile men.LID - 10.1111/bju.14390 [doi]. (Epub ahead of print) BJU Int. |
|
91. |
Patel DP, Williams L, Warner L, O'Neil ME, Aston K, Carrell DT, Grigorescu V, Jamieson DJ, Gannon JR, Eisenberg ML, Walsh TJ, Hotaling JM (2018). Use of secondary contraception following vasectomy: insights from the Pregnancy Risk Assessment Monitoring System, 2007-2011. Transl Androl Urol, 7(Suppl 3), S264-S270. |
|
92. |
Evans P, Keihani S, Breyer BN, Erickson BA, Hotaling JM, Lenherr SM, Myers JB (2018). A Prospective Study of Patient-reported Pain After Bulbar Urethroplasty. Urology, 117, 156-162. |
|
93. |
Hotaling JM, Ramasamy R (2018). Knowledge gaps in male fertility. Transl Androl Urol, 7(Suppl 3), S262-S263. |
|
94. |
Kane AC, Walvekar RR, Hotaling JM (2018). Transoral robotic resection of a retropharyngeal parathyroid adenoma: a case report.LID - 10.1007/s11701-018-0843-0 [doi]. (Epub ahead of print) Journal of Robotic Surgery. |
|
95. |
Patel B, Meeks H, Wan Y, Johnstone EB, Glenn M, Smith KR, Hotaling JM (2018). Transgenerational effects of chemotherapy: Both male and female children born to women exposed to chemotherapy have fewer children. Cancer Epidemiol, 56, 1-5. |
|
96. |
Keihani S, Hanson B, Hotaling JM (2018). Male factor infertility: an opportunity to investigate individual and family health.LID - 10.1111/1471-0528.15398 [doi]. (Epub ahead of print) BJOG. |
|
97. |
Patel B, Byrne JLB, Phillips A, Hotaling JM, Johnstone EB (2018). When standard genetic testing does not solve the mystery: a rare case of preimplantation genetic diagnosis for campomelic dysplasia in the setting of parental mosaicism. Fertil Steril, 110(4), 732-736. |
|
98. |
Moses RA, Keihani S, Craig JR, Basilius J, Hotaling JM, Lenherr SM, Brant WO, Myers JB (2018). Efficacy of Pressure Regulating Balloon Exchange in Men with Post Artificial Urinary Sphincter Persistent or Recurrent Stress Urinary Incontinence.LID - S0090-4295(18)30935-X [pii]LID - 10.1016/j.urology.2018.07.052 [doi]. (Epub ahead of print) Urology. |
|
99. |
Guo J, Grow EJ, Mlcochova H, Maher GJ, Lindskog C, Nie X, Guo Y, Takei Y, Yun J, Cai L, Kim R, Carrell DT, Goriely A, Hotaling JM, Cairns BR (2018). The adult human testis transcriptional cell atlas.LID - 10.1038/s41422-018-0099-2 [doi]. (Epub ahead of print) Cell Res. |
|
100. |
Jorgenson E, Matharu N, Palmer MR, Yin J, Shan J, Hoffmann TJ, Thai KK, Zhou X, Hotaling JM, Jarvik GP, Ahituv N, Wessells H, Van Den Eeden SK (2018). Genetic variation in the SIM1 locus is associated with erectile dysfunction. Proc Natl Acad Sci U S A, 115(43), 11018-11023. |
NON PEER-REVIEWED JOURNAL ARTICLES
|
1. |
Chapman KM, Medrano GA, Jaichander P, Chaudhary J, Waits AE, Nobrega MA, Hotaling JM, Ober C, Hamra FK (2015). Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem Cells. Cell Rep, 10(11), 1828-35. |
|
2. |
Anderson R, Hanson H, Aston KI, Carrell DT, Smith KR, Hotaling JM (2015). Cancer risk in first and second degree relatives of men with poor semen quality. Demography. |
|
3. |
Hotaling JM, Patel DP, Vendryes C, Lopushnyan NA, Presson AP, Zhang C, Muller CH, Walsh TJ (2016). Predictors of sperm recovery after cryopreservation in testicular cancer. Asian J Androl, 18(1), 35-8. |
|
4. |
Anderson R, Hotaling JM (2017). Improving US databases for male fertility. AUA News, 22(5), 10. |
|
5. |
Keihani S, Craig JR, Zhang C, Presson AP, Myers JB, Brant WO, Aston KI, Emery BR, Jenkins TG, Carrell DT, Hotaling JM (2018). Proton-pump inhibitor use does not affect semen quality in subfertile men. Asian J Androl, 20(3), 290-293. |
REVIEW ARTICLES
|
1. |
Hotaling JM, Walsh TJ (2009). Male infertility: a risk factor for testicular cancer. [Review]. Nat Rev Urol, 6(10), 550-6. |
|
2. |
Hotaling JM, Smith JF, Rosen M, Muller CH, Walsh TJ (2011). The relationship between isolated teratozoospermia and clinical pregnancy after in vitro fertilization with or without intracytoplasmic sperm injection: a systematic review and meta-analysis. [Review]. Fertil Steril, 95(3), 1141-5. |
|
3. |
Hotaling JM, Patel Z (2014). Male endocrine dysfunction. [Review]. Urol Clin North Am, 41(1), 39-53. |
|
4. |
Hotaling JM (2014). Genetics of male infertility. [Review]. Urol Clin North Am, 41(1), 1-17. |
|
5. |
Craig JR, Wallis C, Brant WO, Hotaling JM, Myers JB (2014). Management of adults with prior failed hypospadias surgery. [Review]. Transl Androl Urol, 3(2), 196-204. |
|
6. |
Trofimenko V, Hotaling JM (2016). Fertility treatment in spinal cord injury and other neurologic disease. [Review]. Transl Androl Urol, 5(1), 102-16. |
|
7. |
Patel DP, Chandrapal JC, Hotaling JM (2016). Hormone-Based Treatments in Subfertile Males. [Review]. Curr Urol Rep, 17(8), 56. |
|
8. |
Hanson B, Johnstone E, Dorais J, Silver B, Peterson CM, Hotaling J (2017). Female infertility, infertility-associated diagnoses, and comorbidities: a review. [Review]. J Assist Reprod Genet, 34(2), 167-177. |
|
9. |
Myers JB, Brant WO, Hotaling JN, Lenherr SM (2017). Urethral Strictures and Artificial Urinary Sphincter Placement. [Review]. Urol Clin North Am, 44(1), 93-103. |
|
10. |
Craig JR, Jenkins TG, Carrell DT, Hotaling JM (2017). Obesity, male infertility, and the sperm epigenome. [Review]. Fertil Steril, 107(4), 848-859. |
|
11. |
Patel DP, Craig JR Jr, Myers JB, Brant WO, Hotaling JM (2017). Serum Biomarkers of Erectile Dysfunction in Diabetes Mellitus: A Systematic Review of Current Literature. [Review]. Sex Med Rev, 5(3), 339-348. |
|
12. |
Oottamasathien S, Hotaling JM, Craig JR, Myers JB, Brant WO (2017). Amniotic therapeutic biomaterials in urology: current and future applications. [Review]. Transl Androl Urol, 6(5), 943-950. |
|
13. |
Hanson BM, Eisenberg ML, Hotaling JM (2018). Male infertility: a biomarker of individual and familial cancer risk. [Review]. Fertil Steril, 109(1), 6-19. |
|
14. |
Hanson BM, Aston KI, Jenkins TG, Carrell DT, Hotaling JM (2018). The impact of ejaculatory abstinence on semen analysis parameters: a systematic review. [Review]. J Assist Reprod Genet, 35(2), 213-220. |
|
15. |
Cardinal J, Slade A, McFarland M, Keihani S, Hotaling JN, Myers JB (2018). Scoping Review and Meta-analysis of Hyperbaric Oxygen Therapy for Radiation-Induced Hemorrhagic Cystitis. [Review]. Curr Urol Rep, 19(6), 38. |
|
16. |
Armstrong JM, Keihani S, Hotaling JM (2018). Use of Ultrasound in Male Infertility: Appropriate Selection of Men for Scrotal Ultrasound. [Review]. Curr Urol Rep, 19(8), 58. |
|
17. |
Hanson BM, Hotaling JM (2018). Limitations and opportunities in male fertility databases. [Review]. Transl Androl Urol, 7(Suppl 3), S292-S302. |
|
18. |
Anderson R, Moses R, Lenherr S, Hotaling JM, Myers J (2018). Spinal cord injury and male infertility-a review of current literature, knowledge gaps, and future research. [Review]. Transl Androl Urol, 7(Suppl 3), S373-S382. |
BOOK CHAPTERS
|
1. |
Broghammer J, Hotaling JM (2013). Traumatic Ureteral Injuries. In Wessells H (Ed.), Urologic Emergencies (2nd, pp. 39-53). Philadelphia: Springer. |
|
2. |
Hotaling J, Niederberger C (2014). Fertility and Cancer Therapy. In Gomella LG (Ed.), The 5-Minute Clinical Consult Urology (3rd). Philadelphia: Lippincott Williams & Wilkins. |
|
3. |
Jason Chandrapol and James Hotaling (2017). Genetic Testing of Y Chromosome Micro Deletion. In Nicolas Garrido Rocio Rivera (Ed.), Practical Guide to Sperm Analysis: Basic Andrology in Reproductive Medicine (pp. 37-52). CRC Press. |
|
4. |
Carrell DT, Jenkins TG, Emery BR, Hotaling JM, Aston KI (2018). The Role of Reproductive Genetics in Modern Andrology. In Palermo GD and Sills ES (Eds.), Intracytoplasmic Sperm Injection: Indications, Techniques and Applications (pp. 23-38). Springer. |
|
5. |
Sorena Keihani, Jeremy B. Myers, James M. Hotaling (2018). Spermatogenesis: Fertile Ground for Contributing to Recurrent Implantation Failure? In Jason F. Franasiak Richard T Scott (Ed.), Recurrent Implantation Failure Etiologies. |
OTHER (Commentary/Letters/Editorials/Case Reports/Video/Film)
Case Reports
|
1. |
Hsi RS, Hotaling JM, Spencer ES, Bollyky PL, Walsh TJ (2011). Isolated infection of a decommissioned penile prosthesis reservoir with Actinomyces neuii. J Sex Med, 8(3), 923-6. |
Editorials
|
1. |
Hotaling (2013). Finasteride and male infertility: a case for prospective collaborative research databases? Fertil Steril, 100(6), 1528-1529. |
|
2. |
Hotaling JM, Aston KI, Carrell DT (2014). Refined phenotyping, large cohorts, and collaborative research are vital for realizing the potential of genomics to transform care for male infertility. Fertil Steril, 102(4), 967. |
|
3. |
Brant WO, Hotaling JM (2014). Is there still a role for primary realignment for stricture due to pelvic fracture? J Urol, 192(6), 1595-6. |
|
4. |
Myers JB, Brant WO, Hotaling JM (2015). Editorial comment. Urology, 85(1), 244-5. |
|
5. |
Hotaling JM, Jenkins TG (2015). MicroRNA: a step beyond bulk seminal parameters? Fertil Steril, 104(3), 554. |
|
6. |
Anderson RE, Hotaling JM (2015). Inherent difficulties of meta-analysis for surgical techniques in male infertility: an argument for standardizing reporting and outcomes. Fertil Steril, 104(5), 1127-8. |
|
7. |
Hotaling JM (2015). Global deoxyribonucleic acid methylation: a window into the spermatogonial stem cell's reproductive potential. Fertil Steril, 104(6), 1374-5. |
|
8. |
Schaeffer AJ, Hotaling JM (2016). Claims-based analysis of male infertility: a cautious step in the right direction. Fertil Steril, 105(3), 599-600. |
|
9. |
Johnstone EB, Hotaling JM (2016). Conservation of ovarian reserve across ethnicities: evidence of the evolutionary importance of maintenance of ovarian reserve. Fertil Steril, 106(2), 272. |
|
10. |
Jensen CF, Dupree JM, Sonksen J, Ohl D, Hotaling JM (2017). A call for standardized outcomes in microTESE. Andrology, 5(3), 403. |
Letters
|
1. |
Ohlander S, Hotaling J, Kirshenbaum E, Niederberger C, Eisenberg ML (2014). Use of fresh versus cryopreserved sperm [Letter to the editor]. Fertil Steril, 101(2), e12. |
Other
|
1. |
Hotaling J (2002). "An Attempted Synthesis of 1.2 Difluorocyclobutadine" Honors Thesis. Hanover, NH: Dartmouth College. |
|
2. |
Patel B, Johnstone EB, Presson A, Zhang C, Jenkins T, Aston KI, Carrell DT, Hotaling J (2016). The Effect of ADHD Medications on Semen Analysis In Sub-Fertile Couples. Poster selected for phone-in briefing for journalists prior to 72nd American Society for Reproductive Medicine 2016 Scientific Congress & Expo, Oct.10, Salt Lake City, UT. |
Patents
|
1. |
Hotaling JM (2014). Systems and Methods for Identifying Instruments. U.S. Patent No. App#61/80847. Washington, D.C.:U.S. Patent and Trademark Office. |
|
2. |
Hotaling JM (Published). Apparatus for Noninvasively Measuring Corporal Hemodynamic and Mechanical Parameters for the Diagnosis of Sexual Dysfunction in Men and Women. U.S. Patent No. App#14/102,504. Washington, D.C.:U.S. Patent and Trademark Office. |
|
3. |
Hotaling JM (2014). Telemicroscopy Device. U.S. Patent No. App#61/825361. Washington, D.C.:U.S. Patent and Trademark Office. |
|
4. |
Hotaling JM (2014). Sperm-DNA: An Automatic Algorithm for Sperm Cell Detection and Motility Analysis. U.S. Patent No. App#61/861701. Washington, D.C.:U.S. Patent and Trademark Office. |
|
5. |
Hotaling JM (Published). Systems and Methods for Monitoring Physiological Parameter of a Cyclist. U.S. Patent No. App#61/764696. Washington, D.C.:U.S. Patent and Trademark Office. |
|
6. |
Hotaling JM (2014). A Novel Circumcision Device. U.S. Patent No. App#61/722278. Washington, D.C.:U.S. Patent and Trademark Office. |
|
7. |
Hotaling JM (2015). Fluid Analysis Device and Associated Systems and Methods. U.S. Patent No. Patent S/N PCT/US2015/023364. Washington, D.C.:U.S. Patent and Trademark Office. |
|
8. |
Bruce K. Gale, Douglas T. Carrell, Kristin Murphy, Jim Hotaling, Jiyoung Son (2015). Tissue sample processing system and associated methods. U.S. Patent No. US15520795. Washington, D.C.:U.S. Patent and Trademark Office. |
|
9. |
Hotaling JM (2015). Inverse Tomographic Construction: A Non-Layered Construction Paradigm for Rapid Prototypin. U.S. Patent No. Patent S/N PCT/US2015/056494. Washington, D.C.:U.S. Patent and Trademark Office. |
Video/Film/CD/Web/Podcast
|
1. |
Kerr RR (2014). Infertility research explores linkage to all-cause mortality, psychiatric disorders. Expert resource: Hotaling jM [Web]. Urologytimes.modernmedicine.com. |
|
2. |
Office of Public Affairs (2014). Men's Myth Busters [Video]. Salt Lake City: University Of Utah. Available: http://healthcare.utah.edu/healthfeed/postings/2014/06/061214_mens-myth-busters.php. |
|
3. |
Hotaling JM (2014). High-volume surgeons show multiple options for IPP placement [Video]. Urologytimes.modernmedicine.com. |
|
4. |
Commentary by Hotaling JM (2014). Erectile dysfunction: Multiple treatment options. Edited by Brant WO and Trueheart K [Video]. UrologyTimes.com. |
|
5. |
Commentary by Hotaling JM (2014). 'Men's health' more than a marketing ploy. Edited by Kerr RR [Video]. Urolotytimes.modernmedicine.com. |
|
6. |
Hilton L (2014). Urologists helping driving male-specific centers: Men's health clinics bring needed care under one roof. Expert resource: Hotaling J [Web]. Urologytimes.modernmedicine.com. |
|
7. |
Hilton L, Iannetta A (2014). The University of Utah's men's health clinic (slideshow). Expert Resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com. |
|
8. |
Commentary by Hotaling JM (2014). IPP: Semi-rigid prosthesis placed via subcoronal approach. Edited by Carrion R [Video]. UrologyTimes.com. |
|
9. |
Commentary by Hotaling JM (2014). IPP: Retractor-less approach to IPP placement. Edited by Walsh T [Video]. UrologyTimes.com. |
|
10. |
Commentary by Hotaling JH (2014). IPP: Ventral phalloplasty and IPP placement. Edited by Carrion R [Video]. UrologyTimes.com. |
|
11. |
Commentary by Hotaling JM (2014). IPP: Approaches to prosthesis an AUS placement. Edited by Jones L [Video]. UrologyTimes.com. |
|
12. |
Commentary by Hotaling JH (2014). IPP: Penoscrotl IPP placement with ventral phalloplasty. Edited by Carrion R [Video]. UrologyTimes.com. |
|
13. |
Hotaling J, Brant WO (2014). Let's Talk Men's Health: Alternatives to T therapy: Lessons from male infertility [Web]. Urologytimes.com, Nov, PP 18-20. |
|
14. |
Hotaling JM, Brant WO (2014). Alternatives to T therapy: Lessons from male infertility [Web]. Urologytimes.mondernmedicine.com. |
|
15. |
Kerr RR (2014). Study links sunscreen to impaired male fertility. Expert Resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com. |
|
16. |
Hotaling JM (2015). Let's Talk Men's Health; How to conduct a cost-effective evaluation of the infertile male patient Thorough history/physical, high-quality semen analyses among critical components [Web]. Urologytimes.modernmedicine.com. |
|
17. |
Commentary by Hotaling JH (2015). Williams Vasectomy Reversal (epididymovasostomy) Video [Video]. UrologyTimes.com. Available: http://www.youtube.com/watch?v=AMc1_ntLbuw. |
|
18. |
Commentary: Hotaling JM (2015). Excision and Primary Anastomosis Anterior Urethroplasty. Editor: Myers J; [Video]. UrologyTimes.com. |
|
19. |
Hotaling JM (2015). The Device Will See You Now: Point of Care Diagnostic Devices in Urology [Web]. Urologytimes.modernmedicine.com. |
|
20. |
Commentary By Hotaling JM (2015). Varicocelectomy: Microsurgical, subinguinal technique. Edited By Goldstein M [Video]. UrologyTimes.com. |
|
21. |
Commentary by Hotaling JM (2015). Williams Vasectomy Reversal (vasovasostomy) Video [Video]. UrologyTimes.com. Available: http://www.youtube.com/watch?v=onePH0MF64Q. |
|
22. |
Hilton L (2015). Men's Health Matters; Expert Resource Hotaling JM [Web]. UrologyTimes.com. |
|
23. |
Commentary by Hotaling JM (2015). Vasectomy reversal: Microsurgical two-layer vasovasostomy. Edited by Karpman E [Video]. UrologyTimes.com. Available: https://www.youtube.com/watch?v=1kg619Fbw0Y. |
|
24. |
Saylor BP (2015). ICSI use doubles despite lack of improved outcomes. Expert resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com. |
|
25. |
Commentary by Hotaling JM (2015). Urethroplasty: Posterior Urethroplasty for pelvic fracture urethral injury. Editor Myers J/ [Video]. UrologyTimes.com. |
|
26. |
Commentary by Hotaling JM (2015). Urethroplasty: Perineal Urethrostomy for Severe Urethral Strictures. Editor Myers J [Video]. UrologyTimes.com. |
|
27. |
Commentary Hotaling, JM (2015). Urethroplasty Bulbospongiosus Sparing Dorsal Onlay Bulbar Urethroplasty. Editor: Vanni A [Video]. UrologyTimes.com. |
|
28. |
Saylor BP (2015). FDA moves to change TRT product labeling. Expert Resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com. |
|
29. |
Saylor BP (2015). State of Urology: Our experts' top picks for AUA 2015. Expert Resource Hotaling JM [Web]. Urologytimes.modernmedicine.com. |
|
30. |
Commentary by Hotaling JM (2015). Varicocelectomy: Single-port laparoscopic technique. Edited by Alukal J [Video]. Urologytimes.modernmedicine.com. |
|
31. |
Commentary by Hotaling JM (2015). Sperm extraction: Two percutaneous techniques. Edited by Hsieh TM [Video]. UrologyTimes.com. |
|
32. |
Commentary by Hotaling JM (2015). Sperm extraction: MicroTESE and multiphoton microscopy. Edited by Ramasamy R [Video]. UrologyTimes.com. |
|
33. |
Commentary by Hotaling JH (2015). Vasectomy: A different approach to isolating the vas. Edited by Williams DH [Video]. UrologyTimes.com. |
|
34. |
Commentary by Hotaling JM (2015). Vasectomy: Crucial steps for a bloodless procedure. Edited by Goldstein M, and Li PS [Video]. UrologyTimes.com. |
|
35. |
Hotaling JM (2000). Robotic Cystectomy with Neobladder; commentary from Dr. Dechet [Video]. UrologyTimes.com. |
|
36. |
Commentary by Hotaling JM (2016). Robotic cystectomy: Intracorporeal neobladder using studer technique. Edited by Santomauro MG [Video]. UrologyTimes.com. |
|
37. |
Commentary by Hotaling JM (2016). Robotic cystectomy: ileal conduit. Edited by Dechet CB [Video]. UrologyTimes.com. |
|
38. |
Commentary by Hotaling JM (2016). Robotic cystectomy: Y-shaped neobladder technique. Edited by Warner JN [Video]. UrologyTimes.com. |
|
39. |
Hotaling JM, Carrell DT (2016). Let's Talk Men's Health: Epigenetics and genetics: The future of cost-effective care? [Web]. Urologytimes.modernmedicine.com. |
|
40. |
Hilton L (2016). 'T' clinics create concerns about care, competition. Expert resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com. |
|
41. |
Hotaling JM (2016). AUS placement: Key steps in the Duke technique. Edited by Paterson AC and Zaid UB [Video]. UrologyTimes.com. |
|
42. |
Saylor BP (2016). AUA 2016: Experts offer guidance on the meeting. Expert Resource Hotaling JM [Web]. Urologytimes.modernmedicine.com. |
|
43. |
Hilton L (2016). TTrials: T therapy improves sexual desire, activity. Expert resource: Hotaling JM [Web]. urologytimes.modernmedicine.com. |
|
44. |
Hilton, L (2016). Testosterone therapy improves 65-and-older men’s sex lives. Expert Resource: James Hotaling [Web]. Urology Times (enews). |
|
45. |
Hilton Lisette (2016). FDA adds new warning, updated labeling for T products. Expert resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com. |
|
46. |
Craig JR, Brant WO, Hotaling JM (2016). "Men's Health Mythbuster" Does heat exposure affect spermatogenesis [Web]. Urologytimes.modernmedicine.com. |
|
47. |
Myers JB, Vanni A, Voelzke B, Witten J, Dugi D, Hotaling JM (2016). Buried penis repair: Videos illustrate aesthetic, functional considerations [Video]. Urologytimes.modernmedicine.com. |
|
48. |
Hotaling JM (2017). Experts Perspective: Sperm 101: How to Interpret the Semen Analysis [Web]. FertilityIQ. Available: https://www.fertilityiq.com/male-factor-infertility/sperm-101-how-to-interpret-the-semen-analysis. |
|
49. |
Baldwin DD, Ghani KR, Borofsky MS, Hotaling JM (2017). Ureteroscopy: Surgeons show techniques, tips in videos [Web]. Urologytimes.modernmedicine.com. |
|
50. |
Hilton L (2017). Take charge of your online reputation. Expert resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com. |
|
51. |
Zhao L, Shi D, Groatas A Djordjevic ML. Dy GW, Hotaling JM (2017). Transgender surgery: Videos demonstrate cutting-edge techniques [Video]. Urologytimes.modernmedicine.com. |
|
52. |
Kerr RR (2017). AUA '17 puts ephasis squarelyon 'value'. Expert resource Hotaling JM [Web]. Urologytimes.modernmedicine.com. |
|
53. |
Craig J, Hotaling JM (2017). Cord denervation: Surgeons describe microsurgical techniques in men with scrotal pain [Video]. urologytimes.modernmedicine.com. |
|
54. |
Masterson TA, Ramasamy R, Hotaling JM (2017). Varicocele: Treatment indications and repair techniques [Web]. |
|
55. |
Ellimoottil C (2017). "Tech talk with Jim and Steve" Video visits in urology: How clinicians, patients benefit [Web]. Urologytimes.modernmedicine.com. |
|
56. |
Hotling JM, Kaplan SA (2017). "Tech Talk with Jim and Steve" Tech advances catalyze paradigm shifts in patient care [Web]. urologytimes.modernmedicine.com. |
|
57. |
Ramasamy R, Hotaling JM (2017). Urologists illustrate key steps in management of duct obstruction [Video]. Urologytimes.modernmedicine.com. |
|
58. |
James M. Hotaling (06/05/2018). 12 Things You Should Know About Your Guy's Fertility [Web]. health.com. Available: http://www.health.com/infertility/male-infertility. |
PENDING PUBLICATIONS
Journal Articles
|
1. |
Joseph M. Armstrong, Sorena Keihani, James M. Hotaling (pending). Use of Ultrasound in Male Infertility: Appropriate Selection of Men for Scrotal Ultrasound. Curr Urol Rep. |
|
2. |
Son J, Samuel R, Gale BK, Carrell DT, Hotaling JM (In Press). Separation Of Sperm Cells From Samples Containing High Concentrations Of White Blood Cells Using A Spiral Channel. Biomicrofluidics. |
|
3. |
Gui J, Grow EJ, Yi C, Murphy PJ, Wike CL, Carrell DT, Hotaling JM, Cairns BR (In Press). Transcription, signaling and metabolic transitions during human spermatogonial stem cell differentiation. Cell Stem Cell. |
|
4. |
Sorena Keihani MD, Brent Hanson, MD and James M. Hotaling MD (pending). Male Factor Infertility: A window into individual and familial health. Br J Obstet Gynaecol. |
Book Chapters
|
1. |
Biren V. Patel1, James M. Hotaling2 (Pending). Genomics and Epigenetics. In Drs. Ralf Henkel, Luna Samanta and Ashok Agarwal (Eds.), Oxidants, Antioxidants and the Impact of the Oxidative Status in Male Reproduction. Elsevier. |
|
2. |
Yetunde Ibrahim and James Hotaling (pending). Sperm Epigenetics and its Impact on Male Fertility, Pregnancy Loss and Somatic Health of Future Offspring. In Seminar in Reproductive Medicine. |
|
3. |
Kelley Taylor ARNP, James Hotaling MD MS FECSM (Pending). A Men’s Health Clinic Exemplar: Experience at the University of Utah. In Susanna Quallich (Ed.), The Nurse Practitioner in Urology: Men’s Health. Springer. |
|
4. |
Brent Hanson and James Hotaling (In Press). Inflammation and Men's Health. In Faysal A. Yafi (Ed.), The Effects of Lifestyle on Men's Health. |
|
5. |
Biren V. Patel, MD1 and James M. Hotaling, MD2 (In Press). Identified Epigenetic Effects. In Prof. Bernard Jégou & Prof. Michael Skinner (Eds.), Encyclopedia of Male Reproduction (4B-Reproductive Medicine: Male "Genetics", 1). |
|
6. |
Brent M. Hanson and James M. Hotaling (In Press). Male Infertility As A Marker Of Future Health. In EMERGING TOPICS IN REPRODUCTION (5, pp. 1-21). Springer. |
|
7. |
Patel DP, Hotaling JM, Niederberger CS (In Press). Azoospermia-Obstruction. In Case Studies In Male Infertility. |
|
8. |
Y. Ibrahim and J. Hotaling (In Press). Numerical chromosomal abnormalities. In Prof. Bernard Jégou & Prof. Michael Skinner (Eds.), Encyclopedia of male reproduction; (4B-Reproductive Medicine: Male "Genetics", 1). |
|
9. |
Brent Hanson and James Hotaling (In Press). Comorbidities associated with male infertility. In Prof. Bernard Jégou & Prof. Michael Skinner (Eds.), Encyclopedia of Male Reproduction (4B-Reproductive Medicine: Male "Genetics", 1). |
RECENTLY PUBLISHED ABSTRACTS (Last 3 Years)
|
1. |
Hotaling JM, Chow V, Zini A, Spitz A, Fischer MA, Zeitlin S, Sandlow J, Brannigan R, Goldstein M, Smith J, Ko E, Jarvi K (2016). Infertility: Epidemiology & Evaluation [Abstract]. American Association of Urology, Sand Diego, CA. |
|
2. |
Anderson R, Hanson H, Aston KI, Carrell D, Smith K, Hotaling JM (2016). P9-36: Cancer Risk in First and Second Degree Relatives of Men with Poor Semen Quality [Abstract]. Population Association of America Annual Meeting, Washington, D.C. |
|
3. |
Jarvi K, Lau S, Lo K, Grober E, Hotaling JM, Chow V, Zini A, Spitz A, Fischer MA, Zeitlin S, Fuchs E, Samplaski M, Sandlow J, Brannigan R, Goldstein M, Smith JF, Ko E (2016). First Report from the Andrology Research Consortium. Presented at the Annual Meeting of the American Urologic Association, New Orleans, LA, May 6 [Abstract]. Journal of Urology, 195(4S), e1160. |
|
4. |
Anderson R, Hanson H, Oottamasathien S, Redshaw J, Schaeffer A, Johnstone EB, Aston KI, Carrell DT, Lowrance W, Smith K, Cartwright P, Hotaling JM (2016). Childhood Cancer Risk In The Siblings and Cousins Of Men With Poor Semen Quality. Prize Abstract. Presented at the 64th Annual Meeting of the Society for Pediatric Urology, San Diego, CA, May 6-8 [Abstract]. |
|
5. |
Son J, Gale B, Samuel R, Jafek A, Jenkins TG, Hotaling J, Carrell DT (2016). Purification of sperm from high WBC semen sample using a spiral channel [Abstract]. MicroTAS 2016: The 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences, Dublin, Ireland, October 9-13. |
|
6. |
Patel B, Johnstone EB, Presson A, Zhang C, Jenkins T, Aston KI, Carrell DT, Hotaling JM (2016). The Effect of ADHD Medications on Semen Analysis in Sub-Fertile Couples. 72nd American Society for Reproductive Medicine 2016 Scientific Congress & Expo, Oct.15-19, Salt Lake City, UT [Abstract]. Fert & Steril, 106(3S), 197. |
|
7. |
Jenkins T, Carrell DT, Hotaling J, Aston KI (2016). Cigarette Smoking and Associated Effects on the Rate of Aging in Sperm DNA Methylation Patterns. 72nd American Society for Reproductive Medicine 2016 Scientific Congress & Expo, Oct.15-19, Salt Lake City, UT [Abstract]. Fert & Steril, 106(3S), 198. |
|
8. |
Johnstone EB, Link M, Patel B, Hotaling JM, Moore AK, Dorais J, Carrell DT, Peterson CM, Aston KI (2016). Does Outcome of the First IVF Cycle Allow Selection of Candidates for Repeat IVF Prior to PGS? 72nd American Society for Reproductive Medicine 2016 Scientific Congress & Expo, Oct.15-19, Salt Lake City, UT [Abstract]. Fert & Steril, 106(3S), 184. |
|
9. |
Tam M, Brant WO, Oottamasathien S, Myers J, Hotaling JM (2016). Use of Amniotic Membrane In Benign Urology: A Novel Solution For Optimal Wound Healing. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. |
|
10. |
Patel DP, Myers JB, Brant WO, Aston KI, Carrell DT, Hotaling JM (2016). Recent Exogenous Testosterone Use Among Men Presenting for Infertility Evaluation. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. |
|
11. |
Pathak P, Chandrapal JC, Redshaw J, Hotaling JM, Lenherr S, Brant WO, Myers JB (2016). Outcomes And Morbidity Of Right Colon Pouch Urinary Diversion: A Single Center Retrospective Case Series. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. |
|
12. |
Hanson HA, Pathak Piyush, Taddie M, Mayer EN, Smith KR, Vanderslice J, Hotaling JM, Lowrance WT (2016). Prostate Cancer: How and When Does Geography Matter? Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. |
|
13. |
Pathak P, Lenherr S, Hotaling JM, Brant WO, Myers JB (2016). Treatment of Urethral Stricture Disease With Direct Vision Internal Urethrotomy and Pentoxifylline Injection. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. |
|
14. |
Presson A, Trofimenko V, Zhang C, Hanson HA, Smith KR, Carrell DT, Aston KI, Hotaling JM (2016). Seasonal Variation in Male Fertility Measures and Corresponding Birth Patterns. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. |
|
15. |
Piyush P, Chandrapal JC, Erickson B, Elliot S, Levy ME, Voelzke B, Lenherr S, Hotaling JM, Brant WO, Meyers JB (2016). Use Of Continent Catheterizable Ileal Cecocystoplasty For The Treatment of Devastated Lower Urinary Tract Outlet. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. |
|
16. |
Jenkins T, Aston K, Hotaling J, Carrell DT (2017). The impact of grand paternal aging on sperm DNA methylation patterns [Abstract]. 42nd Annual conference for the American Society of Andrology, Miami, FL, April 21-25. |
|
17. |
Pathak P, Hanson H, Anderson R, Lowrance W, Smith K, Aston KI, Carrell DT, Hotaling JM (2017). Sex-specific thyroid cancer and melanoma risk in relatives of men with poor semen quality [Abstract]. Annual Meeting of the American Urological Association, Boston, MA, May 12-16. |
|
18. |
Hotaling JM (2017). The back-up vasectomy reversal. Testicular sperm extraction at the time of vasectomy reversal in the couple with advanced maternal age: a cost-effectiveness analysis [Abstract]. Annual Meeting of the American Urological Association, Boston, MA, May 12-16. |
|
19. |
James E, Jenkins T, Alonso D, Hotaling J, Carrell DT, Aston KI (2017). Sperm DNA methylation and epigenetic variability in tobacco smokers [Abstract]. At the Annual Meeting of the American Society of Andrology, Miami FL, May 12-16. |
|
20. |
Hotaling JM (2017). Subfertility Health Assisted Reproduction and the Environment (SHARE): Trans-generational impacts of male infertility [Abstract]. Early Career Investigator Showcase Top Presentation at the Annual Meeting of the American Urologic Association, Boston, MA, May 12-16. |
|
21. |
Society for the Study of Male Reproduction Andrology Research Consortium (2017). Results of a North American survey on the characteristics of men being assessed in male infertility clinics: the Andrology Research Consortium [Abstract]. Annual Meeting of the American Urological Association, Boston, MA, May 12-16. |
|
22. |
Keihani S, Craig JF, Zhang C, Presson AP, Myers JB, Brant WO, Aston KI, Emery BR, Carrell DT, Hotaling JM (2017). Proton-pump inhibitor use and semen quality in subfertile men: is there a harmful effect? [Abstract]. Annual Meeting of the American Urological Association, Boston, MA, May 12-16. |
|
23. |
Martin L, Peche W, Peterson K, Chan S, Morton R, Wan Yuan, Emery BR, Aston KI, Jenkins T, Presson A, Zhang C, Carrell DT, Hotaling JM (2017). Population-based semen analysis results among patients with inflammatory bowel disease [Abstract]. Annual Meeting of the American Society of Andrology, Miami FL, May 12-16. |
|
24. |
Craig JR, Keihani S, Zhang C, Presson AP, Myers JB, Brant JO, Aston KI, Emery BR, Jenkins TJ, Carrell DT, Hotaling JM (2017). Impact of abstinence time on semen parameters in a large population based cohort of subfertile men [Abstract]. Annual Meeting of the American Urological Association, Boston, MA, May 12-16. |
|
25. |
Jorgenson E, Palmer MR, Yin J, Shan J, Hotaling JM, Wessells H, Van Den Eeeden SK (2017). Erectile Dysfunction Genomics (EDGE): A GWAS of Erectile Dysfunction in the Kaiser Permanente of Northern California (KPNC) Genetic Epidemiology Research on Aging (GERA) Cohort [Abstract]. 2017 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, San Antonio, TX, October 26-29. |
|
26. |
Patel B, Meeks H, Wan Y, Johnstone EB, Glenn M, Hotaling JM, Smith KR (2017). Children of men exposed to chemotherapy have normal fecundity [Abstract]. Scientific Congress of the American Society for Reproductive Medicine, San Antonio, TX, Oct 28-Nov 1. |
|
27. |
Morin SJ, Juneau CR, Neal SA, Landis JN, Scott RT, Hotaling JM (2017). Comparison of the relative efficiency of ICSI and extended culture with epididymal sperm versus testicular sperm in patients with obstructive azoospermia [Abstract]. Scientific Congress of the American Society for Reproductive Medicine, San Antonio, TX, Oct 28-Nov 1. |
|
28. |
Morin SJ, Juneau CR, Neal SA, Scott RT, Hotaling JM (2017). Total motile sperm count is negatively correlated with fertilization rate but not blastulation, euploidy, or implantation in ICSI cycles [Abstract]. Scientific Congress of the American Society for Reproductive Medicine, San Antonio, TX, Oct 28-Nov 1. |
|
29. |
Jenkins T, Samuel R, Jafek A, Feng H, Gale B, Carrell DT, Hotaling JM (2017). Rapid microfluidic sperm isolation from microTESE samples in men with non-obstructive azoospermia [Abstract]. Scientific Congress of the American Society for Reproductive Medicine, San Antonio, TX, Oct 28-Nov 1. |
|
30. |
Patel, B, Meeks H, Wan Y, Johnstone EB, Glenn M, Smith KR, Hotaling JM (2017). Intergenerational effects of chemotherapy on fecundity: Both male and female children born to women exposed to chemotherapy have fewer children [Abstract]. Scientific Congress of the American Society for Reproductive Medicine, San Antonio, TX, Oct 28-Nov 1. |
|
31. |
Karandeep Singh*, Aruna V. Sarma, Rodney L. Dunn, Ann Arbor, MI, Sarah K. Holt, Seattle, WA, Hotaling, JM, Salt Lake City, UT, Rodica Pop-Busui, WilliamHerman, Ann Arbor, MI, Alan M. Jacobson, Mineola, NY, Barbara H. Braffett, Rockville, MD, Hunter Wessells, Seattle, WA, for the DCCT/EDIC Research Group, Rockville, MD (2018). Trajectories of Erectile Dysfunction Subphenotypes in Men with Longstanding Type I Diabetes. American Urological Association, San Francisco, CA, May 17-May 22 [Abstract]. |
|
32. |
Karandeep Singh*, Ann Arbor, MI, Hunter Wessells, Seattle, WA, J. Quentin Clemens, Rodney L. Dunn, Ann Arbor, MI, Sarah K. Holt, Seattle, WA, JamesHotaling, Salt Lake City, UT, Rodica Pop-Busui, William Herman, Ann Arbor, MI, Alan M. Jacobson, Mineola, NY, Barbara H. Braffett, Rockville, MD, Aruna V.Sarma, Ann Arbor, MI, for the DCCT/EDIC Research Group, Rockville, MD (2018). Longitudinal Subphenotypes of Urinary Symptoms in Type I Diabetes. American Urological Association, San Francisco, CA, May 17-May 22 [Abstract]. |
|
33. |
Nnenaya Agochukwu*, Bahaa Malaeb, Ann Arbor, MI, Hunter Wessells, Seattle, WA, James Hotaling, Salt Lake City, UT, Barbara Braffett, Washington, DC, Rodney Dunn, Ann Arbor, MI, Sarah Holt, Seattle, WA, Rodica Pop-Busui, William Herman, Ann Arbor, MI, Alan Jacobsen, Mineola, NY, Aruna Sarma, Ann Arbor, MI (2018). Orgasmic and Erectile Dysfunction in Men with Longstanding Type 1 Diabetes. American Urological Association, San Francisco, CA, MAy 17-May 22 [Abstract]. |
|
34. |
Andrology Research Consortium (2018). Results of a North American survey on the characteristics of men presenting for infertility investigations: The Andrology Research Consortium [Abstract]. Annual Meeting of the American Urological Association, May 18. |
|
35. |
Nnenaya Agochukwu, Bahaa Malaeb, Hunter Wessells, James Hotaling, Barbara Braffett, Rodney Dunn, Sarah Holt, Rodica Pop-Busui, James M. Hotaling (4/2018). Orgasmic and Erectile Dysfunction in Men with Longstanging Type I Diabetes [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), 1128-1129. |
|
36. |
Rachel A. Moses, MD, MPH, James R. Craig, MD, Sorena Keihani, MD, Jeremy B. Myers, MD, Sara M. Lenherr, MD, MS, William O. Brant, MD, James M. Hotaling, MD, MS (4/2018). Erectile Dysfunction Management After Failed Phosphodiesterase 5-Inhibitor Trail: A Cost-Effectiveness Analysis [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), e558. |
|
37. |
Darshan Patel, Kent Ogden, William Anderl, Suzette Mastrangelo, Alvin Le, James Hotaling, Stephen Summers (4/2018). Non-Inferiority of a Novel Capacitance Fluid Height Design Compared to Rotating Disc and Weight Transducer Designs for Home Uroflometry Applications [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), 972. |
|
38. |
Sorena Keihani, Rachel Moses, Jeremy Myers, James Hotaling (4/2018). Baseline Body Mass Index and Estradiol Levels Predict Combination Therapy With Anastrozole In Hypogonadal Men Treated with Clomiphene Citrate [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), e88. |
|
39. |
Biren Patel, Huong Meeks, Yuan Wan, Erica B. Johnstone, Martha Glenn, Darshan P. Patel, Ken Smith, James M. Hotaling (4/2018). Bipolar Disorder Seen At Higher Rate in the Offspring of Men Exposed tp Chemotherapy [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), e244. |
|
40. |
Karandeep Singh, Hunter Wessells, J. Quentin Clemens, Rodney L. Dunn, Sarah K. Holt, James Hotaling, Rodica Pop-Busui, William Herman (4/2018). Longitudinal Subphenotypes of Urinary Symptoms in Type I Diabetes [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), 31-31. |
|
41. |
Sorena Keihani, Rachel Moses, Yizhe Xu, Bryn Putbrese, Douglas Rogers, Xian Luo-Owen, Kaushik Mukherjee, Bradley Morris, James M Hotaling (4/2018). Imaging Findings Assopciated With Renal Bleeding Interventions After High-Grade Renal Trauma: Results From the American Assoication for Surgery of Trauma (AAST) Genito-Urinary Trauma Study [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), e333-334. |
|
42. |
Keith Jarvi, Susan Lau, Kirk Lo, Ethan Grober, J.C. Trussell, James Hotaling, Thomas Walsh, Peter Kolettis, James M. Hotaling (4/2018). Results of a North American Survey on the Characteristics of Men Presenting for Infertility Investigation: The Andrology Research Consortium [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), 247. |
|
43. |
Patrick Evans, Sorena Keihani, Benjamin Breyer, Bradley Erickson, James Hotaling, Sara Lenherr, Jeremy Myers (4/2018). A Prospective Study of Patient-Reported Pain After Bulbar Urethroplasty. Presented at the Annual Meeting of the American Urological Association, SanFrancisco, CA, May [Abstract]. Urology, 199(4), 637-638. |
|
44. |
Sorena Keihani, Darshan Patel, Bryn Putbrese, Douglas Rogers, Xian Luo-Owen, Kaushik Mukherjee, Bradley Morris, Sarah Majercik, James M. Hotaling (4/2018). The Importance Of The Timinig Of Excretory Phase CT Scan In The Diagnosis Of Urinary Extravasation After High-Grade REnal Trauma [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), e68. |
|
45. |
Karandeep Singh, Aruna V. Sarma, Rodney L. Dunn, Sarah K. Holt, James Hotaling, Rodica Pop-Busui, William Herman, Alan M. Jacobson, James m. Hotaling (4/2018). Trajectories of Erectile Dysfunction Subphenotypes in Men with Longstanging Type I Diabetes [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), 1006. |
|
46. |
Keihani S, Moses RA, Zhang C, Presson AP, Smith KR, Carrell DT, Hanson H, Hotaling JM (2018). Ability of Semen Analysis To Predict The 5-year Probability of Fathering A Child. Presented at the 74Th American Society for Reproductive Medicine Scientific Congress & Expo, Denver, CO, Oct 6-10 [Abstract]. |
|
47. |
Teigs AW, Landis J, Garrido N, Scott R, Hotaling JM (2018). Total Motile Sperm Count Trend Over Time Across Two Continents: Evaluation of Semen Analyses From 119,972 Infertile Men. Presented at the 74th American Society for Reproductive Medicine Scientific Congress & Expo, Denver, CO, Oct 6-10 [Abstract]. |
|
48. |
Guo J, Grow EJ, Carrell DT, Hotaling JM, Cairns B (2018). The Adult Human Testis Cell Atlas Via Single Cell RNA Sequencing [Abstract]. |
|
49. |
Slade A, Keihani S, Brant WO, Hotaling JM (2018). Stretcched Penile Length and Infertility, A New Asociation. Presented at the 74th American Socieity for Reproductive Medicine Scientific Congress & Expo, Denver, CO, Oct 6-10 [Abstract]. |
|
50. |
Hanson B, Hawkins C, Stark L, Hotaling JM, Mehta A (2018). Qualitative Analysis of Male Partner Needs In Infertile Couples. Presented at the 74th American Socieity of Reproductive Medicine Scientific Congress & Expo, Denver, CO Oct 6-10 [Abstract]. |
UNPUBLISHED POSTER PRESENTATIONS
|
1. |
Craig JR, Foss W, Hotaling JM, Brant WO (2016). Use Of Dehydrated Amniotic Membrane Allograft At The Time Of Microscopic Denervation Of The Spermatic Cord For Chronic Orchalgia Improves Outcomes. Poster session presented at 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov 3-6. |
|
2. |
Basilius J, Redshaw J, Foss W, Craig J, Hotaling JM, Myers JB, Brant WO (2016). Scrotal Pain After Microsurgical Denervation Of The Spermatic Cord: Patient Reported Quality Of Life Outcomes. Poster session presented at 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov. 3-6. |
|
3. |
Anderson RE, Hotaling JM, Myers JB, Brant WO (2016). Surgical Management And Outcomes Of Congenital Chordee In Adults. Poster session presented at 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov. 3-6. |
|
4. |
Martin L, Peche W, Peterson K, Chan S, Morton R, Wan Y, Emery B, Aston KI, Jenkins T, Presson A, Zhang C, Carrell D, Hotaling J (2017). Population-based semen analysis results and fertility among men with inflammatory bowel disease: Results from Subfertility Health Assisted Reproduction and the Environment (SHARE) study. Poster session presented at Utah Chapter Meeting of the American College of Surgeons, Salt Lake City, May 11. |
|
5. |
Alder, N, Keihani, S, Myers, J, Hotaling, J (October 2017). Outcomes of Combination Therapy with Clomiphene and Anastrozole in Subfertile Hypoandrogenic Men. Poster session presented at 18th Annual Fall Scientific Meeting of SMSNA, San Antonio. |
|
6. |
Rachel A. Moses MD, MPH, Sorena Keihani MD, Sarah Majercik* MD, Frank N. Burks MD, SeanP. Elliott MD, Kaushik Mukherjee* MD, Bradley A. Erickson MD, Richard A. Santucci MD, BrianP. Smith* MD, Christopher M. Dodgion* MD, MPH, Scott A. Zakaluzny* MD, Benjamin N. BreyerMD, James M. Hotaling MD, Raminder Nirula* MD, MPH, Jeremy B. Myers MD (09/28/2018). Current Management Of Extraperitoneal Traumatic Blader Injuries: Results From The American Association For The Surgery of Trauma (AAST) Genitourinary Trauma Study. Poster session presented at AAST Annual Fall Meeting, San Diego, CA.. |
|
7. |
Sorena Keihani MD, Douglas M. Rogers MD, Bryn E. Putbrese MD, Kaushik Mukherjee* MD, Sarah Majercik* MD, Christopher M. Dodgion* MD, MPH, Scott A. Zakaluzny* MD, Brian P. Smith* MD, Jurek F. Kocik* MD, MatthewM. Carrick* MD, Reza Askari* MD, Angela P. Presson Ph.D., James M. Hotaling MD, Raminder Nirula* MD, MPH, Jeremy B. Myers M (09/28/2018). A NOMOGRAM PREDICTING THE NEED FOR BLEEDING INTERVENTIONS AFTER HIGH-GRADE |
ORAL PRESENTATIONS
Meeting Presentations (Not Published Abstracts and Not Unpublished Posters)
|
National |
|
|
2014 |
An Update on Epididymovasostomy Indications and Technique. American Society for Reproductive Medicine Annual Meeting Lunch With The Experts, Honolulu HI, Oct 17-23. |
|
2015 |
Male Infertility and Comorbidities: Improving Male Health Through Proper Evaluation. American Society for Reproductive Medicine Annual Meeting, Lunch With The Experts, Baltimore MD, Oct 17-23. |
|
2015 |
Moderator, State of Urology 2015 poster session, American Urological Association Annual Meeting, New Orleans LA, May . |
|
2016 |
Post-Vasectomy Pain Syndrome: Epidemiology, Evaluation and Treatment. Annual Meeting of the American Urological Association Society for the Study of Male Reproduction (SSMR), San Diego CA, May 8. |
|
2016 |
Biomarkers of Erectile Dysfunction. 2016 Annual Fall Scienfific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov 3-6. |
|
2016 |
Oncofertility. 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov 3-6. |
|
2016 |
Invited Moderator: Erectile Dysfunction Epidemiology and Medical. 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov 3-6. |
|
2016 |
Moderator: Sexual Medicine. 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov 3-6. |
|
2017 |
Creating a successful men's health center - an evidence based approach. Presented at the Annual Meeting of the American Urological Association, Boston MA, May 12-16. |
|
2017 |
Profiling of human adult spermatogonial stem cells reveals transcription and signaling programs for self renewal and differentiation. Presented at the Annual Meeting of the American Urologic Association, Boston, MA, May 12-16. |
|
2017 |
Subfertility Health Assisted Reproduction and the Environment (SHARE): Trans-generational impacts of male infertility. Presented for the Rising Star Award at the Annual Meeting of the American Urologic Association, Boston MA, May 12-16. |
|
2017 |
Results of a North American survey on the characteristics of men being assessed in male infertility clinics: the Andrology Research Consortium. Presented at the Annual Meeting of the American Urologic Association, Boston, MA, May 12-16. |
|
2017 |
Erectile Dysfunction Genomics (EDGE): A GWAS of Erectile Dysfunction in the Kaiser Permanente of Northern California (KPNC) Genetic Epidemiology Research on Aging (GERA) Cohort. 18th Annual Fall Scientific Meeting of SMSNA. San Antonio, TX, Oct. 26-29. |
|
2017 |
Round table moderator: Update on Culturing Human Spermatogonial Stem Cells for Oncofertility. Annual meeting of the American Society for Reproductive Medicine. San Antonio, TX. Oct 30. |
|
2017 |
Oral abstract session: Male Reproduction and Urology. Annual meeting of the American Society of Reproductive Medicine. San Antonio,TX, Oct. 30 |
|
Local/Regional |
|
|
2016 |
Seasonal Variation In Male Fertility Measures And Corresponding Birth Patterns. Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. |
|
2016 |
Use Of Continent Catheterizable Ileal Cecocystoplasty For The Treatment Of Devastated Lower Urinary Tract Outlet. Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. |
|
2016 |
Treatment of Urethral Stricture Disease With Direct Vision Internal Urethrotomy And Pentoxifylline Injection. Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. |
|
2016 |
Prostate Cancer: How And When Does Geography Matter? Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. |
|
2016 |
Use of Amniotic Membrane in Benign Urology: A Novel Solution For Optimal Wound Healing. Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. |
|
2016 |
Recent Exogenous Testosterone Use Among Men Presenting For Infertility Evaluation. Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. |
|
2017 |
StreamDx Urine Flowmeter. University of Utah Translational Medicine Symposium 2017, Salt Lake City, UT, Feb. 27. |
|
2017 |
"Male Infertility: Counseling & Referral for the REI" at the Pacific Coast Reproductive Society, Palm Springs, CA, March 21-25 |
|
2017 |
"Male Infertility" at the Pacific Coast Reproductive Society, Palm Springs, CA, March 21-25 |
|
2017 |
Male Infertility- A Comprehensive Update. 65th Annual Meeting of the Pacific Coast Reproductive Society, Indian Wells CA, March 22-26. |
|
2017 |
The Medical Treatment of Idiopathic Oligospermia and Unexplained Male Infertility Update. 65th Annual Meeting of the Pacific Coast Reproductive Society, Indian Wells CA, March 22-26. |
Invited/Visiting Professor Presentations
|
International |
|
|
2018 |
Male Infertility & Somatic Health: Nature or Nurture? UAE Reproductive Symposium Fertility Forward 2018. Dubai, March 23-24. |
|
National |
|
|
2013 |
Hotaling J, Eisenberg M, Rao P, Ross L. Use of a novel electronic medical record to study male infertility. Invited Presentation to the Center for Disease Control (CDC) Working Group on Men's Health, Atlanta, GA, August |
|
2016 |
The Spermatogonial Stem Cell: A biomarker of male infertility & Somatic Health. RAMANJ January 21 |
|
2016 |
Male Infertility: A biomarker for cancer risk? Rutgers University, Camden, NJ, January 21 |
|
2017 |
Male Infertility. At Frontiers in Reproductive Endocrinology. Arlington, VA, March 2-5. |
|
2017 |
"Breakout Session I: Transitioning From Residency to Fellowship" at the Society for Reproductive Endocrinology & Infertility (SREI) Annual Fellow Retreat, Park City, UT, Aug 10 |
|
2017 |
"Breakout Session II: Developing Your Own Priorities for Fellowship" at the Society for Reproductive Endocrinology & Infertility (SREI) Annual Fellow Retreat, Park City, UT, Aug 10 |
|
2017 |
Male Infertility: Counseling & Referral for the REI" at the Society for Reproductive Endocrinology & Infertility (SREI) Annual Fellow Retreat, Park City, UT, Aug 10 |
|
2017 |
Efficiency & Academic Success: Educational Tools" at the Society for Reproductive Endocrinology & Infertility (SREI) Annual Fellow Retreat, Park City, UT, Aug 11 |
|
2017 |
"Breakout Session V: Your Research and Thesis" at the Society for Reproductive Endocrinology & Infertility (SREI) Annual Fellow Retreat, Park City, UT, Aug 12 |
|
2017 |
Health Risks & Male Infertility: Towards an Ideal Database" NIH Symposium on Andrology, Rockville, MD, Aug 25 |
|
2017 |
"Male Infertility for Epidemiologists" NIH Symposium on Andrology, Rockville, MD, Aug 25 |
|
Local/Regional |
|
|
2017 |
Male Infertility for the IVF RN. Presented at Reproductive Medical Associates of New Jersey, Basking Ridge, NJ, March 7. |
|
2017 |
Male Factor Infertility: Where Do We Go From Here. Utah Infertility Conference, Sandy, Utah, Oct. 7. |
Grand Rounds Presentations
|
2014 - 2015 |
Presenter. Hypogonadism. University of Utah Urology Grand Round, Salt Lake City, Utah |
|
2014 - Present |
Presenter. Fertility Overview. University of Utah Urology Grand Rounds, Salt Lake City, Utah |
|
2015 |
Presenter. Men's Health for the Patient and the Provider. Grand Rounds, Elko Nevada Regional Health Center, Elko, NV |
|
2017 |
"Male Factor Infertility In The Setting of IVF Failure: Diagnosis & Treatment at Reproductive Medicine Associates of New Jersey, Basking Ridge, NJ, Sept 5 |
|
2017 |
Presenter. The Other half: Male Infertility & The Sins of our Fathers. Grand Rounds OBGYN. University of Utah, Salt Lake City, Utah |
|
2018 |
Presenter. Erectile Dysfunction Management. University of Utah Urology Grand Round, Salt Lake City, Utah |
|
2018 |
Presenter. Male Infertility: A Window Into Men’s Health. Grand Rounds, Lakeview Hospital, Salt Lake City, Utah. |
Outreach Presentations
|
2013 |
Presenter, Utah Fertility Center, Men's Health for the Patient and the Provider. |
|
2013 |
Presenter, Granger Medical West Jordan, Men's Health for the Patient and the Provider. |
|
2013 |
Presenter, Riverton Hospital, Men's Health for the Patient and the Provider. |
|
2014 |
Presenter, Utah Valley University, Student Health Center, "5 Myths of Male Infertility" |
|
2014 |
Presenter, Utah Infertility Awareness, Men's Health for the Patient and the Provider. |
|
2014 |
Presenter, South Valley Women's Health Care, Men's Health for the Patient and the Provider. |
|
2014 |
Presenter, Villas at Jordan Landing, Men's Health for the Patient and the Provider. |
|
2014 |
Presenter, St. Mark's Hospital, Men's Health for the Patient and the Provider. |
|
2014 |
Presenter, Jordan Meadows Medical Center, Men's Health for the Patient and the Provider. |
|
2014 |
Presenter, Wade Family Medicine, Men's Health for the Patient and the Provider. |
|
2014 |
Presenter, Lakeview Hospital, Lakeview OB/GYN |
|
2014 |
Presenter, Intermountain Medical Center, Intermountain OB/GYN Outreach |
|
2014 |
Presenter, Salt Lake Regional Medical Center, Men's Health for the Patient and the Provider. |
|
2014 |
Presenter, Cottonwood Hospital, Cottonwood OB/GYN Outreach Talk |
|
2014 |
Presenter, University of Utah Health Care, Marketing and Outreach for Male Infertility |
|
2014 |
Presenter, Central Utah Clinic, Central Utah Clinic Women's center Outreach Talk |
|
2015 |
Presenter, Utah Department of Health, Erectile dysfunction in diabetes |
|
2015 |
Presenter, Reproductive Care Center, Utah Infertility Journal Club Outreach Talk |
|
2015 |
Presenter, Rocky Mountain Women's Health Center, Men's Health for the Patient and the Provider. |
|
2015 |
Presenter, Tanner Clinic, Men's Health for the Patient and the Provider. |
|
2015 |
Presenter, Brigham Young University, Student Health Center, "5 Myths of Male Infertility" |
|
2015 |
Presenter, University of Utah Health Care, Men's Health for the Patient and the Provider. |
|
2018 |
Presenter, University Health Care System, Erectile Dysfunction Causes and Treatments |
OTHER SCHOLARLY ACTIVITIES
Other Scholarly Activities
|
2012 - Present |
Andro360, Salt Lake City, Utah. Co-founder of a medical device company making a non-invasive wearable ring to monitor penile erectile function. Company has one issued patent, has been through multiple incubators and is raising a SEED round as well as moving forward with a clinical trial. |
|
2013 - Present |
StreamDx Inc. |
|
2016 - Present |
NANONC Inc., Salt Lake City, Utah. Co-founder of a microfluidic sperm sorting company with Bruce Gale, Doug Carrell, Tim Jenkins, Ki Aston and Raheel Samuel. Company has received a SSTR grant, had a funded SBIR grant that was declined due to overlap with SSTR grant and has one full time and four part time employees. We have two pending patents and received a Fast Track Phase I/II NIH SBIR funding at $1.6M in 2017. |
Peter Humaidan
Professor Peter Humaidan is a specialist in reproductive endocrinology, professor at The Fertility Clinic Skive Regional Hospital, Aarhus University, Denmark and Honorary professor at Odense University, Denmark. During his scientific work he has primarily focused on developing individualized treatment protocols for the infertile patient. His doctoral thesis (DMSc) explored the role of LH during the follicular and luteal phases in controlled ovarian stimulation. His main fields of interest are triggering of ovulation with GnRH agonist, role of LH during the follicular and luteal phases, role of the female genital tract microbiota for reproductive outcomes, OHSS prevention, and role of sperm DNA fragmentation for spontaneous and assisted reproduction. He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group” who introduced the GnRHa trigger in modern IVF, changing trigger policies worldwide. Moreover, he is co-founder of the POSEIDON group which suggested a new stratification of the poor responder patient. Finally, he is past board member of the ESHRE SIG Endocrinology Group. He authored and co-authored 230 + articles (H-index 60, Google Scholar) in international peer reviewed journals as well as the Danish guidelines for OHSS prevention, and chapters in textbooks. Peter Humaidan has a wide international scientific network and is frequently invited as a speaker at international conferences.
Juan Carlos Izpisua
Juan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte, previously the Roger Guillemin Chair and Professor in the Gene Expression Laboratory at Salk Institute for Biological Studies, is currently the scientific founder of Director of Altos Labs Institute of Science in San Diego. During life’s early stages cells display high levels of plasticity, regeneration and resilience against stress, disfunction and injury, which are key features of human health. Dr. Juan Carlos Izpisua Belmonte, has contributed towards understanding the molecular basis underlying embryogenesis and early postnatal life, as well as gained insights into how to program and rejuvenate adult and diseased cells. He is developing technologies to program cells to states similar to those observed in the early, healthy stages of life, with the objective of developing universal health therapeutics to overcome human disease.
Chaim Jalas
Chaim Jalas
COO & Director of Technology Development – Juno GeneticsChaim Jalas has been an active researcher and investigator in the area of Genetics and Fertility since the start of his career more than 15 years ago. With over 50 peer reviewed publications, he has played a significant role in the development of multidisciplinary research, technology and clinical research in the area of Genetics and Fertility. He has been named Principal Investigator or Co-investigator for numerous studies conducted at prestigious institutions such as the Broad institute of MIT and Harvard in Boston and Hadassah Medical Center in Jerusalem. He served on the board of Columbia University’s genomics IRB.
Csilla Krausz
Csilla Krausz
Current job: Professor in Endocrinology and research team leader at the University of Florence, Italy and co-director of the Florence European Academy of Andrology (EAA) Training Center in Andrology Responsible for the Rare Endocrine diseases of the University Hospital of Careggi.
Education: obtained her MD cum laude in 1990 and her specialization in Endocrinology in 1995 at the University of Florence, Italy, and her PhD in Human Genetics in 2001 at the Pasteur Institute/University Paris 7, France.
Research activity : her major scientific achievements concern the discovery of many genetic factors of male infertility (with specific focus on meiotic genes), X and Y chromosome-linked CNVs (deletions) and the identification of their clinical significance. Has authored > 150 scientific publications in international peer-reviewed journals and her H-index:66 (Google scholar); H-index=57 (Scopus). According to a recent worldwide survey, she is among the top 20 most productive authors on male infertility research from 1995.
Honors & Recognitions: She is an Academician of the EAA and was the President of the EAA from 2014-2022. Currently chair of the EAA Clinical andrologist Examination and the Accreditations Committee. She has served the European Society of Endocrinology as the Clinical Lead of the Reproductive Endocrinology focus area from 2017-2021.
Elena Labarta
Current Job
Dr. Elena Labarta. MD, Ph.D, is an attending physician at Valencian Institute of Infertility (IVI), Valencia, Spain, where she serves as a specialist in Human Reproduction and Assisted Reproductive Techniques, and as a surgeon specialized in Endoscopic surgery since 2005. Since 2008, she is associate professor and medical coordinator of several Master related to Human Assisted Reproduction by the University of Valencia.
Education and Training
| MD | The University of Zaragoza | 2000 |
| Residency OBGYN | The Autonomous University of Madrid | 2005 |
| Master (first cycle) in Research on Health Sciences | The Autonomous University of Barcelona | 2008 |
| Master in Advanced Gynaecological Endoscopic Surgery | The University of Valencia | 2009 |
| Doctoral Degree (Ph.D) | The University of Valencia | 2014 |
| Master Level in Reproductive Endoscopic Surgery | The European Academy of Gynaecological Surgery and ESGE (GESEA Programme) | 2017 |
Research activity
Dr. Labarta has participated in several clinical research projects and has contributed to over 25 publications on assisted reproduction in peer reviewed international journal and written more than 45 book chapters. She is an international speaker. Dr. Labarta was awarded a Doctor Cum Laude in Medicine, University of Valencia in 2014, the title of her thesis being “Influence of Ovarian stimulation during in vitro fertilization treatment on the incidence of embryo aneuploidies”. Dr Labarta´s research is now focused on the predictive value of luteal serum progesterone levels in ART; Ovarian Stimulation and Embryo Quality; Uterine Evaluation and treatment in infertile patients, and the impact of autologous mitochondrial transfer on Oocyte and Embryo Quality in IVF Patients, among others.Honors and Recognition
- As a co-author, she received the Scientific Program Prize Paper Award at the 2008 Annual Meeting of the American Society for Reproductive Medicine (ASRM).
- Golden Medal “Foro Europa 2001”, for her professional career. 2015, Madrid.
Joop Laven
Short CV Professor Joop S.E. Laven
Professor of Reproductive Medicine, Erasmus Medical Centre, Rotterdam The Netherlands.
Professor Joop S.E. Laven is professor in Obstetrics and Gynaecology and subspecialist Reproductive Endocrinology and Infertility and he holds the chair of the Division of reproductive Endocrinology and Infertility of Erasmus University Medical Centre in Rotterdam The Netherlands. He is a member of ESHRE, ASRM, the Endocrine Society, the Society of Gynaecological Investigation (SRI) and the Royal Dutch College of Obstetrics and Gynaecology. He is the president of the Androgen Excess-PCOS Society.
For many years he had a particular interest in the management of polycystic ovary syndrome covering the full spectrum from the effects of the syndrome during adolescence and adult life on the menstrual cycle, fertility, body weight and cosmetic aspects. During the last decade the research focussed on more fundamental genetic background of ovarian ageing with POI and PCOS as extremes in this spectrum. As such he was one of the founders of the i-PCOS consortium and was also involved in Genome Wide Association Studies (GWAS) exploring the genetic basis of menarche and menopause as well as PCOS, and POI.
Clinical work focuses on women’s health in particular reproductive endocrinology and menopause as well as on infertility treatment and ART and pregnancy outcome in infertile couples especially women with PCOS. He is the person responsible for the Rotterdam Erasmus MC Reproductive Medicine Unit, which performs approximately 2500 IVF cycles, 400 IUI cycles and about 150 cycles of ovulation induction per annum. Within the outpatient clinic of the unit about 10,000 individual patient visits take place on a yearly basis.
He has published over 350 peer-reviewed papers and several reviews as well as chapters in books, and has delivered over 300 lectures to international scientific audiences. He is a visiting professor at the University of Shandong, Shandong, China. He is also a member of the international guideline groups for PCOS, POI and unexplained infertility within the Center of Research Excellence (WHIRL) Monash University, Melbourne, Australia.
Nicholas Macklon
Current Job
- Medical Director, London Womens Clinic, London UK
- Profoessor of Obstetrics and Gynaecology, Zealand University Hospital, University of Copenhagen, Denmark
- Specialist training in Edinburgh
- Doctoral thesis research Glasgow
- Senior Lecturer, Erasmus Medical Centre Rotterdam
- Professor, Utrecht Medical Centre 2005-2009
- Professor, UNiversity of Southampton, 2009-2017
- Endometrial- embryo signalling
- Recurrent implantation failure
- Periconceptional determinants of fertility and health
- Florey Prize Lecture, University of Adelaide
- Diksfaluzy Prize Lecture, Karolinska Institute
- John Collins Prize Lecture, Canadian Andrology and Fertility Society
Svetlana Madjunkova
Svetlana Madjunkova
Biosketch
Dr Svetlana Madjunkova is Senior Director and Head of Reproductive Genetics Department at CReATe Fertility Centre Toronto, Canada and adjunct faculty with Department of Laboratory Medicine and Pathobiology, Temetry Faculty of Medicine, at University of Toronto. She holds an MD degree with honors and MSc and PhD in reproductive genetics. She also has completed fellowships in advanced prenatal diagnosis Mount Sinai and SickKids Hospitals in Toronto. She has been dedicated and actively working in the field of reproductive genetics for more than 15 years.
Her laboratory is uniquely positioned to provide advanced clinical preimplantation testing; fertility related genetic testing and translate research and new genomic technologies into clinical tests. Dr Madjunkova and her team developed PGT-SR test for couples with balanced rearrangements and are leading the clinical adaptation of non-invasive PGT testing. Her research team works on projects aimed at improving embryo selection, preimplantation testing and further research in reproductive failure and improving outcomes in ARTs. Her interest is in the development of novel technologies for non-invasive and comprehensive multi-omic assessment of embryos and fetuses and well as in the parental genetic and epigenetic contribution to developing embryo, fetus and offspring. She is leading an International collaborative effort to study the effects of mosaicism on early embryo development and short- and long- term consequences on child development.
She has published over 50 peer reviewed papers, over 100 scientific communications and frequent speaker at National and International meetings. Dr Madjunkova is a recipient of many awards and fellowships and recognized for her educative work.
Dr Madjunkova is co-directing Reproductive Genetics course for the Master of Health Sciences program in Clinical Embryology with the Department of LMP and is actively involved in reproductive genetics training for Genetic counselling students from MSc program at University of Toronto, supervising graduate, postgraduate students and REI fellows.
Dr Madjunkova is a member of the Board of Directors of Canadian Fertility and Andrology Society and the Preimplantation Genetic Diagnosis International Society.
Marcos Meseguer
Marcos Meseguer
SHORT BIO
Dr. Marcos Meseguer received his Biological Sciences Degree from the University of Valencia in Spain. He performed a pre-doctoral fellowship in St Mary´s Hospital, Manchester University, United Kingdom. He received his Ph.D. Degree in Obstetrics and Gynecoloy and the European Doctor Degree in 2002 from the University of Valencia, Spain. He has also a master degree in Research Methods; Design and Statistics from Universidad Autónoma de Barcelona, Spain.
Actually is Scientific Supervisor and Senior Embriologist in the IVF unit of IVIRMA Valencia. Dr. Meseguer has received and nominated twice the prize paper of the American Society of Reproductive Medicine (ASRM), Four times the Star Award from ASRM. Three times the Lalor Foundation International Award from the American Society of Andrology, three times the research award from the Spanish Society of Fertility and 5 times the research award from the Spanish Society of Embriology. He received the Robert Edwards prize paper award from RBM on line and was ASRM star award winner. The primary areas of his research are embryology and male infertility.
As Principal Investigator, his work has been funded through 25 projects sponsored by the Spanish Government, including 10 EUREKA. Horizon 2020 EUROSTAR projects (granted to high quality technological projects) supported by the European Community). He has two international patents.
He is part of the group of researchers most cited in the world according to Standford University has published over 175 scientific articles, with 9135 citations and h-index of 53, including the most cited paper in Human Reproduction. Additionally published 70 reviews or book chapters, edited the first time-lapse book and made more than 700 presentations at national and international congresses. He has been the Director of 16 Doctoral Thesis all qualified with "Cum Laude", and actually is directing 7 PhD candidates.
He is also Statistics Advisor of Equipo IVI and Associate Professor of the Master in Biotechnology from Valencia University.
Tom Molinaro
Tom Molinaro
Dr. Molinaro is the Director of IVI America and Physician Partner of RMA of New Jersey. Dr. Thomas Molinaro is a board certified Reproductive Endocrinologist, Obstetrician and Gynecologist, as well as Clinical Assistant Professor for the Department of Obstetrics, Gynecology, and Reproductive Science at Rutgers-Robert Wood Johnson Medical School. He holds a Master of Science degree in Clinical Epidemiology from the University of Pennsylvania and earned his medical degree from New Jersey Medical School – University of Medicine and Dentistry of New Jersey. He completed his Obstetrics and Gynecology residency and fellowship training in Reproductive Endocrinology at the Hospital of the University of Pennsylvania. His areas of specialty include assisted reproductive technology and treatment of ectopic pregnancy.
Scott Morin
Scott Morin
Dr. Scott J. Morin is a recognized leader in infertility care and the author of numerous scientific publications and international presentations. His research has contributed to significant advances in infertility treatment that improve patient outcomes, and he has been the recipient of several awards, including the Society for Reproductive Investigation’s President’s Presenter Award (2018) and the Society for Male Reproduction and Urology’s Traveling Scholar Award (2017). Dr. Morin has also been awarded the Prize Research Presentation at the American Society for Reproductive Medicine (2016) and the College for Reproductive Biology (2016).Dr. Morin completed his Reproductive Endocrinology and Infertility (REI) fellowship at Reproductive Medicine Associates of New Jersey (RMANJ), during which he trained as an embryologist, earning the distinction as a Technical Supervisor of the Andrology and Embryology laboratories. He completed his OB/GYN residency at New York University School of Medicine in New York City and received his M.D. from the University of California, Irvine. He has published research on the most vital parts of the In Vitro Fertilization (IVF) process, from single embryo transfer and pre-implantation genetic screening to optimal oxygen concentrations for embryo growth during fertilization.
Santiago Munne
Ph.D. in Genetics from Pittsburgh University. In 1993 he developed the first Preimplantation Genetic Test for Aneuploidy (PGT-A) (1994, 1995 SART prizes). As PGT director of IRMS-Saint Barnabas he developed PGT for translocations (1996, SART prize), and demonstrated that PGT-A reduces miscarriages and increases implantation rates (1998 SART prize). Santi has published >260 scientific publications, received SART and ASRM prize papers in 1994, 1995, 1998, 2005, 2015, 2016, 2020, SRBT in 2022 and the ASRM Star Award consecutively for 2011-2022.
In 2001 founded Reprogenetics with Jacques Cohen and David Sable, and as its CEO Reprogenetics became the first commercial US PGT laboratory, performing over 100K procedures. Reprogenetics was sold in 2016 to Cooper Companies (NYSE: COO).
In 2011 he co-founded with Alex Bisignano Recombine, which offered genetic carrier screening and was bought by Cooper Companies in 2016, together with Genesis Genetics. These companies became CooperGenomics and Dr. Munné became its CSO.
He has also co-founded MedAnswers with CEO Alice Crisci, an infertility digital health platform, and the genomics company Phosphorus with Alex Bisignano, providing comprehensive germ-line genomics panels.
In 2017 he joined Martin Varsavsky and Joson Horcajadas to co-found Overture Life, a company focused on automating the IVF Laboratory and to which day he is its Chief Innovation Officer. In 2020 co-founded HoMu invest, an accelerator for early-stage biomedical research specialized in reproductive medicine, such as SAMA, Butterfly Bio and GenEmbryomics. He serves in several Board of Advisors of companies in reproductive medicine.
Craig Niederberger
Dr. Craig Niederberger is Clarence C. Saelhof Professor and Head of the Department of Urology in the College of Medicine at the University of Illinois at Chicago and holds a joint appointment as Professor in the Department of Bioengineering in the College of Engineering. He was Co-Editor in Chief of Fertility and Sterility and a prior section editor for the Journal of Urology. He is a primary editor of the fourth and upcoming fifth editions of Infertility in the Male. He served as general program chair for the American Society for Reproductive Medicine's annual meeting in Atlanta in 2009 and has served as president of the Society for the Study of Male Reproduction within the American Urological Association and as president of the Society for Male Reproduction and Urology within the American Society for Reproductive Medicine.
Alberto Pacheco
Dr. Alberto Pacheco
Dr. Pacheco is the Director of the Andrology Laboratory and the Sperm Bank at IVI Madrid, IVI Valladolid and IVI Salamanca. He is also assistant professor of Immunology at Alfonso X “El Sabio” University in Madrid since 2000. He completed his Bachelor’s degree in Biology in 1992, and obtained his Ph.D. in Biological Sciences in 1997, both from the Complutense University, in Madrid. He also received a Masters degree in Reproductive Medicine in 2005.As a researcher, his areas of interest includ molecular markers of male and female infertility, sperm DNA fragmentation, laboratory QA/QC, peripheral and uterine natural killer (NK) cell characterization in women with recurrent miscarriages and implantation failure. Dr Pacheco has published over 25 original peer review articles in leading reproductive journals, many of these were in Immunology journals. He also contributed several book chapters and made over 80 presentations at national and international scientific meetings.
Dr. Pacheco is the recipient of several grants from public and private organizations in Spain (FIS Projects, CDTI), and serves as reviewer in reproductive journals including Fertility Sterility, RBM online, Asian Journal of Andrology, Journal of Assisted Reproduction and Genetics and Journal of Cellular and Molecular Medicine. He has also served on the executive board of Andrology Special Interest Group in the Spanish Society for Reproductive Biology (ASEBIR).
Dr. Pacheco has been involved in teaching since his early career, and has a number of teaching commitments. He is among the faculty for a number of post graduate/Masters courses in Human Reproduction, provided by Spanish Fertility Society, Rey Juan Carlos University of Madrid, University of Valencia, and Europea University of Madrid. Dr. Pacheco is also the coordinator of Immunology courses for students enrolled in Medicine, Pharmacy and Veterinary degrees at Alfonso X “El Sabio” University of Madrid.
Richard Paulson
Richard J. Paulson, MD, MS
Dr. Richard Paulson holds the Alia Tutor Chair in Reproductive Medicine and is Professor and vice-chair in the Department of Obstetrics and Gynecology. He is Chief of the Division and Director of the Fellowship in Reproductive Endocrinology and Infertility. Dr. Paulson received his BS degree in Physics and MD degree from UCLA. He completed residency in Obstetrics & Gynecology at Harbor-UCLA Medical Center and fellowship in Reproductive Endocrinology and Infertility at LA County-USC medical center. He returned to graduate study six years later and obtained an MS degree in Biostatistics and Study Design from USC.
Dr. Paulson is past president of the American Society for Reproductive Medicine, of the Pacific Coast Reproductive Society, the Society for Reproductive Endocrinology and Infertility and the Los Angeles Obstetrical and Gynecological Society. He is the Editor-in-Chief of “Fertility & Sterility Reports” and past deputy editor of “Fertility and Sterility.” Dr. Paulson has authored over 200 scientific articles and has received more than 35 research awards for scientific publications.
Nuria Pellicer
Nuria Pellicer
Dr. Pellicer has participated as a researcher in several clinical research projects, including phase II and phase III clinical trials. She has given more than 25 national and international lectures and has published more than 20 scientific articles and 6 book chapters. Her current research areas are based on ovarian rejuvenation with autologous stem cells and platelet-rich plasma, in patients with low ovarian reserve and premature ovarian insuficiency, compression of the origin of preeclampsia in assisted reproduction treatments, analysis of the effect of expression of proteins in patients with PCOS. She completed her Doctorate in Medicine in 2020, receiving the recognition of CUM LAUDE. She is also one of the coordinators of 4 different masters: Master Oficial en Biotecnología de la Reproducción Human Asistida, Master Degree in the Biotechnology of Human Assisted Reproduction and Embryology, Máster de Formación Permanente Bases Teóricas y Procedimientos de Laboratorio en la Reproducción Asistida, Máster de Formación Permanente en Reproducción Human.
Laura Rienzi
Associate Professor, Department of Biomolecular Sciences, University of Urbino “Carlo Bo”, Italy Director of the Scientific Executive Committee of GeneraLife and co-founder of Genera
With 30 years’ experience in human assisted reproduction technologies, pre-implantation genetic testing and cryopreservation of human oocytes, sperm and embryos, Laura Francesca Rienzi is the Director of the Scientific Executive Committee of the GeneraLife network of IVF clinics in Europe.
Laura obtained her degree in Biology magna cum laude at the University of Rome “La Sapienza", and a Master degree and a Course of Specialization in Reproductive Medicine at the University of Padua.
She has authored >230 articles (Scopus Index 57), reviews and book chapters, she has also been invited to speak in >330 national and international scientific meetings and has won several awards regarding fertility investigation and innovation.
In 2008 she founded together with Dr. Filippo Maria Ubaldi the Genera IVF centers, with 4 different locations in Italy, where she’s been Laboratory Director.
Since 2016, she’s been Adjunct Professor of Biotechnology in Assisted Reproduction at the Faculty of Biology, University of Urbino “Carlo Bo”, Italy. Since 2022, she was appointed as Associated Professor, Department of Biomolecular Sciences, University of Urbino “Carlo Bo”, Italy.
In 2020, she was actively involved in the creation of GeneraLife, a network of >30 clinics in 5 different countries in Europe: the name GeneraLife was inspired by the group she founded 12 years before.
Dennys Sakkas
Dr. Denny Sakkas received his undergraduate training at the University of Melbourne, Australia and received his Doctorate of Philosophy at Monash University, Melbourne, Australia. His Ph. D. was performed at one of the leading Reproductive Research Units in the world.Dr. Sakkas has been the Laboratory Director of IVF units in Switzerland, England and the USA. He has aided numerous groups in establishing their own IVF units around the world. He has extensive experience in clinical IVF and reproductive research. He is internationally recognized, having organized conferences and workshops on reproduction related topics, and is frequently invited as a speaker at major conferences worldwide. He has published more than 150 peer reviewed manuscripts and chapters in the field of fertilization, early embryo development and male infertility. He has been extensively funded in his career and has led productive basic research groups investigating many aspects of gamete and embryo biology.He also served as Chief Scientific Officer of Molecular Biometrics Inc. and was part of a team raising venture capital funding to develop a novel platform to non-invasively assess embryo viability. Dr Sakkas is currently Scientific Director at Boston IVF and remains as an Associate Professor at the Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale University School of Medicine.
Emre Seli
Emre Seli, MD
Emre Seli, MD, is Professor of Obstetrics, Gynecology, and Reproductive Sciences and Medical Director of Yale Reproductive Endocrinology and Infertility Division. He is also the Research Director of IVI-RMA USA and the Chief Scientific Officer of March of Dimes. Dr. Seli received his medical degree from the University of Istanbul and completed his Residency in Obstetrics and Gynecology at Yale University. His postdoctoral training included a fellowship in Reproductive Endocrinology and Infertility as well as a research fellowship in molecular biology, both at Yale University. His laboratory characterized the mechanisms regulating translational activation of gene expression in the oocyte. Dr. Seli and his colleagues also made seminal contributions to our understanding of oocyte and embryo senescence and competence. Dr. Seli is the recipient of many National Institutes of Health (NIH) and pharmaceutical industry-sponsored research grants. He has trained more than 100 pre- and post-doctoral fellows, and published more than 150 scientific articles. In addition, he edited five books including the 9th edition of “Speroff’s Clinical Gynecologic Endocrinology and Infertility“. Dr. Seli is the recipient of the “Ira and Ester Rosenwaks New Investigator Award” from the American Society for Reproductive Medicine (ASRM), and the “President’s Achievement Award” from the Society for Reproductive Investigation (SRI). In addition his work has been shortlisted for nineteen major conference prizes (ASRM and SRI), winning sixteen. He currently serves on the boards of several international journals and professional societies.
Henriette Svarre Nielsen
Henriette Svarre Nielsen
EDUCATION
2015 Specialist in Reproductive Medicine
2014 Specialist in ObGyn Auth. ID 00SW4
2012 DMSc in Medicine, University of Copenhagen (UCPH)
2001 MD, UCPH
SCIENTIFIC ACTIVITIES
My research focuses on reproductive and women’s diseases specifically (recurrent) pregnancy loss and infertility with a motivation to understanding the underlying pathophysiology and use this knowledge for diagnostics, prognostics, and treatments. My research group is international and rapidly growing. We are successful in designing and running extensive and ambitious clinical investigations with a range of collaborators within genetics, microbiome, endocrinology, and immunology. We bridge basic, epidemiological, and clinical research including several randomized controlled trials.
PUBLICATIONS
112 pubmed indexed and 5 in press publications including our latest in The Lancet. H-index 39; i10-index 67 (google scholar)
PRIMARY INVESTIGATOR (Total sum of research grants > 80 mill DKK)
AWARDS
2013 Best doctoral thesis 2012 (DMSK), 2013 Best thesis in OB/GYN 2012 (Karl Brogaards prize)
SUPERVISION
Post Docs: 7, PhD students: 12 of which 4 have successfully defended their thesis
ACADEMIC ASSESSMENTS
PhD: 5, Professorship: 3, Professor renewal: 8, Associate Professorship: 6
COMMISSION OF TRUST
Representing all Prof. and ass. Prof. in Ob/Gyn at UCPH (Ordførende Professor), Executive board ReproUnion www.reprounion.eu, Coordinator SIG, ESHRE www.eshre.eu, Steering group postgraduate PhD Program SUND “life cycle in medicine”, Founder and Chairperson Maternity Foundation www.maternity.dk Aim: Saving lives in childbirth.
Jason Swain
- Current Job: Chief Lab Officer, President of Laboratory Operations, CCRM Fertility
- Education & Training : BS- Hillsdale College, MS – Purdue University, PhD- University of Michigan
- Research Activity: Improvement of preimplantation embryo culture and ART outcomes through modifications of the chemical and physical environment and via use of new technologies
Filippo Ubaldi
Filippo Maria Ubaldi is the Scientific Director of GeneraLife, International Reproductive Medicine network (more than 30 Centres in Italy, Spain, Sweden and Czech Republic).
He is also Member of the Technical Table for in-depth study of issues related to medically assisted procreation, established by the Italian Ministry of Health on January 2023.
With academic degrees in Ob & Gyn, Masters in Andrology and Reproductive Medicine, PhD in Andrology at the Vrije Universiteit Brussel, he is also intensely dedicated to scientific activity.
Author and co-author >230 scientific papers with Scopus H-index of 56, he has been invited as speaker at >600 National and International congresses on the topic of Reproductive Medicine. Member of the ESHRE Executive Committee during 2005-2009, he has been Chairman of the 26th ESHRE Annual Meeting held in Rome in June 2010.
In 2008 he founded together with Prof. Laura Rienzi the Genera IVF centers, with 4 different locations in Italy, where he’s been Clinical Director.
In 2014 and 2019 he received the Italian National Scientific License as full Professor in Obstetrics and Gynaecology and at the present is the Chairman of the Italian Society of Fertility and Sterility (SIFES).
In 2020, he was actively involved in the creation of GeneraLife, a network of >30 clinics in 5 different countries in Europe: the name GeneraLife was inspired by the group he founded 12 years before.
For further information link to:
http://www.generaroma.it/equipe/direzione-clinica-dott-filippo-maria-ubaldi/
Antonio Urda
Antonio Urda
Doctor in Medicine, Orthopedics and Trauma Surgeon. He trained and worked for years in one of the greatest hospitals in Madrid, where he developed his passion for training, innovation and challenges.Once he became a doctor, Antonio could also spend part of his time in his second expertise, technology.
By keeping contact with the hospital environment, he continues identifying current healthcare problems and limitations, contributing with Savana to ensure that technological advances are created based on real needs and reaching those who really need them, the patients
Frauke Von Versen-Höynck
- Associate Professor of Ob/Gyn, Division of Gynecologic Endocrinology and Reproductive Medicine, Hannover Medical School, Germany
- Head of Research Group Molecular Perinatology
- MD from Humboldt University, Berlin, Germany in 2001
- Doctoral degree (Dr. med.), Humboldt University, Berlin, 2003
- Residency in Ob/Gyn at the University Hospitals in Aachen (2001-2005) and Hannover (2009-2012), Germany
- Postdoctoral Fellowship at University of Pittsburgh, USA working on preeclampsia pathophysiology (2005-2009)
- MSc in Clinical Research from University of Pittsburgh, USA, 2009
- Habilitation (2nd, doctoral degree/PhD), Hannover Medical School, 2010
- Fellowship in Gynecologic Endocrinology and Reproductive Medicine at Hannover Medical School, 2012-2014
- Visiting Associate Professor at Stanford University (2014-2018) working on preeclampsia risk and pregnancy outcomes after infertility
- Established research group Molecular Perinatology at Hannover Medical School with focus on pregnancy complication preeclampsia
- Research interest in impact of assisted reproduction on maternal and offspring health
Dagan Wells
Professor Dagan Wells has been involved in the diagnosis of inherited disorders in human embryos (preimplantation genetic testing - PGT) and research into the earliest stages of development for almost three decades. He spent several years at University College London, where he accomplished the first comprehensive chromosome analysis of cells from human embryos. This work revealed the remarkable spectrum of cytogenetic abnormalities that exist during the first few days of life and received the ASRM General Program Prize in 1999. Dagan later joined the faculty of Yale University and also served as a Laboratory Director for Reprogenetics, at the time the largest provider of PGT services in the world, establishing its monogenic PGT program. Dagan now serves as Director of Juno Genetics, a state-of-the-art clinical diagnostics laboratory based in Oxford (UK), offering PGT, non-invasive prenatal testing and other genetic tests related to infertility and pregnancy. Dagan also continues to teach and direct research at the University of Oxford where he is a Professor within the Nuffield Department of Women’s and Reproductive Health. Dagan’s work has frequently been noted for its innovation and has led to the publication of over 200 scientific papers. In the last decade his work has been shortlisted for eighteen major conference prizes (ASRM and ESHRE), winning ten. Dagan has been elected to fellowship of the Royal College of Pathologists, the Royal Society of Biology, the Royal College of Obstetricians and Gynaecologists and the Institute of Biomedical Science. He currently serves on the Boards of several international journals and professional societies.
Important Dates
- ABSTRACTS
Abstract Submission form will end on
March, 15th 2023 - REGISTRATIONS
Early Bird Registration until
February 21st, 2023
The organization of the congress has agreed with RENFE (the national Railway Company) a 5% discount for the train tickets for national round trips for all participants. The discount will be available between April 18th – April 24th (both inclusive). In order to obtain the discount you need to be registered to the Congress.
Maria Cubí, 4 - Pral | 08006 Barcelona (SPAIN)
Tel. +34 932.388.777
IVI | All rights Reserved.